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 1 
1 Introduction 
In consideration of a decreasing availability of non-renewable resources along with a heightened 
awareness for environmental aspects, the development of sustainable synthetic methods is 
currently a major goal of chemists. Therefore, novel, safer and environmentally-benign 
procedures for the synthesis of compounds with applications in pharmaceutical and 
agrochemistry, functional materials, and a plethora of other areas continue to be of great interest. 
Catalysis represents one important technique for the minimization of the environmental footprint 
as was already recognized by Anastas and Warner in their 12 Principles of Green Chemistry.[1] 
Furthermore, the application of catalytic instead of stoichiometric transformations inherently 
reduces the amount of waste, which was declared as another principle. 
Catalysis does not only offer advantages in terms of ecological aspects, but also economic benefits 
can be gained. Indeed, employing selective catalytic transformations usually allows for robust and 
broadly applicable syntheses of compounds of interest, such as drugs and functional materials, 
along with a minimized formation of side-products under mild reaction conditions, thereby 
resulting in a cost-effective synthetic strategy. 
 
1.1 Transition Metal-Catalyzed C–H Activation 
The development of novel strategies for the selective and efficient construction of C–C and C–Het 
bonds continues to be in high demand. Especially the functionalization of arenes is of key 
importance in organic synthesis, due to the ubiquitous occurrence of decorated arenes in natural 
products and bioactive molecules, among others.[2] 
Although classical methods for the synthesis of substituted arene moieties are well-known for 
many years, these methods often suffer from significant drawbacks, including harsh reaction 
conditions and the necessity for stoichiometric reagents. A major breakthrough was achieved in 
the 1970s and 1980s with the development of palladium-catalyzed cross-coupling reactions. 
Kumada-Corriu,[3] Negishi,[4] Stille,[5] Suzuki-Miyaura,[6] and Hiyama[7] cross-coupling reactions 
provide access to arylated, alkylated and alkenylated compounds, while alkenyl- and alkynyl-
substituents can be introduced via Mizoroki-Heck,[8] and Sonogashira-Hagihara[9] reactions, 
respectively. Since these reactions have undoubtedly vastly expanded the toolbox of organic 
synthesis and found numerous applications in academia as well as in industry,[10] the contributions 
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of R. F. Heck, E.-i. Negishi, and A. Suzuki were recognized with the Nobel Prize in Chemistry in 
2010.[11] 
Despite these undisputable advances, cross-coupling reactions still poses a number of significant 
drawbacks. Generally, these transformations do not only require the use of organic 
(pseudo-)halides as starting materials, but also rely on highly reactive, toxic and difficult to handle 
organometallic compounds, e.g. RMgX, RZnX or RSi(Alk)3, as nucleophiles. In addition, the 
synthesis of organometallic reagents usually involves tedious multi-step procedures (Scheme 1). 
Furthermore, stoichiometric amounts of environmentally problematic metal-waste are generated 
in the cross-coupling process. In contrast, the selective functionalization of C–H bonds under 
transition metal catalysis has gained enormous momentum over the last decades as an efficient 
and sustainable alternative.[12] In case of direct C–H functionalization, the organometallic reagent 
is replaced by a simple C–H bond, which reacts with an organic (pseudo-)halide, thereby avoiding 
the need for prefunctionalization and greatly improving the step- and atom-economy[13] of this 
process. Additionally, the formation of C–C bonds can be realized by the activation of two C–H 
bonds within a dehydrogenative transformation. Although formally H2 is generated as the sole 
byproduct, the oxidative nature of the C–H/C–H activation manifold requires the use of an oxidant 
in stoichiometric amounts. 
 
 
Scheme 1: Comparison of classical cross-coupling reactions with direct C–H functionalization and 
oxidative C–H/C–H activation. 
 
Excluding outer-sphere/radical-type mechanisms,[14] the key C–H bond activation step of these 
transformations can occur through five distinct mechanistic pathways, which are governed by the 
electronic properties and the coordination environment of the metal center.[15] 
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Scheme 2: Mechanistic pathways for C–H activation. 
 
The oxidative addition of a C–H bond to a metal-complex is usually observed for electron-rich, 
coordinatively unsaturated late transition metals. The corresponding transition state is often 
preceded by the formation of a σ-complex, which is stabilized by an agostic interaction of the        
C–H bond with the metal center (Scheme 2a). σ-Bond metathesis involves the concerted cleavage 
of two σ-bonds and formation of two new σ-bonds without any change in oxidation state of the 
metal center and is the prevalent pathway for early transition metals, especially in a d0 
configuration, as well as lanthanides and actinides (Scheme 2b). With complexes bearing a metal-
ligand multiple bond, e.g. alkylidene or imido ligands, or a formally anionic ligand with significant 
π-donation C–H activation can occur via 1,2-addition of the C–H bond onto the M=X bond. This 
formal [2π+2σ] process is mostly observed for early transition metals (Scheme 2c). For late 
transition metals or post-transition metals, typically in higher oxidation states, C–H activation can 
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proceed via electrophilic substitution. Within this mechanistic pathway, electrophilic attack of the 
metal center on the carbon atom takes place, resulting in the substitution of one proton by the 
metal (Scheme 2d). The base-assisted metalation[16] is observed for complexes bearing 
carboxylate or carbonate ligands and is closely related to the electrophilic substitution 
mechanism, but exhibits significant mechanistic differences. Within this mechanistic manifold, the 
C–H cleavage occurs simultaneously to the formation of a new R–M bond and a transfer of the 
proton to the coordinated base (Scheme 2e). 
Depending on the exact transition state structure and the involved accumulation of partial 
charges,[17] the base-assisted metalation pathway can be further categorized. For a deprotonative 
transition state, the term concerted metalation-deprotonation (CMD) was coined by 
Fagnou/Gorelsky (Scheme 3).[18] The same mechanism, although explicitly including an agostic 
interaction between the C–H bond and the metal center, was also described by Macgregor/Davies 
and named ambiphilic metal ligand activation (AMLA).[15c, 19] Due to the deprotonative nature of 
this pathway, a preferential activation of electron-deficient substrates is observed through kinetic 
C–H acidity control. In contrast, the base-assisted internal electrophilic substitution (BIES) was 
introduced by Ackermann for the preferred activation of electron-rich substrates and proceeds in 
a electrophilic substitution-type pathway.[20] 
 
 
Scheme 3: Comparison of transition state structures in base-assisted metalation. 
 
Due to the omnipresence of C–H bonds in organic molecules and their often comparable acidities 
and bond dissociation energies, selectivity control is one of the major challenges in C–H activation 
chemistry.[21] By exploiting the inherently higher acidities and lower bond dissociation energies of 
certain C–H bonds in heterocyclic compounds,[22] a selective activation of specific heteroaromatic 
C–H bonds can be achieved (electronic bias, Figure 1a). The introduction of sterically demanding 
substituents in the substrate can prevent access to adjacent C–H bonds, thereby enforcing an 
activation of the desired, less hindered C–H bond (steric bias, Figure 1b). Unfortunately, the use 
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of an electronic or steric bias intrinsically limits the number of viable substrates. A more general 
approach is the use a of heteroatom-containing, Lewis-basic directing group (DG), which 
coordinates the metal complex and brings it in close proximity to the desired C–H bond (Figure 
1c).[23] Over the years, a large number of directing groups, such as amides and N-heterocycles, 
were explored for a variety of substrate classes, allowing for example the ortho-selective 
activation of arenes. Furthermore, in many cases the directing group can be removed after the 
transformation (removable or traceless directing group) or transformed into other valuable 
functional groups (transformable directing group).[24] Recently, the use of transient directing 
groups, which are reversibly installed and removed during the catalytic C–H activation, has gained 
considerable interest.[25] 
 
 
Figure 1: Selectivity-control in C–H bond activation. 
 
1.2 Ruthenium-Catalyzed ortho-Selective C–H Alkylation 
During the last decades, transition metal-catalyzed C–H activation chemistry has witnessed an 
enormous development and a multitude of transformations was achieved by means of 4d and 5d 
metal catalysis. In this context, ruthenium-catalysis has proven to be an efficient alternative to 
costly palladium-, rhodium-, platinum- or iridium-based catalysts[26] and, consequently, a plethora 
of methods for ruthenium-catalyzed C–H activation were disclosed.[27] 
The first C–H activation reaction employing ruthenium complexes was already reported in 1965 
by Chatt, disclosing the stoichiometric C–H activation of sodium naphthalene (2) by oxidative 
addition to an in situ generated ruthenium(0)-phosphine complex, thus resulting in the formation 
of ruthenium(II) species 3 (Scheme 4).[28] 
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Scheme 4: Stoichiometric C–H activation of sodium naphthalene (2). 
 
More than 20 years later, Lewis/Smith reported the ruthenium-catalyzed C–H alkylation of phenol 
(5) with ethene (6a) utilizing phosphites as a transient directing group, thereby representing the 
first example of C–H activation under ruthenium catalysis (Scheme 5).[29] Nevertheless, the 
reaction required the use of harsh conditions, led to the formation of mono- and dialkylated 
products and was limited to phenol and ethene as the substrates. 
 
 
Scheme 5: Catalytic C–H alkylation of phenol (5) with ethene (6a). 
 
In 1993, Murai achieved the ortho-selective C–H alkylation of aromatic ketones 8 with alkenes 6, 
employing [RuH2(CO)(PPh3)3] as the catalyst precourser (Scheme 6).[30] A variety of decorated 
ketones and alkenes were smoothly transformed into the alkylated products 9, therefore, 
representing the first broadly applicable method for C–H alkylation in general. Although no 
mechanistic experiments were reported, the authors proposed the formation of the five-
membered ruthenacycle 10 by chelation-assisted oxidative addition, followed by insertion of the 
alkene and subsequent reductive elimination. 
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Scheme 6: Ruthenium-catalyzed C–H alkylation of ketones 8. 
 
Later on, the group of Gunnoe employed a ruthenium-trispyrazolylborate (Tp) catalyst for the 
undirected hydroarylation of ethene (6a) and propene with benzene (11).[31] In a subsequent 
study, thiophene as well as furan were also shown to be viable substrates in the undirected 
hydroarylation manifold (Scheme 7).[32] 
 
 
Scheme 7: Undirected hydroarylation of ethene (6a) under ruthenium catalysis. 
 
In a pioneering study, Ackermann reported the ruthenium-catalyzed direct C–H alkylation of 
arenes 15 with electrophilic primary and secondary alkyl halides 16 (Scheme 8).[33] Optimal results 
were obtained with bulky AdCO2H (17) as the additive and the transformation proved applicable 
to a number of different substrates, including synthetically useful imines. 
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Scheme 8: Direct C–H alkylations with alkyl halides 16. 
 
In a later publication, the group of Ackermann performed a series of mechanistic studies to gain 
insight into the catalyst’s mode of action.[34] Based on these results, the following catalytic cycle 
was proposed (Scheme 9): Starting from ruthenium(II)-carboxylate complex 19, coordination of 
the directing group and reversible C–H ruthenation gives rise to ruthenacycle 21. Afterwards, 
oxidative addition of alkyl halide 16 generates ruthenium(IV) intermediate 22, which then 
undergoes reductive elimination to deliver the C–H alkylated product 18. 
 
 
Scheme 9: Proposed catalytic cycle for C–H alkylations with alkyl halides 16. 
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In 2014, a procedure for ruthenium-catalyzed C–H alkylations of C(sp3)–H bonds was reported for 
the first time by Ackermann.[35] A catalytic system consisting of [RuCl2(PPh3)3] together with 
catalytic amounts of BINAP (24) and AgOTf facilitated the mono-alkylation of N-pyridylpyrrolidines 
23 with various olefins 6 (Scheme 10). 
 
 
Scheme 10: C(sp3)–H alkylations of pyrrolidines 23. 
 
1.3 Ruthenium-Catalyzed C–H Alkenylation 
The synthesis of alkenylated compounds via C–H activation under ruthenium catalysis was 
pioneered by Milstein, who developed a method for dehydrogenative C–H alkenylations of simple 
arenes 26 with acrylates 27 (Scheme 11).[36] The reaction was conducted under a high pressure of 
O2, which acts as the terminal oxidant, and CO, and requires high temperatures. Interestingly, 
comparable catalytic performances were reported with a number of different ruthenium(II) and 
ruthenium(III) complexes. 
 
 
Scheme 11: Oxidative C–H alkenylations of arenes 26 with acrylates 27. 
 
Over the years, the contribution of Milstein inspired many research groups and led to the 
development of numerous ruthenium-catalyzed oxidative C–H alkenylations.[24] In a notable 
example by Satoh/Miura heterocyclic carboxylic acids 29 were efficiently converted to the 
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corresponding alkenylated products 30 using Cu(OAc)2 as the oxidant (Scheme 12).[37] In contrast 
to previous reports for palladium catalysis,[38] the formation of any decarboxylated products was 
not observed. 
 
 
Scheme 12: Oxidative alkenylation of heterocyclic carboxylic acids 29. 
 
Furthermore, in an independent study by Ackermann C–H alkenylations of benzoic acids 31 with 
activated alkenes 32 were realized in water as reaction medium (Scheme 13).[39] Notably, 
phthalides 33 were obtained in an ortho-C–H alkenylation/oxa-Michael regime. Afterwards, this 
methodology was further improved by employing molecular oxygen as the terminal oxidant[40] and 
by the use of biomass-derived γ-valerolactone (GVL) as the reaction medium of choice.[41] 
 
 
Scheme 13: Synthesis of phthalides 33 under ruthenium catalysis. 
 
In 2011, Ackermann presented the synthesis of isoquinolones 36 via ruthenium-catalyzed 
oxidative annulation of benzamides 34 with aryl- or alkyl-substituted alkynes 35 (Scheme 14).[42] 
The best results were obtained with Cu(OAc)2 as the oxidant and protic t-AmOH as the reaction 
medium. 
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Scheme 14: Oxidative annulation for the synthesis of isoquinolones 36. 
 
The groups of Ackermann (Scheme 15),[43] and Jeganmohan[44] independently reported an 
oxidative annulation approach for the construction of isocumarin-scaffolds, employing benzoic 
acids 31 and internal alkynes 35 as the substrates and an in situ generated cationic 
[Ru(OAc)(p-cymene)]+ species as the catalyst. 
 
 
Scheme 15: Oxidative annulation for the synthesis of isocumarins 37. 
 
Both authors proposed the reaction to commence with formation of cationic ruthenium complex 
38, which facilitates the base-assisted ortho-metalation of substrate 31a (Scheme 16). Then, 
migratory insertion occurs to generate the seven-membered ruthenacycle 40. Ensuing reductive 
elimination and reoxidation of ruthenium(0) to ruthenium(II) by copper(II) leads to formation of 
isocumarin 37 and regenerates the catalytically active complex 38. 
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Scheme 16: Proposed catalytic cycle for oxidative annulations of benzoic acids 31. 
 
Ruthenium-catalyzed C–H alkenylations with weakly coordinating substrates via the formation of 
a six-membered ruthenacycles was first explored by Ackermann in the reaction of anilides 41 and 
carbamates 43 with acrylates 27 (Scheme 17).[45] It should be noted that afterwards comparable 
studies were reported by Li/Wang.[46] Shortly after, Jeganmohan disclosed the alkenylation of aryl 
acetates using a similar catalytic system.[47] 
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Scheme 17: Weak O-coordination for ruthenium-catalyzed C–H alkenylations. 
 
1.4 Direct C–H Arylation under Ruthenium Catalysis 
An early contribution in direct C–H arylation under ruthenium catalysis was reported by Oi/Inoue 
in 2001.[48] By employing a ruthenium(II)-arene complex along with catalytic amounts of PPh3, 
phenylpyiridines 45 were successfully reacted with aryl bromides 46, thus delivering the desired 
ortho-arylated compounds (Scheme 18). Notably, when meta-substituted arenes were subjected 
to the reaction conditions, the reaction exclusively took place in the sterically less-hindered ortho-
position. 
 
 
Scheme 18: Ruthenium(II)-catalyzed C–H arylation of phenylpyridines 45. 
 
For the ruthenium-catalyzed C–H arylation the proposed catalytic cycle commences with oxidative 
addition of aryl bromide 46 to ruthenium(II) species 48 (Scheme 19). Afterwards, zwitterionic 
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ruthenacycle 50 is formed and subsequently undergoes elimination of HBr. Reductive elimination 
from intermediate 51 leads to the formation of the new C–C bond and regenerates the catalytically 
active ruthenium(II) complex. 
 
 
Scheme 19: Proposed catalytic cycle for C–H arylations under ruthenium catalysis. 
 
Unfortunately, a later study revealed a lack of reproducibility of these results due to a strong 
beneficial effect of solvent impurities on the reaction outcome.[49] 
In 2007, Ackermann disclosed the chelation-assisted C–H arylation of alkenes and arenes with aryl 
halides 46, 54 using simple RuCl3 as catalyst, which represents a rare example of ruthenium(III)-
catalyzed C–H activation (Scheme 20).[50] 
 
1.4 Direct C–H Arylation under Ruthenium Catalysis 
15 
 
Scheme 20: Ruthenium(III)-catalyzed C–H arylation of alkenes and arenes 45, 52-53. 
 
A breakthrough in direct C–H arylation was achieved in 2008, when the group of Ackermann 
introduced carboxylic acids as additives in ruthenium catalysis.[51] Sterically demanding MesCO2H 
(58) outperformed previously employed NHC and phosphine ligands and facilitated the C–H 
arylation of aryl pyridines 45, oxazolines 52, pyrazoles 53, and triazoles 57 in a robust manner 
(Scheme 21). The authors proposed the C–H activation event to occur via a base-assisted 
metalation process, involving a cyclic, six-membered transition state structure. 
 
 
Scheme 21: Ruthenium-catalyzed C–H arylations with carboxylic acid additives and 
representative transition state structure 60. 
 
In a subsequent contribution, the synthesis of ruthenium-carboxylate complex 
[Ru(O2CMes)2(p-cymene)] (61) was reported and the complex was shown to exhibit excellent 
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performance in direct C–H arylations.[52] Furthermore, the reaction was proposed to proceed via 
a reversible, chelation-assisted C–H activation in a base-assisted metalation process (Scheme 22). 
Oxidative addition of Ar–X to 21 generates ruthenium(IV) intermediate 62 and ensuing reductive 
elimination leads to formation of arylated product 63. 
 
 
Scheme 22: Proposed catalytic cycle for ruthenium-carboxylate-catalyzed C–H arylations. 
 
A method for the synthesis of biaryl motifs in a dehydrogenative C–H/C–H activation process 
under ruthenium catalysis was disclosed in a contribution by Oi/Inoue.[53] In this transformation, 
allylic acetate 67 acted as the stoichiometric oxidant and enabled the homocoupling with various 
heterocyclic directing group decorated arenes 52-53, 64-66 (Scheme 23). 
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Scheme 23: Dehydrogenative C–H/C–H activation with allyl acetate 67 as oxidant. 
 
The C–H arylation of fluoroarenes 73 with aryl halides 46 was presented in 2016 by Larrosa,[54] 
again by carboxylate assistance, as introduced by Ackermann in 2008.[51] A catalytic system 
consisting of cationic [Ru(NCt-Bu)6][BF4]2 as catalyst in combination with catalytic amounts of 
benzoate and pivalate as ligands and base proved crucial for achieving high conversions (Scheme 
24). 
 
 
Scheme 24: C–H Arylation of fluoroarenes 73. 
 
Recently, a cyclometalated ruthenium(II)-nitrile complex was successfully employed as catalyst in 
the chelation-assisted C–H arylation with aryl (pseudo-)halides 46, 54 by the group of Larrosa 
(Scheme 25).[55] The reaction was performed on heteroaryl-substituted arenes 15, some of which 
were coupled to pharmaceuticals and natural products. 
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Scheme 25: C–H arylations with cyclometalated complex 75 as catalyst. 
 
1.5 Ruthenium-Catalyzed Decarboxylative C–H Activation 
Throughout the years, carboxylic acids have been recognized as versatile traceless directing 
groups in a C–H functionalization/decarboxylation manifold.[56] While numerous palladium-, 
rhodium-, and iridium-catalyzed transformations are well-established, the use of stoichiometric 
amounts of copper or silver is often required to facilitate a decarboxylative process, thereby 
compromising the sustainability of the C–H activation approach. 
The first example of domino C–H activation/decarboxylation under ruthenium(II) catalysis was 
reported by Li in 2015 for the amidation of benzoic acids 31 with isocyanates 76 (Scheme 26).[57] 
It should be noted that the reaction proceeded in the absence of any transition metal apart from 
the employed ruthenium catalyst and delivered 34 in high yield. 
 
 
Scheme 26: Decarboxylative amidations with isocyanates 76. 
 
In the same year, α-keto carboxylic acids 77 were shown to efficiently undergo C–H 
alkenylation/decarboxylation with internal alkynes 35 (Scheme 27).[58] Incorporation of oxygen 
from air and oxidative annulation leads to the formation of isocumarins 37. Unfortunately, the use 
of stoichiometric amounts of copper(II) salts proved necessary. 
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Scheme 27: Decarboxylation and oxidative annulations of α-keto acids 77. 
 
Thereafter, the groups of Ackermann,[59] Gooßen,[60] and Zhao/Hartwig[61] independently disclosed 
the decarboxylative C–H alkenylation of benzoic acids 31 with alkynes 35 (Scheme 28). Opposed 
to the report by Gooßen, who opted for a ruthenium-dichloro complex in combination with a 
carbonate base, Ackermann, and Zhao/Hartwig employed well-defined ruthenium-carboxylate 
catalysts in the absence of additional base. 
 
 
Scheme 28: C–H alkenylations/decarboxylations of benzoic acids 31. 
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Additionally, a method for domino C–H alkenylation/decarboxylation reactions of benzoic acids 
80 with acrylates 27 was explored by Ackermann (Scheme 29).[59] The choice of V2O5 as the oxidant 
and the introduction of an ether-substituent in the ortho-position proved beneficial for obtaining 
high conversions in the oxidative C–H alkenylation process. 
 
 
Scheme 29: Domino C–H alkenylations/decarboxylations with acrylates 27. 
 
The use of indole carboxylic acids 82, a privileged structural motif that easily undergoes 
decarboxylation, in an intramolecular C–H alkenylation/decarboxylation reaction for the synthesis 
of tetrahydropyridoindoles 83 bearing an exocyclic double bond was recently described with 
environmentally benign oxygen as the sole oxidant (Scheme 30).[62] 
 
 
Scheme 30: Intramolecular C–H alkenylations/decarboxylations of indole carboxylic acids 82. 
 
1.6 meta-Selective C–H Activation under Ruthenium Catalysis 
The control of selectivity continues to be one of the major challenges in C–H activation chemistry 
(vide supra). In contrast to a plethora of reports on ortho-selective C–H activations of arenes, 
methods for the selective activation of C–H bonds in the meta-position continue to be scarce.[63] 
In the last decade, mainly six different approaches for meta-selective C–H activation were 
established. The use of substrates bearing bulky substituents can prevent the activation of C–H 
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bonds in neighboring positions, resulting in a reaction at a non-hindered meta-position (Figure 
2a). So far, this strategy is limited to iridium-catalyzed borylation reactions.[64] By employing 
traceless directing groups, such as carboxylic acids, formal meta-selective C–H activations can be 
achieved (Figure 2b). However, introduction of a substituent in the ortho-position with respect to 
the directing group is required. The installation of a template in the substrate can lead to a 
coordination of the catalyst,[65] thereby bringing it into close proximity to the desired C–H bond in 
meta- or para-position (Figure 2c).[66] The installation and subsequent removal of the template 
requires additional synthetic operations and constitutes a major drawback of this method. In an 
elegant approach Kuninobu/Kanai developed a reversible hydrogen bonding linker, allowing for 
C–H borylations to occur in the meta-position (Figure 2d).[67] Unfortunately, hydrogen bonding 
linkers are so far limited to iridium catalysis and are not broadly applicable. Reminiscent of the 
Catellani reaction,[68] norbornene can be employed as a transient meditator to obtain meta-
functionalized compounds via a palladium-catalyzed ortho/ortho activation manifold (Figure 
2e).[69] Furthermore, the formation of cyclometalated ruthenium complexes by chelation-assisted 
ortho-C–H metalation strongly increases the electron density at the para-position with respect to 
ruthenium,[70] thus acting as an ortho/para-directing substituent and enabling functionalizations 
at a remote C–H bond (Figure 2f).[71] 
 
 
Figure 2: Strategies for meta-selective C–H activation. 
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The first example of chelation-assisted remote C–H functionalization[72] was reported by van Koten 
in 1994 for the stoichiometric reaction of complex 84 (Scheme 31).[73] Along with homocoupled 
complex 85, small amounts of chlorinated product 86 were obtained. 
 
 
Scheme 31: Stoichiometric remote C–C bond formation. 
 
In 1998, the group of Coudret discovered the meta-selective C–H bromination and iodination of 
cyclometalated phenylpyridine complexe 87 under mild conditions.[74] Thereafter, Roper/Wright 
accomplished the remote, iron-catalyzed bromination of related ruthenium complexes (Scheme 
32).[75] 
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Scheme 32: Remote C–H halogenations of cyclometalated complexes. 
 
Catalytic remote C–H functionalizations via ortho-metalation were first disclosed in a pioneering 
contribution by Ackermann in 2011.[34] Phenylpyridine 45b was reacted with primary alkyl halide 
92 to deliver meta-alkylated arene 93, albeit in very low yield, together with 93’ as the major 
product (Scheme 33). 
 
 
Scheme 33: Ruthenium catalysis for meta-C–H alkylation with n-hexyl bromide (92). 
 
A protocol for meta-selective sulfonations of phenylpyridines 45 under ruthenium catalysis was 
presented by Frost in the same year (Scheme 34).[76] When the well-defined ruthenacycle 96 was 
subjected to the reaction conditions, a quantitative formation of 95 was observed. The authors 
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attributed this observation to the strongly activating, ortho/para-directing properties of the Ru–C 
bond,[70] thereby enabling an electrophilic substitution SEAr process at the remote position. 
 
 
Scheme 34: meta-C–H Sulfonations of phenylpyridines 45 with sulforyl chlroides 94. 
 
In continuation of their previous study, the group of Ackermann explored the pyridyl- and azole-
directed meta-C–H alkylation with secondary alkyl halides 97 (Scheme 35).[77] For this 
transformation, a reversible C–H ruthenation and a subsequent alkylation was proposed, which 
was later on investigated in more detail (vide infra). Here, it was shown that TEMPO inhibits the 
reaction, while enantiomerically enriched alkyl halides racemize. 
 
 
Scheme 35: Remote meta-C–H alkylations with secondary alkyl halides 97. 
 
In 2015, Ackermann,[78] and Frost[79]almost simultaneously presented protocols for ruthenium-
catalyzed tertiary C–H alkylations, occurring exclusively in the meta-position (Scheme 36). In 
addition to heterocyclic directing groups, Ackermann’s method was also applicable to removable 
pyrimidyl anilines. 
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Scheme 36: meta-C–H alkylations with tertiary alkyl halides 100, 103. 
 
Both contributions provided strong evidence for a radical pathway rather than an electrophilic 
one as was already earlier indicated by Ackermann.[77] The following catalytic cycle was proposed 
by Ackermann (Scheme 37):[78] Starting from ruthenium(II) complex 105, reversible ortho-C–H 
metalation generates intermediate 106. Subsequent radical addition of 107, which is formed via 
single-electron transfer to alkyl halide 100, 103, occurs at the para-position with respect to the 
ruthenium. Afterwards, rearomatization and hydrogen-atom abstraction leads to the formation 
of 109. Finally, proto-demetalation delivers the alkylated compound 104 and regenerates the 
active catalyst. Notably, Frost presented a very similar, albeit less detailed mechanistic 
proposal.[79] 
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Scheme 37: Proposed catalytic cycle for remote C–H alkylations via ortho-ruthenation. 
 
Thereafter, the transformable/removable directing group approach for meta-C–H alkylation was 
expanded to the use of diazobenzenes 110[80] and phenoxypyridines 112[81] by the groups of 
Li/Yang, and Li, thus providing access to substituted anilines and phenols after removal of the 
directing groups (Scheme 38). 
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Scheme 38: Remote C–H alkylations of diazobenzenes 110 and phenoxypyridines 112. 
 
Very recently, a breakthrough in meta-C–H alkylations was reported independently by the groups 
of Ackermann,[82] and Greaney.[83] Photochemical generation of the alkyl radical species allowed 
for a significant decrease in the reaction temperature from 120 °C to ambient temperature 
(Scheme 39). Although considerably milder reaction conditions were employed and no additional 
photocatalyst was required, the use of powerful blue LEDs proved to be necessary. 
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Scheme 39: Photochemical remote C–H alkylations of phenylpyridines 45. 
 
Greaney,[84] and Huang[85] simultaneously disclosed the ruthenium-catalyzed meta-selective 
bromination of phenylpyridines 45 under ruthenium catalysis (Scheme 40). The obtained products 
116 were afterwards employed in cross-coupling reactions to access a variety of compounds. 
 
 
Scheme 40: meta-C–H brominations of phenylpyridines 45. 
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1.7 Manganese-Catalyzed C–H Activation 
While C–H activation chemistry with 4d or 5d transition metal catalysts is well-established for 
numerous transformations and a multitude of compound classes, a number of drawbacks is 
associated with the use of 4d- and 5d-transition metals. Compared to inexpensive 3d transition 
metals,[86] precious 4d and 5d transition metals exhibit a higher toxicity[87] and a significantly lower 
natural abundance.[88] With these aspects in mind, it is hardly surprising, that the application of 
base metal catalysts for sustainable C–H activation has gained enormous momentum throughout 
the last decade.[12b] Especially manganese catalysis has emerged as a powerful tool for the 
construction of C–C bonds via a C–H activation strategy and was successfully employed in various 
transformations.[89] 
In a seminal contribution, Bruce/Stone reported the synthesis of cyclometalated manganese 
complexes through a reaction of azobenzene (110a) with manganese(I) or manganese(0)-carbonyl 
complexes (Scheme 41).[90] Thereafter, several ortho-manganated compounds were synthesized 
and investigated in stoichiometric transformations.[91] 
 
 
Scheme 41: Synthesis of managanacycle 119. 
 
In 2007, Kuninobu/Takai presented the first example of manganese-catalyzed C–H activation 
operating through an organometallic mode of action.[92] In the presence of [MnBr(CO)5] as catalyst 
phenylimidazole 66a was reacted with aldehyde 120 and silane 121 to deliver silylether 122 
(Scheme 42). The presence of silane 121 was required to achieve catalytic turnover, since only 
trace amounts of the corresponding alcohol were observed in the absence of 121. 
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Scheme 42: Manganese-catalyzed C–H activation of phenylimidazole 66a. 
 
The group of Wang disclosed the C–H alkenylation of phenylpyridines 45 with terminal alkynes 
123 under manganese catalysis (Scheme 43).[93] Key to success was the use of catalytic amounts 
of Cy2NH as additive, since only trace amounts of the desired product were obtained, when the 
additive was omitted. Based on computational studies, the authors proposed the formation of a 
manganese-alkynyl complex and C–H activation via a ligand-to-ligand hydrogen transfer 
process.[94] 
 
 
Scheme 43: Manganese-catalyzed C–H alkenylations with terminal alkynes 123. 
 
The use of bromoalkynes 126 for the manganese-catalyzed C–H alkynylation of indoles 125 
containing a pyridyl or pyrimidyl directing group was reported by Ackermann (Scheme 44).[95] It is 
notable that the developed method was not only applicable to indoles, but could also be applied 
to tryptophan and small peptides. 
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Scheme 44: Manganese-catalyzed C–H alkynylations of indoles 125. 
 
1.8 C–C Activation by Transition Metal Catalysis 
Despite a plethora of methods for selective C–H bond activations, strategies for the activation of 
equally ubiquitous C–C bonds via an organometallic mode of action continue to be less 
explored.[96] Due to the thermodynamic and kinetic stability of C–C bonds, the selective activation 
of C–C bonds in the presence of other σ-bonds represents a major challenge. With bond 
dissociation energies of 85–100 kcal mol–1 C–C σ-bonds can be considered comparatively stable 
and inert.[97] In contrast, the cleavage of a strong C–C bond and the formation of a much weaker 
M–C bond is usually energetically unfavorable, since bond dissociation energies for M–Alkyl bonds 
are typically in the range of 35–50 kcal mol–1.[98] Furthermore, the activation of one C–C bond of 
the substrate and the subsequent formation of a new C–C bond in the desired product often does 
not constitute a considerable change in energy, thus no large thermodynamic driving force can be 
exploited to enable the desired transformation. Another issue is the kinetic stability of C–C bonds, 
which is caused by the pronounced directional character of C–C σ-bonds.[96d] An efficient overlap 
between the bonding C–C σ-orbital and a metal-centered d-orbital requires an energy-demanding 
distortion of the C–C σ-orbital (Figure 3a). The interaction of a d-orbital with the antibonding σ*-
orbital is also challenging, due to the high energy of the σ*-orbital (Figure 3b). 
 
 
Figure 3: Orbital interactions for C–C bond activation. 
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Nevertheless, a number of protocols for selective C–C bond activations was developed throughout 
the years by utilizing various strategies to overcome these inherent challenges. One approach, 
which was first applied by Tipper in the stoichiometric reaction of cyclopropane (128) with a 
platinum complex to form four-membered metalacycle 130,[99] is the use of highly strained ring 
systems to provide a thermodynamic driving force (Scheme 45).[100] Later on, the opening of 
strained rings was utilized in a number of catalytic C–C activation reactions.[96b] 
 
 
Scheme 45: Stoichiometric reaction of cyclopropane (128) with platinum complex 129. 
 
By combining sustainable transition metal-catalyzed C–H activation methodologies with C–C 
activation reactions, highly versatile transformations can be achieved. In this context, Fürstner 
reported the intramolecular cycloisomerization of substrates 132 bearing an 
alkylidenecyclopropane motif under rhodium catalysis to deliver entropically favored 
cycloheptens 133 (Scheme 46).[101] 
 
 
Scheme 46: Rhodium-catalyzed C–H/C–C activations of alkylidenecyclopropanes 132. 
 
Ackermann reported the ruthenium-catalyzed intermolecular C–H/C–C activation of 
phenylpyridines 45 with methylencyclopropane 134 (Scheme 47).[102] While geminal diphenyl-
substituted substrate 134 led to a complete opening of the cyclopropane ring, a conservation of 
the cyclopropane was observed for other substitution patterns.[103] 
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Scheme 47: Ruthenium-catalyzed C–H/C–C activation with methylenecyclopropane 134. 
 
The group of Huang/Li/Wang disclosed the synthesis of allylated arenes via a chelation-assisted, 
rhodium-catalyzed C–H/C–C activation approach with vinylcyclopropanes 136 (Scheme 48).[104] 
The E-configured product was obtained predominantly with E/Z ratios of more than 7:1. 
Thereafter, a similar reaction, albeit employing a less expensive cobalt catalyst, was developed by 
Ackermann in 2016. It is noteworthy that, in contrast to previous reports, the thermodynamically 
less stable Z-isomer was observed as the major product.[105] In addition, manganese complexes 
were also found to be competent catalysts for this C–H/C–C activation reaction, again leading to 
a prevalent formation of the E-isomer.[106] 
 
 
Scheme 48: Transition metal-catalyzed C–H/C–C activations with vinylcyclopropanes 136. 
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Over the years, the cleavage of C–C bonds in α-position to a coordinating functional group via a 
β-carbon elimination process and the subsequent installation of a new C–C bond was well-
established for various functional groups, including nitriles, carboxylic acids, aldehydes, and 
ketones.[96d, 96f] A C–C activation strategy for the formation of biaryls 140 was first applied to 
benzylic alcohols 139 by Miura in 2001 (Scheme 49).[107] The reaction was proposed to occur via 
β-carbon elimination, leading to the stoichiometric formation of ketone 141 as byproduct. 
 
 
Scheme 49: Synthesis of biaryls 140 by C–C arylation of benzylic alcohols 139. 
 
Afterwards, structurally related secondary benzylic alcohols 142 were successfully employed in a 
chelation-assisted C–C alkenylation reaction under rhodium catalysis by the group of Shi (Scheme 
50).[108] In contrast to the previous report by Miura, the introduction of a pyridyl substituent as 
directing group proved necessary to deliver the alkenylated compounds 143. Thereafter, Morandi 
reported the cobalt-catalyzed C–C cyanation and allylation employing the same substrate.[109] 
 
 
Scheme 50: C–C alkenylations, cyanations, and allylations of benzylic alcohols 142. 
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2 Objectives 
During the last years, transition metal-catalyzed C–H activation has emerged as a powerful 
method for the selective construction of C–C and C–Het bonds and has greatly expanded the 
toolbox of synthetic chemistry.[12, 21, 25] Ruthenium catalyst were recognized as a potent alternative 
to costly palladium or rhodium catalysts and have enabled a number of unique transformations, 
especially in terms of remote σ-activation.[27, 71] However, a detailed mechanistic understanding 
of these transformations is often lacking and thus impedes the improvement of established 
catalytic systems as well as the rational design of novel synthetic protocols. Therefore, the main 
objective of this thesis was directed towards detailed mechanistic investigations of various C–H 
and C–C activation processes by means of experiment and computation. 
Protocols for ruthenium-catalyzed meta-selective C–H activations are frequently restricted to 
strongly coordinating, nitrogen-containing heterocycles as directing groups, thereby limiting the 
applicability towards biologically relevant structures (vide supra). With this in mind, a method for 
the meta-C–H bromination of bioactive purines should be investigated and used as a platform for 
further diversifications (Scheme 51). 
 
 
Scheme 51: meta-C–H bromination of purines 148 under ruthenium catalysis. 
 
Furthermore, based on the ruthenium-catalyzed meta-C–H alkylation strategies developed by 
Ackermann,[77, 78] the application of ketimines as easily transformable directing groups in meta-
selective C–H alkylations should be explored. In addition to the development of a novel synthetic 
protocol, detailed mechanistic investigations should provide valuable insights into the catalyst’s 
mode of action (Scheme 52). 
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Scheme 52: Ruthenium catalysis for remote C–H alkylation of ketimines 151. 
 
In the context of remote C–H activations, the prediction of ortho/meta-selectivities by means of 
computational chemistry could contribute to a deeper understanding of the reaction mechanism 
and to the identification of potential key intermediates. To this end, various conceivable 
cyclometalated complexes with different substrates and coordination environments should be 
evaluated and compared to experimental observations. 
The use of easily accessible carboxylic acids as traceless directing groups in transition metal-
catalyzed C–H activation holds enormous potential.[56] So far, detailed insights into the reaction 
mechanism of decarboxylative C–H activations under ruthenium catalysis remained scarce and 
should prove instrumental to the development of novel transformations. Especially the 
competition between decarboxylative and annulative processes is worth investigating (Scheme 
53). 
 
 
Scheme 53: Decarboxylative C–H activation of benzoic acids 31 under ruthenium catalysis. 
 
The C–H activation of weakly coordinating aryl acetamides 153 was previously achieved by 
palladium catalysis, but was thus far not explored with less costly ruthenium catalysts.[110, 111] Due 
to a presumed formation of an unusual and challenging six-membered ruthenacycle, the 
utilization of these substrates in ruthenium-catalyzed C–H activation should be experimentally 
studied and a comparison with the corresponding, more commonly occuring five-membered 
metalacycle conducted (Scheme 54). 
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Scheme 54: Ruthenium-catalyzed distal C–H activation of aryl acetamides 153. 
 
Furthermore, the development of sustainable protocols for the diversification of ferrocenes via a 
C–H activation approach is highly desirable due to the application of substituted ferrocenes as 
inter alia ligands[112] and bioactive molecules.[113] Different weakly coordinating directing groups 
for direct C–H arylations of ferrocenes under ruthenium catalysis should be investigated with 
respect to the C–H ruthenation step and the stability of the generated metalacycle (Scheme 55). 
 
 
Scheme 55: C–H arylation of ferrocenes 156 with ruthenium catalysts. 
 
During the last years, transition metal-catalyzed C–H activation was recognized as a convenient 
strategy for the last-stage diversification of peptides and amino acids.[114] Computational studies 
on the hydroarylation with indoles 125 as a model substrate for tryptophan should be conducted 
to gain insight into the catalytic pathway. In addition, an analysis of the ligand influences on the 
energy profile could lead to the identification of more efficient catalysts (Scheme 56). 
 
 
Scheme 56: Hydroarylation with indoles 125 under ruthenium catalysis. 
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In an earlier report on ruthenium-catalyzed C–H arylations with aryl halides, the group of 
Ackermann observed a competing oxidative C–H/C–H activation process, in which the aryl halide 
acts as the oxidant.[115] However, no explanation concerning this change in mechanism was 
presented at that time and the selectivity-controlling parameters remained unclear. An in-depth 
study on the rate- and selectivity-controlling factors as well as the catalyst’s mode of action should 
be performed and should prove invaluable, not only to the understanding of oxidative C–H/C–H 
activations with ruthenium catalysts, but also in providing new insights into well-established C–H 
arylation processes (Scheme 57). 
 
 
Scheme 57: Ruthenium-catalyzed C–H/C–H activation and C–H arylation. 
 
Throughout the last years, a trend towards the use of earth-abundant, inexpensive[86] base metal 
catalysts for C–H activation could be witnessed (Figure 4). In that regard, the potential of 
manganese catalysis for the late-stage diversification of tryptophan-containing peptides was 
revealed in a previous report on C–H alkynylation (vide supra).[95] Consequently, computational 
investigation of the key elementary steps of a related manganese-catalyzed C–H allylation of 
tryptophan 160 should contribute to a deeper understanding of the turnover-limiting steps of the 
reaction mechanism (Scheme 58). 
 
 
Figure 4: Prices of commonly employed metals in € per kg. 
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Scheme 58: Manganese-catalyzed C–H allylation of tryptophan 160. 
 
Through transition metal-catalyzed C–C activation strategies a number of C–C and C–Het bond 
formations can be achieved, which cannot be realized by other methods.[96] The use of benzylic 
alcohols 142 as substrates in the context of manganese-catalyzed C–C allylations with cyclic 
carbonates and carbamates should be explored. In addition to the user-friendly access to 
synthetically useful allylated arenes, detailed studies of the manganese-catalyzed C–C activation 
process could provide novel insights into the fundamental differences of C–C and C–H activation 
reactions (Scheme 59). 
 
 
Scheme 59: C–C allylation of benzylic alcohols 142 under manganese catalysis. 
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3 Results and Discussion 
3.1 Ruthenium-Catalyzed meta-Selective C–H Bromination 
Despite a multitude of protocols for directing group-enabled ortho-selective C–H activation, 
procedures for the selective functionalization of remote C–H bonds are considerably less explored 
and are often limited to biologically less relevant phenylpyridine as the substrate (vide supra). 
Purines are important structural motifs in biology and biomolecular chemistry, while unnatural 
nucleosides are employed as anticancer or antiviral agents in drugs or as biological probes.[116] 
Therefore, procedures allowing for the diversification of purine-based molecules are highly 
desirable and could lead to the discovery of novel, biologically active compounds. 
To this end, Dr. S. Warratz and Dr. D. J. Burns in the Ackermann group developed a strategy for 
the meta-selective C–H bromination of arylated purines 148 under ruthenium catalysis (Scheme 
60).[117] Excellent catalytic performance was observed with inexpensive RuCl3∙3H2O as catalyst and, 
remarkably, also heterogeneous Ru@SiO2 proved to be a viable and recyclable catalyst for this 
transformation. 
 
 
Scheme 60: Optimized reaction conditions for the meta-selective C–H bromination of purines 
148. 
 
3.1.1 Fluorescent Tag Labelling 
To demonstrate the synthetic utility of the meta-selective C–H bromination strategy, a pyrene 
motif was introduced as a fluorescent tag into the purine base via a palladium-catalyzed 
Sonogashira-Hagihara cross-coupling reaction, delivering alkynylated compound 150b in 
excellent yield (Scheme 61).[118] 
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Scheme 61: Fluorescent tag labelling of brominated purine 149a. 
 
The pyrene-labelled compound 150b exhibited very good fluorescence properties with emission 
maxima at 402 and 423 nm at excitation wavelengths of 295 or 360 nm, which corresponds to a 
Stokes shift of up to 128 nm. In contrast, compound 150a, substituted with a simple phenyl 
moiety, only showed neglectable emission intensities (Figure 5). 
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Figure 5: Fluorescence spectra of 150a and 150b. 
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3.1.2 Mechanistic Studies 
To gain insight into the catalyst’s mode of action, mechanistic investigations were performed. 
When the reaction was performed in the presence of isotopically labelled D2O as cosolvent, a 
significant H/D exchange was not observed in the product 149a or in the reisolated substrate 148a, 
which is indicative of a irreversible C–H activation step (Scheme 62). 
 
 
Scheme 62: H/D exchange study. 
 
Kinetic analysis of the reaction revealed saturation kinetics with respect to the concentration of 
RuCl3∙3H2O (Figure 6a). For catalyst loadings of up to 8 mol % a reaction order of 1 was 
determined, while at higher concentrations an independence of the rate towards the 
concentration was observed. This observation can be rationalized by a limited solubility of 
RuCl3∙3H2O in DMA, which limits the actual concentration in solution. Furthermore, the observed 
rate was found to be independent of the phenylpurine 148a concentration, suggesting that the 
substrate is not involved in any kinetically relevant elementary step during the catalysis (Figure 
6b). 
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Figure 6: Reaction order with respect to the (a) RuCl3∙3H2O and (b) purine 148a concentration. 
 
To test if the independence towards the substrate concentration is a unique behavior of 
phenylpurines 148, phenylpyridine (45a) was studied as well. As expected, the concentration of 
phenylpyridine (45a) was also not kinetically relevant (Figure 7). Based on these results it can be 
assumed, that the substrate is involved in a reversible process – most likely a coordination of the 
substrate to ruthenium – taking place before the turnover-limiting step. 
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Figure 7: Reaction order with respect to phenylpyridine 45a concentration. 
 
3.2 Ruthenium-Catalyzed meta-C–H Alkylation of Ketimines 
During the last years, an increasing number of protocols for remote C–H functionalization has 
been developed and various transition metal catalysts could be successfully employed (vide 
supra). Nevertheless, many protocols are only applicable to a single class of substrates and cannot 
be readily adapted to the syntheses of different target molecules. Furthermore, meta-selective 
transformations under ruthenium catalysis were so far limited to strongly coordinating, nitrogen-
containing heterocycles, such as pyridines and pyrimidines, as directing groups.[71] These 
heterocycles are usually difficult to modify and their removal often requires harsh conditions, 
which represents a major drawback of the otherwise elegant strategies. 
The use of ketimines as directing groups constitutes an ideal choice as these compounds can be 
easily hydrolyzed to yield synthetically useful ketones or directly converted into numerous 
valuable functional groups.[119] 
meta-Alkylated arenes are a structural motif, that can be found in a number of drug molecules, 
natural products, and crop protection agents (Scheme 63).[120] Therefore, the development of 
novel, sustainable protocols for the introduction of alkyl-substituents in positions, which are not 
accessible via classical synthetic approaches, is highly desirable. 
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Scheme 63: Representative meta-alkylated phenones in pharmaceuticals. 
 
K. Korvorapun, Dr. J. Li, and Dr. S. De Sarkar in the Ackermann group optimized the reaction 
conditions for the ruthenium-catalyzed remote C–H alkylations of ketimines 151 with optimal 
results being achieved with an in situ formed ruthenium-bisadamantylcarboxylate complex as the 
catalyst and PhCMe3 as the solvent (Scheme 64).[121] 
 
 
Scheme 64: Optimized reaction conditions for meta-selective C–H alkylations of ketimines 151. 
 
3.2.1 Scope of the meta-Selective C–H Alkylation 
The versatility of the ruthenium-catalyzed remote C–H alkylation was investigated with a number 
of differently substituted ketimines 151 (Scheme 65). Substituents in the para-position were 
generally well tolerated including a structurally complex cholesterol moiety, which delivered the 
desired product 165aa in acceptable yield. In addition, dimethylamino and even thiophene motifs 
were well accepted in the ruthenium catalysis, highlighting the robustness of the established 
procedure (165ba, 165bb and 165ca). 
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Scheme 65: Ruthenium-catalyzed meta-C–H alkylations of ketimines. 
 
3.2.2 Additive Test 
To further evaluate the tolerance of the remote meta-alkylation strategy towards various 
functionalities, a robustness test was performed (Table 1). This additive test allows for the 
evaluation of functional groups, that cannot be readily incorporated into the substrate, such as 
amines or carbonyls. Although steric and electronic influences on the substrate are neglected in 
this methodology, it provides a general overview of potentially viable functional groups. Among 
others, ketones, alkenes, chlorides, and benzofuranes were well-tolerated (entries 2, 6, 11, and 
15), whereas benzoxazole, 2-chloroquinoline and N-methylimidazole completely suppressed all 
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reactivity (entries 18, 19, and 22). Additives containing Brønsted-basic functionalities underwent 
protonation during hydrolysis of the ketimine and could therefore not be detected afterwards. 
 
Table 1: Additive test for meta-C–H alkylations. 
 
Entry Additive Yield 165da / %[a] Remaining Additive / %[a] 
1 none 97 -- 
2 
 
96 93 
3 
 
52 45 
4 
 
78 0 
5 
 
64 0 
6  71 n.d.
[b] 
7 
 
79 0 
8  41 77 
9 
 
74 96 
10  48 0 
11 
 
72 100 
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12 
 
4 38 
13 
 
61 n.d.[b] 
14 
 
71 0 
15 
 
96 91 
16 
 
86 41 
17 
 
81 0 
18 
 
10 0 
19 
 
2 10 
20 
 
64 n.d.[b] 
21 
 
63 88 
22 
 
3 0 
[a] Determined by GC analysis with n-dodecane as the internal standard. [b] Not detected due 
to overlap with the solvent signal. 
 
3.2.3 One-pot two-fold C–H Activation 
The catalyst was also active for ortho-selective C–H arylations and alkylations, allowing for 
unprecedented sequential two-fold meta/ortho-C–H activations (Scheme 66). Operationally 
simple addition of aryl or primary alkyl bromide provided access to densely substituted arenes 
166a and 166b with perfect levels of regioselectivity in high yields of 69% and 56%, respectively. 
These results showcase the stability of the in situ formed ruthenium catalyst, which retains its 
activity even after longer reaction times at elevated temperatures. 
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Scheme 66: Sequential one-pot two-fold C–H activation. 
 
3.2.4 Mechanistic Studies 
Earlier studies on ruthenium-catalyzed meta-C–H alkylations of phenylpyridines provided 
evidence for the formation of an alkyl radical species.[78] Consequently, the involvement of alkyl 
radicals in the alkylation of ketimines was probed by the addition of the radical scavenger TEMPO, 
which completely suppressed product formation and resulted in the formation of an TEMPO-alkyl 
adduct. When enantiomerically enriched alkyl bromide (S)-100d was subjected to the reaction 
conditions, racemization of the stereogenic center in product 165ed was observed, thereby 
rendering the formation of an alkyl radical highly probable (Scheme 67). 
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Scheme 67: Reaction with enantiomerically enriched alkyl bromide 100d. 
 
To gain further insights into the nature of the active catalyst, a series of kinetic investigations with 
well-defined complex [Ru(O2CAd)2(p-cymene)] (167) was performed. Variation of the catalyst 
loading in the range of 2.5–10 mol %, which corresponds to concentrations of 6.3–25 mmol L–1, 
resulted in a reaction order of 1 with respect to the [Ru(O2CAd)2(p-cymene)] (167) concentration 
(Figure 8). 
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Figure 8: Reaction order with respect to the [Ru(O2CAd)2(p-cymene)] (167) concentration. 
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A first order dependence of the rate with respect to the concentration of 151d was determined, 
while a more complex behavior was observed, when the concentration of alkyl bromide 100c was 
altered (Figure 9). Here, first an increase of the reaction rate with increasing concentrations was 
observed. In contrast, the rate was found to decrease at higher concentrations, leading to the 
assumption, that bromide 100c is either facilitating catalyst deactivation or the formation of a 
resting state. It should be noted that the measurements were performed with relatively high 
concentrations of 100c in the range of 0.25–1.13 mol L–1, where a limited solubility could effect 
the theoretical concentration and thereby cause the observed behaviour. 
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Figure 9: Reaction order with respect to the concentration of (a) ketimine 151d and (b) alkyl 
bromide 100c. 
 
Additionally, the temperature dependence of the reaction rate was studied and the obtained rates 
were evaluated using the Arrhenius equation. A linearized plot resulted in values for the activation 
energy EA of 24 kcal mol–1 (Figure 10). 
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Figure 10: Arrhenius plot analysis of the meta-alkylation of ketimine 151d. 
 
Based on the results of the mechanistic studies and previous reports (vide supra), a plausible 
catalytic cycle commences with carboxylate-assisted ortho-C–H bond activation to generate five-
membered ruthenacycle 169 (Scheme 68). Afterwards, homolytic C–Br bond cleavage leads to the 
formation of alkyl radical species 107 and ruthenium(III) intermediate 171. Ruthenium acts as a 
strongly ortho- and para-directing substituent on the arene[70] and, due to steric congestion in 
ortho-position, facilitates selective attack of 107 in the para-position with respect to the C–Ru 
bond. Cleavage of the C–H bond results in the rearomatization of the arene, while the reduction 
of ruthenium(III) to ruthenium(II) formally generates HBr, which is trapped by the base. Proto-
demetalation liberates the final product and regenerates the catalytically active complex 168. 
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Scheme 68: Plausible catalytic cycle for ruthenium-catalyzed meta-C–H alkylations of ketimines 
151. 
 
3.3 Ruthenium-Catalyzed meta-C–H Alkylation of Phenylpyridines 
In a previous study by Ackermann, meta-selective C–H alkylations of 2-phenylpyridines were 
achieved using an in situ generated catalyst derived from of [RuCl2(p-cymene)]2 and mono-
protected amino acid Piv-Val-OH (vide supra).[78] Kinetic investigations revealed a first order 
dependence of the reaction rate on the concentration of [RuCl2(p-cymene)]2 as well as the 
concentration of 2-phenylpyridine. 
To investigate a possible bimetallic pathway involving two ruthenium center, further studies were 
required. Hence, kinetic studies were performed with well-defined [Ru(O2CMes)2(p-cymene)] (61) 
complex, which was already shown to be a competent catalyst for meta-C–H functionalizations.[77] 
Variation of the catalyst concentration resulted in a first order rate-dependence, which is evidence 
for a monometallic mechanism. Therefore, the involvement of a second ruthenium complex in a 
kinetically relevant elementary step appears to be unlikely (Figure 11). 
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Figure 11: Reaction order with respect to the [Ru(O2CMes)2(p-cymene)] (61) concentration. 
 
Furthermore, an Arrhenius plot analysis was performed to determine the activation energy of the 
reaction from experimentally derived temperature-dependent rates (Figure 12). For the activation 
energy EA a value of 20 kcal mol–1 was derived, which is in good agreement with the results 
obtained for the meta-alkylation of ketimines (vide supra). 
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Figure 12: Arrhenius plot analysis for the meta-C–H alkylation of phenylpyridine 45c. 
 
3.4 Selectivity Prediction for meta-C–H Functionalization 
In contrast to the rapid development of procedures for meta-selective C–H activation reactions in 
ruthenium catalysis during the last years by a number of research groups (see Section 1.6), a 
reliable method for the prediction and rationalization of experimentally observed selectivities has 
proven elusive. Nonetheless, the rationalization of selectivities by means of computational studies 
would offer enormous benefits for the identification of viable substrates and complexes for meta- 
or para-C–H functionalizations. One method for computationally predicting selectivities is the 
Fukui function and its corresponding indices, as recently employed by Ritter for palladium-
catalyzed C–H activations[122] and Frost for ruthenium catalysis.[123] 
 
3.4.1 Oxazoline-Directed Alkylations 
Based on the results obtained for meta-selective C–H alkylations of ketimines, K. Korvorapun and 
N. Kaplaneris in the Ackermann group developed a strategy for oxazoline-directed meta-C–H 
alkylations with α-bromo esters 173 using a [Ru(O2CR)2(p-cymene)]/PPh3 catalyst, which 
exclusively yielded meta-functionalized product 174 (Scheme 69).[124] 
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Scheme 69: Optimized reaction conditions for oxazoline-assisted meta-C–H alkylations. 
 
To investigate the ortho/meta/para-selectivities, various cyclometalated ruthenium(II) and 
ruthenium(III) complexes, which are likely candidates under the reaction conditions, were 
explored by means of DFT calculations. Geometry optimizations were performed at the TPSS-
D3(BJ)/def2-TZVP level of theory,[125, 126, 127] while Fukui indices were based on NBO charges 
obtained at the B3LYP-D3(BJ)/def2-TZVP level of theory[128] (for full details see Section 6.2). 
Nucleophilicity Fukui indices, which designate the most favorable position for an electrophilic 
attack, predict the reaction to occur in para-position with respect to the C–Ru bond in all studied 
complexes (Figure 13). Nevertheless, the formation of a carbocation through a heterolytic C–Br 
bond cleavage in the alkyl bromide can be safely excluded due to experimental mechanistic 
findings, including spin trapping EPR investigations, and isolation of a TEMPO-alkyl adduct. 
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Figure 13: Relative nucleophilicity Fukui indices for cyclometalated complexes with oxazolines. 
L = 1,4-dioxane. 
 
In contrast, the calculation of radical Fukui indices revealed significant differences between the 
studied complexes. Complex 4.A, featuring a η6-coordinated p-cymene ligand, as well as complex 
4.B exhibited the highest reactivity at the carbon atom in the para-position with respect to the 
directing group, which is opposed to the experimentally observed selectivity (Figure 14). Even 
though for ruthenium(II) complex 4.C the reaction was predicted to occur at the correct position, 
a C5/C4 ratio of only 2.7 was obtained, indicating the formation of a mixture of products. 
Furthermore, 4.C is a coordinatively unsaturated complex, that is presumable not stable under 
the reaction conditions. Increased C5/C4 ratios were found for ruthenium(III) complexes 4.D-4.F, 
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which is in agreement with a homolytic C–Br bond cleavage in a SET fashion leading to an oxidation 
of ruthenium(II) to ruthenium(III). 
 
 
Figure 14: Relative radical Fukui indices for cyclometalated complexes with oxazolines. 
L = 1,4-dioxane.  
 
3.4.2 Purine-Directed Alkylations 
In continuation of the studies on ruthenium-catalyzed meta-selective alkylations of oxazolines, F. 
Fumagalli and Dr. S. Warratz in the Ackermann group explored the purine-directed meta-C–H 
alkylation of purines 148 with various alkyl halides 100 under ruthenium catalysis (Scheme 70).[129] 
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The efficacy of the arene-ligand-free complex [Ru(OAc)2(PPh3)2] (175) was shown by efficiently 
catalyzing the desired transformation. Additionally, the catalyst showed an improved 
performance compared to typically employed [Ru(O2CR)2(p-cymene)] catalysts. 
 
 
Scheme 70: Optimized reaction conditions for purine-assisted meta-C–H alkylations. 
 
Subsequently, this catalyst was investigated by means of DFT calculations. Structures of 
cyclometalated complexes were optimized at the TPSS-D3(BJ)/def2-TZVP level of theory[125, 126, 127] 
and NBO charges for the assessment of Fukui indices were calculated at the B3LYP-D3(BJ)/def2-
TZVP level of theory[128] (for full details see Section 6.2). Nucleophilicity Fukui indices revealed a 
preferential reactivity at the C5 position, that is the para-position with respect to the C–Ru bond, 
and indicate very high C5/C4 ratios of more than 20:1 (Figure 15). Although, significant values 
were also obtained for the C3 position, which would also lead to an overall meta-selective 
functionalization of the substrate, an attack at this position can be disregarded due to steric 
congestion. In line with the experimental mechanistic studies previously performed for the aryl 
oxazolines, EPR experiments and reactions in the presence of radical scavengers again strongly 
suggested the formation of an alkyl radical. 
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Figure 15: Relative nucleophilicity Fukui indices for cyclometalated complexes with purines. 
L = 1,4-dioxane. 
 
Fukui indices for radical reactivity predicted a higher reactivity at the C4 position for all 
investigated complexes in comparison to the nucleophilicity indices. Furthermore, in complex 4.G 
reaction at the C4-position is determined to be even more likely than at the experimentally 
observed C5 position (Figure 16). It is noteworthy that in 4.G the highest value was calculated for 
the 6-position of the purine directing group, where no reaction can possibly occur. Ruthenium(III) 
complexes 4.I-4.K exhibited high C5/C4 ratios, with the highest value obtained for complex 4.K, 
which contains a phosphine as well as a κ2-coordinated acetate ligand. 
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Figure 16: Relative radical Fukui indices for cyclometalated complexes with purines. 
L = 1,4-dioxane.  
 
3.5 Ruthenium-Catalyzed Decarboxylative C–H Activation 
One mayor drawback in the use of directing groups for chelation-assisted C–H bond activation is 
the fact, that a removal of the directing group usually requires further synthetic operations, thus 
compromising the overall step- and atom-economy. In contrast, carboxylic acid directing groups 
can be removed in a traceless fashion during the C–H activation (vide supra). Although 
decarboxylative C–H activations under ruthenium-catalysis were previously reported, detailed 
studies on the catalyst’s mode of action remained scarce (Scheme 71).[59, 130] 
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Scheme 71: Optimized reaction conditions for ruthenium-catalyzed decarboxylative C–H 
alkenylations. 
 
Despite an increasing number of protocols for decarboxylative C–H activations under ruthenium 
catalysis (see Section 1.5), these procedures are often limited to acrylates or alkynes as the 
reagents. In this context, synthetically useful maleimides 177 were identified as viable substrates 
within the versatile hydroarylation/decarboxylation manifold by Dr. N. Y. P. Kumar[131] in the 
Ackermann group and provide access to arylated succinimides,[132] which find applications as 
anticancer and anticonvulsant agents.[133] Optimal results were obtained in DCE as the solvent of 
choice and [Ru(O2CMes)2(p-cymene)] (61) as the catalyst (Scheme 72).  
 
 
Scheme 72: Optimized reaction conditions for ruthenium-catalyzed decarboxylative C–H 
alkylations with maleimides 177. 
 
3.5.1 Alkenylations of Benzoic Acids with Alkynes 
The mechanism of the ruthenium-catalyzed alkenylation of benzoic acid (31a) with 
diphenylacetylene (35a) was studied by means of DFT calculations. Geometry optimizations were 
performed at the PBE0/def2-SVP level of theory[127, 134] and energies were refined through single 
point calculations at the PBE0-D3(BJ) /def2-QZVP*+SMD level[126, 135] (for full details see Section 
6.3). The PBE0 hybrid functional was selected due to an excellent performance in a benchmark 
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study on transition metal complexes and a good performance in the GMTKN55 benchmark by 
Grimme,[136] while the def2-QZVP* basis set provides sufficient accuracy at manageable 
computational cost. 
As a first step, ligand exchange on the complex [Ru(O2CMes)2(p-cymene)] (61) with benzoic acid 
(31a) leads to the formation of [Ru(O2CPh)2(p-cymene)] (5.A), which is the catalytically active 
species (Figure 17). Afterwards, agostic complex 5.B is formed with an energy barrier of 
19.6 kcal mol–1 and subsequently undergoes concerted C–H cleavage and C–Ru formation via 
transition state TS5.2 to form five-membered ruthenacycle intermediate 5.C. In intermediate 5.B 
the C–Ru distance was found to be 2.44 Å, which is 0.25 Å larger than the sum of the covalent radii 
(2.19 Å),[137] which therefore indicates that the C–Ru bond is not yet formed. In contrast, a C–Ru 
distance of 2.05 Å was observed in 5.C. Exchange of the coordinated benzoic acid with alkyne 35a 
generates complex 5.D and turnover-limiting migratory insertion of 35a into the C–Ru bond forms 
seven-membered ruthenacycle 5.E. Surprisingly, intermediate 5.E was calculated to be 
9.9 kcal mol–1 more stable than intermediate 5.D, despite the unfavorable ring size. Then, the key 
decarboxylation step takes place via concerted C–C bond cleavage/C–Ru bond formation in 
transition state TS5.4 (Figure 18). Two-fold proto-demetalation with two molecules of benzoic 
acid leads to the formation of the final product 5.K and regenerates the catalytically active 
complex 5.A. The first proto-demetalation was revealed to proceed via formation of agostic 
intermediate 5.H, whereas no agostic intermediate was located for the second proto-
demetalation process. Compared to 5.I, intermediate 5.J is energetically less favorable by 
9.4 kcal mol–1 due to considerable steric crowding. In total, the reaction is exergonic with a Gibbs 
free energy difference of –19.0 kcal mol–1. 
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Figure 17: Relative Gibbs free energy profile for the reaction of benzoic acid (31a) with alkyne 
35a at the PBE0-D3(BJ)/def2-QZVP*+SMD(PhMe) level of theory.  
 
 
Figure 18: Structure of decarboxylation transition state TS5.4. Distances are given in Å and 
hydrogen atoms are omitted for clarity. 
 
In addition, an evaluation of DCE, TFE, and water as representative polar and apolar solvents 
within the framework of the SMD/IEFPCM model was conducted. C–H ruthenation and migratory 
insertion was found to be energetically feasible in polar solvents with an energy difference of 
9.1 kcal mol–1 for TS5.1 in PhMe and water (Figure 19). In contrast, the energies of the transition 
states and intermediates of the two proto-demetalation steps increased, when polar solvents 
were used in the calculations. It is noteworthy that, while in toluene the turnover-limiting step 
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was represented by the migratory insertion, in TFE or water the decarboxylation event became 
turnover-limiting. 
 
 
Figure 19: Relative Gibbs free energy profile in PhMe (black line), DCE (red), TFE (green), and 
water (blue) for the reaction of benzoic acid (31a) with alkyne 35a. 
 
Furthermore, a significant stabilization of transition states and intermediates of the reaction of 
benzoic acid (31a) with alkyne 35a by dispersion forces was revealed by comparison of single point 
calculations with and without Grimme’s D3(BJ) correction (Figure 20). Especially for the structures 
of the proto-demetalation steps a notable influence of weak dispersive interactions was observed 
with stabilizations of up to 25.1 kcal mol–1 for TS5.7. 
 
 
Figure 20: Relative Gibbs free energy profile in DCE with D3(BJ) (black line) and without 
dispersion correction (red). 
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Following the migratory insertion, reductive elimination can occur as a competing pathway to 
form isochromene-derivative 37aa in an overall [4+2] annulation reaction (vide supra). A 
comparison of the energies of TS5.4 and TS5.8 in toluene resulted in an energy difference ΔΔG‡ 
of 5.0 kcal mol–1 in favor of the decarboxylation regime (Figure 21). This value decreases with an 
increase in solvent polarity and in TFE or water the difference is neglectable with a ΔΔG‡ value of 
only 0.2 kcal mol–1 and 0.1 kcal mol–1, respectively. Independent of the solvent, intermediate 5.F, 
which is formed in the decarboxylation process, was calculated to be energetically less favorable 
than ruthenium(0) complex 5.L by 19.7–22.2 kcal mol–1. Opposed to a report by Hong,[130] these 
findings suggest, that the chemoselectivity of the reaction is not exclusively controlled by the 
energy difference of TS5.4 and TS5.8 and therefore is not solely influenced by the choice of 
solvent, but rather by the presence or absence of a suitable oxidant for the reoxidation of 
ruthenium(0) to catalytically competent ruthenium(II). If no oxidant is present in the reaction, 
intermediate 5.L represents a resting state as no reoxidation to ruthenium(II) can occur, while 5.F 
is an on-cycle intermediate. 
 
 
Figure 21: Comparison of reductive elimination and decarboxylation in PhMe (black line), DCE 
(red), TFE (green), and water (blue). Energies are given in kcal mol–1 relative to 5.A. 
 
3.5.2 Alkylation of Benzoic Acids with Alkenes 
Concerning the reaction of benzoic acids 31 with maleimides 177 (Scheme 72), DFT calculations at 
the PBE0-D3(BJ)/def2-QZVP*+SMD(DCE)//PBE0/def2-SVP level of theory[126, 127, 134, 135] (for full 
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details see Section 6.3) point to a reaction mechanism very similar to the reaction with alkynes 35 
(Figure 22). C–H ruthenation, which is omitted due to similarity with the results presented above, 
is followed by coordination of maleimide 177a, which can either occur with the amide moiety 
oriented away from the p-cymene ligand (5.D’) or towards it (5.D’’) (Figure 23). Although geometry 
5.D’’ is energetically favored by 4.9 kcal mol–1, the energy barrier for migratory insertion is higher 
by 6.2 kcal mol–1. Therefore, it is reasonable that the reaction proceeds via intermediate 5.D’. 
Seven-membered ruthenacycle intermediate 5.E’ then undergoes decarboxylation to form 
complex 5.F’ and proto-demetalation with two molecules of benzoic acid leads to liberation of the 
arylated succinimide and regeneration of complex 5.A. 
Compared to the reaction with alkynes 35 (Figure 17), intermediate 5.E’ and 5.F’ are energetically 
less favorable by 6.0 and 4.3 kcal mol–1, respectively, due to the constrained geometry dictated by 
the succinimide motif. It is noteworthy that intermediate 5.J’ is 16.5 kcal mol–1 higher in energy 
than the corresponding intermediate 5.J, which is caused by the formation of a less favorable 
hydrogen bond (dOH–O = 1.41 Å) between the OH group of the coordinated benzoic acid and the 
ruthenium-coordinated oxygen of the benzoate ligand (Figure 24). 
 
 
Figure 22: Relative Gibbs free energy profile for the reaction of benzoic acid (31a) with 
maleimide 177a at the PBE0-D3(BJ)/def2-QZVP*+SMD(PhMe) level of theory relative to 5.A. 
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Figure 23: Structure of coordination intermediate 5.D’ (left) and 5.D’’ (right). Non-participating 
hydrogen atoms are omitted for clarity. 
 
 
Figure 24: Structure of intermediate 5.J’. Distances are given in Å and non-participating 
hydrogen atoms are omitted for clarity. 
 
Single point calculations with different solvents revealed a trend similar to the one observed for 
alkynes 35. Again, the energies of intermediates 5.D’ and 5.E’ as well as transition state TS5.3’ 
decreased with increasing solvent polarity, while proto-demetalation became energetically 
slightly less favorable (Figure 25). 
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Figure 25: Relative Gibbs free energy profile in PhMe (black line), DCE (red), TFE (green), and 
water (blue) for the reaction of benzoic acid (31a) with maleimide 177a. 
 
A study of the influence of dispersion forces on the mechanism was performed. In line with the 
previously obtained results for the reaction of alkynes 35, considerable destabilization was 
observed, when no dispersion correction was employed (Figure 26). A significant difference of 
21.3 kcal mol–1 was found for intermediate 5.J’, thereby highlighting the importance of accurate 
dispersion corrections in computational investigations. 
 
 
Figure 26: Relative Gibbs free energy profile in DCE with D3(BJ) (black line) and without 
dispersion correction (red). 
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The possibility of a [4+2] cyclization as a competing reaction pathway could be completely 
excluded due to unrealistically high energies for the reductive elimination transition state TS5.8’ 
and ruthenium(0) sandwich-type complex 5.L’ (Figure 27). Independent of the solvent, Gibbs free 
energies in excess of 67 and 22 kcal mol–1 were determined for TS5.8’ and 5.L’, respectively, which 
can be attributed to mainly two factors: a) cyclization via reductive elimination requires the C–C 
bond between the arene and succinimide moieties to bend out of the arene-plane (approx. 22° 
for TS5.8’ and 32° for 5.L’) and b) in complex 5.L’ ruthenium is coordinated by the C–O single bond 
of the formed isochromanone moiety, which represents a disadvantageous, weak ligand. 
 
 
Figure 27: Comparison of reductive elimination and decarboxylation in PhMe (black line), DCE 
(red), TFE (green), and water (blue). Energies are given in kcal mol–1 relative to 5.A. 
 
The computationally obtained results were further confirmed by experimental mechanistic 
investigations. Experiments with deuterium-labelled benzoic acid 31b led to deuterium-
incorporation in the former ipso-position of 178bb and in the succinimide-motif, indicating that 
the carboxylate acts indeed as the proton-acceptor during the C–H scission and, subsequently, the 
corresponding acid serves as the proton-source in the proto-demetalation step (Scheme 73a). 
Additionally, a significant deuterium incorporation in the succinimide-motif was found in the cis-
position with respect to the newly formed C–C bond, which is in line with the calculated proto-
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demetalation step and renders an outer-sphere protonation event unlikely. The observed 
incorporation of deuterium in the para-position to the fluorine-substituent can be attributed to a 
post-transformational H/D scrambling. Initial rate measurements by in situ IR spectroscopy with 
substrate 31b or [D]1-31b resulted in a neglectable kinetic isotope effect value of kH/kD = 1.05, thus 
pointing to a non-turnover-limiting C–H cleavage event (Scheme 73b and Figure 28). The observed 
KIE value is in good agreement with a calculated value of 1.08 for the formation of agostic 
intermediate 5.B as obtained from the DFT calculations (see Section 6.3.3). 
 
 
Scheme 73: (a) Reaction with isotopically labelled substrate (performed by Dr. N. Y. P. Kumar). 
(b) Kinetic isotope effect study by parallel reactions. 
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Figure 28: Kinetic isotope effect study by in situ IR spectroscopy. 
 
3.6 Ruthenium-Catalyzed C–H Alkenylation of Aryl Acetamides 
Aryl acetamides are an important structural motif that can be found in a number of natural 
products and bioactive molecules (Scheme 74). They represent for example a class of κ-opioid 
agonists[138] with applications as analgesic drugs.[139] In addition, atenolol acts as β-blocker and can 
be used as treatment for cardiovascular diseases.[140] Consequently, the development of novel 
methods for the functionalization of aryl acetamides remains highly desirable. 
 
 
Scheme 74: Selected bioactive aryl acetamides. 
 
The application of C–H activation strategies towards the synthesis of substituted aryl acetamides 
was so far limited to precious palladium catalysts with contributions by Yu,[110] among others.[111] 
In sharp contrast, the use of less expensive ruthenium catalysts for C–H activations of aryl 
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acetamides remained undisclosed, due to the challenging formation of an unfavorable six-
membered ruthenacycle through the distal weak coordination of amides. 
Nevertheless, Dr. Q. Bu and Dr. V. Kotek in the Ackermann group developed the oxidative 
alkenylation of aryl acetamides 153 with acrylates 27, employing an in situ generated cationic 
ruthenium complex and a copper(II) salt as the oxidant (Scheme 75).[141] Tertiary, secondary, and 
even challenging primary amides were smoothly transformed under the reaction conditions and 
a number of valuable functional groups was well tolerated. 
 
 
Scheme 75: Optimized reaction conditions for ruthenium-catalyzed C–H alkenylations of 
acetamides 153. 
 
To gain insight into the catalyst’s mode of action, a series of mechanistic experiments was 
performed. When the reaction was conducted in the presence of isotopically labeled methanol as 
cosolvent, significant H/D scrambling was observed in the ortho-position of the product 155aa as 
well as the reisolated substrate 153a, thus indicating a facile C–H ruthenation (Scheme 76a). 
Furthermore, the kinetic isotope effect was determined in two parallel reactions by means of in 
situ IR spectroscopy and resulted in a low, non-significant KIE value of kH/kD = 1.02, which renders 
a turnover-limiting C–H activation event unlikely (Scheme 76b). An intermolecular competition 
experiment between acetamide 153c and benzamide 34a led to exclusive formation of 
alkenylated benzamide 179ab, thereby highlighting the considerably more challenging 
transformation of aryl acetamide substrates (Scheme 76c). 
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Scheme 76: (a) H/D exchange experiment (performed by Dr. Q. Bu). (b) Kinetic isotope effect 
study by parallel reactions. (c) Intermolecular competition reaction (performed by Dr. Q. Bu). 
 
Additionally, the mechanism of the ruthenium-catalyzed oxidative C–H alkenylation was studied 
by means of DFT calculations. Geometry optimizations and frequency calculations were 
performed with the TPSS meta-GGA functional[125] in combination with the Karlsruhe def2-TZVP 
basis set[127] and D3(BJ) correction.[126] For the single point calculations, the B3LYP hybrid 
functional[128] with def2-TZVP basis set, D3(BJ) correction and COSMO solvation model[142] was 
employed (for full details see Section 6.4). 
The experimental studies revealed that the presence of a silver salt containing a weakly 
coordinating anion,[143] such as hexafluoroantimonate or tetrafluoroborate, was required to 
achieve conversion to the desired product. Furthermore, no reaction was observed, when 
Cu(OAc)2 was replaced by other copper(II) salts or by other metal-based oxidants, thus leading to 
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the assumption that a cationic [Ru(OAc)(p-cymene)]+ complex is formed in situ. Based on this 
hypothesis, the computational investigations were started with cationic, O-coordinated complex 
6.A and the weakly coordinating anion was omitted in all calculations for the sake of simplicity 
(Figure 29). Coordination through the deprotonated amide nitrogen can be reasonably excluded 
based on the fact, that tertiary amides as well as substrates bearing bulky N-substituents also 
furnished the desired products in high yields. Decoordination of one oxygen of the κ2-coordinated 
acetate ligand with an energy barrier of 11.8 kcal mol–1 generates five-coordinated intermediate 
6.B, which undergoes concerted C–H cleavage/C–Ru formation to form six-membered 
ruthenacycle 6.C. Afterwards, acetic acid is replaced by acrylate 27a to generate intermediates 
6.D. Turnover-limiting migratory insertion of the alkene into the Ru–C bond generates eight-
membered ruthenacycle intermediate 6.E with an energy barrier of 18.2 kcal mol–1. Finally, 
formation of agostic complex 6.F followed by β-hydride elimination leads to the formation of 
product-coordinated complex 6.G. 
Coordination of the alkene can also occur with the ester substituent facing away from the 
p-cymene ligand as shown in complex 6.D’. Although intermediate 6.D’ and transition state TS6.3’ 
are energetically favorable compared to 6.D and TS6.3 with energy differences of 6.2 kcal mol–1 
for the transition state, subsequent β-hydride elimination requires considerably more energy, 
since TS6.4’ was found to be 8.9 kcal mol–1 higher in energy than TS6.4. These results are in 
agreement with calculations by McMullin/Williams/Frost on a related catalytic system.[144] 
Additionally, 6.G’ features a Z-configured double bond, which is experimentally not observed. The 
two possible coordination geometries with the ester-substituent in proximal position with respect 
to the phenyl ring were disregarded, since these geometries would lead to the formation of the 
experimentally not observed branched product. 
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Figure 29: Relative Gibbs free energy profile for the reaction of amide 153d with acrylate 27a. 
 
A Mayer bond order analysis was employed to investigate the C–H cleavage/Ru–C formation step 
in greater detail (Table 2). For the C–H bond, the bond order decreases from 0.87 in intermediate 
6.B over 0.38 in TS6.2 to a value of 0.11 in intermediate 6.C. At the same time the bond order of 
the O–H bond increases from a neglectable value of <0.10 over 0.39 to a final value of 0.77, which 
is in line with the observed C–H distances. Here, the C–H distance was found to increase from a 
value of 1.08 Å in complex 6.B to 1.34 Å in TS6.2 (Figure 30) and, finally, to 1.96 Å in metallacycle 
6.C. Additionally, the Ru–C bond order was calculated to increase from 0.28 in intermediate 6.B 
to 0.72 in cyclometalated complex 6.C. The nonzero value in complex 6.B can be explained by a 
weak coordination of ruthenium to the π-system of the substrate with a distance of dRu–C = 2.53 Å, 
which is 0.34 Å larger than the sum of the covalent radii (2.19 Å).[137] 
 
Table 2: Bond order analysis for the C–H ruthenation step. 
Bond 6.B TS6.2 6.C 
C–H 0.8700 0.3754 0.1064 
Ru–C 0.2767 0.4471 0.7177 
O–H <0.10 0.3938 0.7676 
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Figure 30: Structure of transition state TS6.2. Distances are given in Å and non-participating 
hydrogen atoms are omitted for clarity. 
 
A comparison with the corresponding benzamide substrate revealed the C–H cleavage transition 
state TS6.25 to be energetically favorable by 2.0 kcal mol–1 and the five-membered ruthencycle 
analogue 6.C5 to be stabilized by 6.1 kcal mol–1 (Figure 31). This stabilization is caused by a more 
favorable planar geometry of 6.C5 as compared to the boat-like geometry of six-membered 
metallacycle 6.C (Figure 32). Furthermore, these findings are congruent with the results obtained 
by intermolecular competition experiments. 
 
 
Figure 31: Relative Gibbs free energy profile for the C–H activation of benzamide 34b. 
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Figure 32: Structure of cyclometalated complex 6.C (left) and 6.C5 (right). Non-participating 
hydrogen atoms are omitted for clarity. 
 
The influence of dispersion effects on the Gibbs free energy profile was investigated by removing 
the D3 correction energies from the single point energies. As expected, omission of dispersion 
contributions led to a considerable destabilization of intermediates as well as transition states 
with energy differences of at least 3.7 kcal mol–1 (Figure 33). Especially eight-membered 
ruthenacycle 6.E was found to be vastly stabilized through dispersion effects by 10.6 kcal mol–1, 
highlighting the importance of weak non-covalent interactions in catalysis. 
 
 
Figure 33: Relative Gibbs free energy profile with D3(BJ) (black line) and without dispersion 
correction (red). 
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The calculated energies at the B3LYP-D3(BJ)/def2-TZVP+COSMO level of theory were further 
evaluated with a number of commonly employed functionals. Hence, single point calculations 
were performed using the PBE0 hybrid GGA functional[134] and the PW6B95 hybrid-meta-GGA 
functional[145] (Figure 34). Energies obtained with Truhlar’s PW6B95 functional were overall in 
good agreement with the B3LYP results, which is in line with a comparable performance of these 
functionals in various benchmark studies.[136, 146] In contrast, calculations at the PBE0 level resulted 
in comparatively more stable intermediates 6.D-6.G and transition states TS6.3 and TS6.4, 
whereas only relatively minor changes in the relative Gibbs free energies for the C–H ruthenation 
step were observed. 
 
 
Figure 34: Relative Gibbs free energy profile at the B3LYP (black line), PW6B95 (red), and PBE0 
(blue) level of theory. 
 
3.7 Ruthenium-Catalyzed Thiocarbonyl-Directed Ferrocene C–H Arylation 
Substituted ferrocenes constitute an important class of compounds with numerous applications 
in organocatalysis and transition metal catalysis.[112] Additionally, bioactivity studies revealed 
promising antimalarial and anticancer properties of functionalized ferrocenes (Scheme 77).[113] 
Therefore, novel methods for the efficient functionalization of ferrocenes continue to be in high 
demand. 
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Scheme 77: Selected ferrocene-containing ligands and drugs. 
 
Despite the undisputable advances in catalyzed C–H activation towards the development of 
environmentally-benign synthetic methods, these reactions are usually conducted in 
environmentally problematic, non-recyclable organic solvents, thus compromising the overall 
sustainability of the C–H activation methodology.[147] While water would at first glance offer an 
alternative as a non-toxic and non-flammable ubiquitous reaction medium, the limited solubility 
of commonly employed catalysts and organic compounds usually leads to an impaired reaction 
outcome. 
With this aspect in mind, Dr. S. R. Yetra in the Ackermann group observed that the use of micelle-
forming surfactant TPGS-750M allowed for the ruthenium-catalyzed C–H arylation of ferrocenes 
156 to occur with high efficacy in water (Scheme 78).[148] Ruthenium(II)-biscarboxylate catalysts 
facilitated the thiocarbonyl-directed direct C–H arylation, delivering the desired mono-
functionalized products 158 in good to excellent yields. Interestingly, replacement of the 
thiocarbonyl directing group with simple ketones resulted in a complete shutdown of the reaction 
under otherwise identical conditions. 
 
 
Scheme 78: Optimized reaction conditions for ruthenium-catalyzed C–H arylations of ferrocenes 
156. 
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Intrigued by the vastly different behavior of thiocarbonyls and ketones, the key C–H activation 
step was studied computationally by means of DFT calculations. Geometry optimization and 
vibrational frequency calculations were performed at the TPSS-D3(BJ)/def2-TZVP meta-GGA level 
of theory.[125, 126, 127] In the single point calculations, Truhlar’s PW6B95 hybrid-meta-GGA 
functional[145] was employed in combination with D3(BJ) dispersion correction and def2-TZVP basis 
set, while solvent effects were accounted for through the use of the COSMO solvation model[142] 
with a dielectric constant corresponding to toluene (for full details see Section 6.5). The use of 
toluene as reaction medium led to comparable results and, therefore, toluene was chosen as the 
solvent in the calculations for the sake of simplicity. Furthermore, the adamantyl carboxylate 
ligands were replaced by acetate, due to a similar performance in the reaction. 
Starting from adduct complex 7.A, which is formed by coordination of 156a to ruthenium and 
dissociation of one acetate ligand, C–H activation proceeds via formation of agostic complex 7.B 
with an energy barrier of 10.9 kcal mol–1 (Figure 35). Afterwards, concerted C–H cleavage/Ru–C 
formation in TS7.2 generates cyclometalated intermediate 7.C with an overall barrier of 
14.8 kcal mol–1, which is in good agreement with studies on comparable ruthenium-catalyzed 
reactions (vide supra). In all calculated structures, the Cp-rings of the ferrocene-moiety adopt an 
eclipsed rather than a staggered configuration,[149] and the Cp-rings are noticeable tilted towards 
each other in cyclometalated intermediate 7.C (Figure 36). In stark contrast, replacing sulfur in 
complex 7.A with oxygen led to a significant destabilization by 8.6 kcal mol–1. Consequently, the 
relative Gibbs free energies of the later intermediates and transition states increased by 10.7–
13.0 kcal mol–1 compared to the respective sulfur analogues along with higher energy barriers of 
13.0 and 19.2 kcal mol–1. Calculations of the corresponding selenium analogues revealed these 
structures to be slightly more stable than the initial sulfur complexes with energy differences of 
0.2–3.1 kcal mol–1. Nevertheless, the energy barriers for the formation of agostic intermediate 7.B 
and cyclometalated complex 7.C are 12.6 and 15.8 kcal mol–1, respectively, which represents a 
small increase compared to thiocarbonyl as the directing group. 
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Figure 35: Relative Gibbs free energy profile for the C–H activation of ferrocene 156a with 
thioketone (black line), ketone (red), and selenoketone (blue) directing group.  
 
 
Figure 36: Structure of cyclometalated complex 7.C (X = S). Non-participating hydrogen atoms 
are omitted for clarity. 
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Although the increasing size of the chalcogen atoms (van-der-Waals radii: 1.52 Å for oxygen, 
1.80 Å for sulfur, and 1.90 Å for selenium[150]) and the consequently greater X–Ru and X–C bond 
lengths should reduce the steric repulsion within the complex and also the ring-strain in 
cyclometalated intermediate 7.C (for selected bond lengths see Section 6.5.3), this effect does not 
rationalize the already considerable energy differences in intermediate 7.A. To this end, a 
distortion-interaction analysis[151] was performed for transition state TS7.1 to quantify differences 
in the complex geometries (Figure 37). The structures were separated into a substrate and a 
[Ru(OAc)(p-cymene)]+ fragment and the energies of the fragments were compared to the freely 
optimized structures. Notably, the distortion energy is almost identical for all structures with 
differences of less than 1.0 kcal mol–1, thereby substantiating the suspected marginal geometric 
influences on the observed energy differences. In contrast, the interaction energies showed more 
pronounced differences with larger stabilizations for the higher chalcogens. With respect to the 
corresponding intermediates 7.A, the interaction energy decreased by 3.1 kcal mol–1 and 
1.3 kcal mol–1, when the ketone was compared to the thioketone and selenoketone, respectively. 
 
 
Figure 37: Distortion-interaction analysis for transition state TS7.1 with distortion energies for 
the substrate (red column) and the metal fragment (orange), interaction energies (blue), and 
total energies (grey). Negative values correspond to stabilizing contributions. 
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Along with an increase in size the polarizability drastically increases for higher chalcogens (in a.u.: 
5.3 for oxygen, 19.4 for sulfur, and 28.9 for selenium[152]), which might result in stronger attractive 
London dispersion interactions within the complexes. A comparison of energies calculated with 
and without Grimme’s D3 correction revealed a largely neglectable influence with differences of 
less than 2.0 kcal mol–1 for all structures (Figure 38). As expected, the largest influence was 
observed for structures containing highly polarizable selenoketone as the directing group. 
 
 
Figure 38: Relative Gibbs free energy profile for C–H ruthenation with thioketone (black line), 
ketone (red), and selenoketone (blue) directing group with (solid lines) and without dispersion 
correction (dashed lines). 
 
3.8 Ruthenium-Catalyzed C–H Alkylation on Peptides 
During the last decade non-natural amino acids and peptides were recognized as an important 
scaffold for pharmaceutical applications and medicinal chemistry.[153] Consequently, novel 
methods for the late-stage diversification of peptides and amino acids are highly sought after. 
While peptide diversification so far largely relies on classical approaches or cross-coupling 
reactions employing precious palladium-catalysts, drawbacks in terms of atom- and step-economy 
remained (vide supra).[154] In contrast, C–H activation strategies offer considerable economical as 
well as ecological advantages for the syntheses of substituted peptides with palladium- and 
ruthenium-catalyzed transformations reported by a number of research groups.[114] 
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Out of the natural occurring amino acids, diversification of tryptophan offers great potential due 
to a low natural occurrence of only 1–2% in peptides,[155] hence minimizing potential 
regioselectivity issues, and a user-friendly installation of directing groups for chelation-assisted C–
H activation via indole N-substitution. 
With these aspects in mind, Dr. A. Schischko and N. Kaplaneris in the Ackermann group achieved 
ruthenium-catalyzed C–H alkylations of tryptophans 160 with acrylates and maleimides, among 
others (Scheme 79).[156] Optimal results were obtained in acetic acid as the reaction medium and 
commercially available [RuCl2(p-cymene)]2 as the catalyst. The reaction was not only applicable to 
tryptophans, but also to small peptides, and even peptide ligations could be realized. It is 
noteworthy that peptides on resin delivered the desired product likewise, thus allowing for user-
friendly purification procedures. 
 
 
Scheme 79: Optimized reaction conditions for ruthenium-catalyzed C–H alkylations of 
tryptophans 160 with acrylates 27. 
 
To gain further insight into the catalyst’s mode of action, the reaction mechanism was explored 
by DFT calculations. Geometry optimizations were conducted at the PBE0-D3(BJ)/def2-SVP level 
of theory[126, 127, 134] and single point calculations were performed at the PBE0-D3(BJ)/def2-QZVP* 
+SMD(HOAc) level of theory[127, 135] (for full details see Section 6.6). For the sake of simplicity and 
a reduction of the computational cost, tryptophan was replaced by N-pyridyl indole (125a) in the 
calculations. 
Due to the use of acetic acid as reaction medium, [RuCl2(p-cymene)]2 likely undergoes salt-
metathesis/ligand exchange with the solvent to generate biscarboxylate complex 
[Ru(OAc)2(p-cymene)] (79). Subsequently, decoordination of one acetate ligand and coordination 
of 125a generates mono-cationic intermediate 8.A (Scheme 80). Although this process was 
calculated to be endergonic by 13.8 kcal mol–1, it involves the formation of cationic complex 8.A 
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and an anionic acetate. Formation of solvent-separated or contact ion-pairs, which unfortunately 
cannot be accurately described within the framework of continuum solvation models, will likely 
occur in polar proctic solvents, such as acetic acid, and should stabilize the charged species, 
thereby reducing the relative energy. 
 
 
Scheme 80: Formation of mono-cationic intermediate 8.A. 
 
Starting from intermediate 8.A, formation of agostic complex 8.B occurs via transition state TS8.1 
with an energy barrier of 10.7 kcal mol–1 (Figure 39). Afterwards, five-membered ruthenacycle 8.C 
is formed (Figure 40), which then undergoes ligand exchange to generate intermediate 8.D. 
Unfortunately, a transition state for the formation of intermediate 8.C could not be located at this 
level of theory (vide infra). Migratory insertion of the coordinated alkene into the Ru–C bond with 
an energy barrier of 13.1 kcal mol–1 leads to the formation of seven-membered ruthenacycle 8.E. 
Coordination of acetic acid facilitates turnover-limiting proto-demetalation via TS8.4 with a 
barrier of 24.7 kcal mol–1 (Figure 41) and generates agostic complex 8.G. Thereafter, κ2-κ1 
coordination shift of the acetate ligand results in the formation of final intermediate 8.H. Overall 
the reaction was found to be exergonic by –12.8 kcal mol–1. 
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Figure 39: Relative Gibbs free energy profile for the reaction of indole 125a with acrylate 27a. 
 
 
Figure 40: Structure of cyclometalated complex 8.C. Non-participating hydrogen atoms are 
omitted for clarity. 
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Figure 41: Structure of key transition state TS8.4. Distances are given in Å and non-participating 
hydrogen atoms are omitted for clarity. 
 
Furthermore, the influence of the η6-coordinated arene ligand on the energy profile of the 
reaction was investigated by replacing p-cymene with sterically more demanding t-butylbenzene 
or unsubstituted benzene (Figure 42). Complexes with benzene as well as t-butylbenzene were 
destabilized compared to the respective p-cymene ligand-containing complexes, due to an 
increased steric demand of t-butylbenzene and a decreased ring-electron density of benzene. The 
t-butylbenzene derivatives of transition state TS8.3 and intermediate 8.G represent the only 
exceptions and were found to be slightly more stable by 0.8 kcal mol–1 and 0.3 kcal mol–1, 
respectively. For the unencumbered and less electron-rich benzene ligand, a considerable 
destabilization of 2.7–5.6 kcal mol–1 was observed for all intermediate and transition states. 
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Figure 42: Relative Gibbs free energy profile for η6-coordinated p-cymene (black line), 
t-butylbenzene (blue), and benzene (red). 
 
To verify that the proto-demetalation event is the turnover-limiting step of the reaction, a number 
of different functionals and basis sets were tested in an attempt to locate the C–H ruthenation 
transition state. By employing the M06 hybrid functional[157] from the Minnesota group of 
functionals an appropriate transition state was successfully identified (for full details see Section 
6.6). Calculations at the PW6B95-D3(BJ)/def2-QZVP*+SMD(HOAc)//M06-D3/def2-SVP level of 
theory[145] resulted in energy barriers, that are largely comparable to the results obtained with the 
PBE0 functional (Figure 43). Indeed, the energy barrier for C–H bond cleavage (TS8.2) was 
calculated to be 14.7 kcal mol–1, which is 10.4 kcal mol–1 lower than the corresponding barrier for 
the proto-demetalation step (25.1 kcal mol–1). Therefore, the calculations confirmed a facile and 
not turnover-limiting C–H cleavage event, which is in agreement with results obtained from H/D 
scrambling experiments.[156] 
It should be noted that the PW6B95/M06 calculations led to significantly higher relative energies 
for ruthenacycle 8.C and all following transition states and intermediates compared to the 
calculations at the PBE0 level. The calculated energy differences between the two methods were 
in the range of 2.4–8.3 kcal mol–1 with the largest difference observed for complex 8.D. 
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Figure 43: Relative Gibbs free energy profile at the PW6B95-D3(BJ)/def2-QZVP*+SMD(HOAc)// 
M06-D3/def2-SVP level of theory. 
 
3.9 Ruthenium-Catalyzed Oxidative C–H/C–H Activation 
Although direct C–H arylations under ruthenium catalysis have received considerable attention 
throughout the years and led to the development of protocols for the functionalization of 
numerous synthetically useful compound classes,[27] ruthenium-catalyzed C–C bond formations 
via dehydrogenative C–H/C–H activations continue to be mostly limited to the use of costly metal 
salts as terminal oxidants.[158] In contrast, a study by Ackermann uncovered the potential of aryl 
halides as oxidants under specific reaction conditions (Scheme 81).[115] 
 
 
Scheme 81: Oxidative C–H/C–H activation versus direct C–H arylation. 
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Thus far, a thorough mechanistic understanding of the reaction mechanism and the parameters, 
which control the switch in selectivity between the C–H arylation and C–H/C–H activation process, 
is lacking. Detailed insight into the catalyst’s mode of action could lead to further improvements 
to both processes with regard to catalyst performance and substrate scope. 
 
3.9.1 Studies on Substrate Control and Solvent Evaluation 
The studies were initiated by reacting 2-(2-methylphenyl)pyridine (45d) with diversly decorated 
aryl halides 46, 54 in the presence of in situ generated ruthenium-biscarboxylate complexes as 
catalysts (Figure 44). While aryl halides devoid of ortho-substituents (46c-e) as well as 2-
fluorobromobenzene (46f) led to exclusive formation of the arylated product 47, arenes bearing 
a substituent in the 2-position resulted in a mixture of products. Electron-withdrawing 
substituents favored the C–H/C–H activation process and 2-bromobenzonitrile (46k) proved 
optimal in facilitating the dehydrogenative pathway, delivering the desired product 181d in 73% 
yield. Furthermore, a 2,6-disubstitution pattern did not result in any synthetically useful reaction 
outcome. Compared to aryl bromide 46j, aryl chloride 54a exhibited a reduced reactivity, whereas 
aryl iodides 54b and 54c led to a reaction outcome comparable to aryl bromides 46j and 46k. 
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Figure 44: Influence of the aryl halide substitution pattern. [a] Determined by crude 1H-NMR 
with 4-(MeO2C)2C6H4 as the internal standard. 
 
With 2-bromobenzonitrile (46k) being identified as the optimal reagent for the oxidative C–H/     
C–H activation, the influence of the phenylpyridine 45 substitution pattern on the reaction 
outcome was evaluated (Figure 45). While 2-fluoro-, and 3-alkyl-substituted arenes delivered the 
arylated product 47 in good to excellent yield, moderate amounts of 181 were obtained with 
2-dimethylamino-, 2-methoxy-substituted, and unsubstituted arenes 45i-j, 45a. It is noteworthy 
that the introduction of a PMP group in the ortho-position resulted in the formation of minor 
amounts of C–H/C–H activated product and high amounts of arylated product. In contrast, ortho-
alkylated, benzylated, and trifluoromethylated phenylpyridines 45d, 45l-n facilitated the 
formation of 181 in very good yield, hence suggesting that the selectivity is governed by steric as 
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well as electronic properties. Gratifyingly, pyridylnaphthalene 45k also favored the C–H/C–H 
activation process, thus allowing for the rapid construction of π-conjugated, fluorescent 2,2’-
binaphthyl 181k in moderate yield (Figure 46). In addition, the structure of 181k was 
unambiguously determined by single crystal X-ray diffraction analysis (Figure 47). 
 
 
Figure 45: Influence of the phenylpyridine substitution pattern. [a] Diarylated product was 
obtained. [b] Performed by Dr. Y. Bourne-Branchu. 
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Figure 46: Fluorescence spectra of 45k and 181k with excitation at 270 nm. 
 
 
Figure 47: Crystal structure of 181k. Hydrogen-atoms are omitted for clarity. 
 
Furthermore, various solvents were tested in the ruthenium-catalyzed direct C–H arylation and 
oxidative C–H/C–H activation reaction. The use of apolar 1,4-dioxane instead of toluene as the 
reaction medium delivered comparable amounts of arylated product 47dj, even though a 
decreased C–H/C–H activation efficiency was observed (Table 3, entries 1 and 2). In contrast, a 
vastly increased yield of product 181d was obtained in polar, aprotic MeCN, while the competing 
C–H arylation pathway was almost completely suppressed (entry 3). Unfortunately, other polar 
solvents did not prove beneficial (entries 4-6), which indicates that MeCN serves a dual role as the 
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solvent as well as a potential ligand. Furthermore, the essential role of the ruthenium catalyst and 
MesCO2H (58) was verified (entries 7-8), highlighting the importance of carboxylate-assistance[15a] 
for ruthenium-catalyzed C–H activation. The use of well-defined [Ru(O2CMes)2(p-cymene)] (61) or 
a cylometalated complex resulted in a similar reaction outcome and did not constitute a major 
improvement (entry 9 and 11). Cationic complex [Ru(NCMe)6][SbF6]2 fell short in facilitating the 
desired transformation (entry 11). 
 
Table 3: Influence of reaction media and catalysts.[a] 
 
Entry [Ru] Solvent Yield 47dj / % Yield 181d / % 
1 [RuCl2(p-cymene)]2 PhMe 22 51 
2 [RuCl2(p-cymene)]2 1,4-dioxane 25 40 
3 [RuCl2(p-cymene)]2 MeCN trace 78 
4 [RuCl2(p-cymene)]2 NMP 13 18 
5 [RuCl2(p-cymene)]2 DMSO -- -- 
6 [RuCl2(p-cymene)]2 DMF 11[b] 18[b] 
7 -- PhMe -- -- 
8[c] [RuCl2(p-cymene)]2 PhMe 8 8 
9[c] [Ru(O2CMes)2(p-cymene)] (61) PhMe 24 57 
10 [Ru(NCMe)6][SbF6]2 PhMe trace trace 
11 
 
PhMe 22 55 
[a] Reaction conditions: 45d (0.50 mmol), 46j (0.75 mmol), [Ru] (5.0 mol %), MesCO2H (58) 
(30 mol %), K2CO3 (1.00 mmol), solvent (2.0 mL), 120 °C, 20 h. Yields of isolated products are 
given. [b] Determined by crude 1H-NMR with 4-(MeO2C)2C6H4 as the internal standard. [c] 
Without MesCO2H (58). 
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3.9.2 Mechanistic Studies 
Intrigued by the unusual switch between the direct C–H arylation and dehydrogenative C–H/C–H 
activation pathways, the reaction mechanism was further explored by experimental mechanistic 
studies. Kinetic isotope effect (KIE) studies with deuterated substrate 45d resulted in a KIE value 
of kH/kD ≈ 2.2 and 1.8 when using 2-bromobenzonitrile (46k) and 2-bromotrifluorotoluene (46j) as 
the oxidant, respectively, as determined by parallel reactions (Scheme 82 and Section 5.3.6.2). 
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Scheme 82: Kinetic isotope effect studies by parallel reactions. The graph corresponds to the 
reaction with 2-bromobenzonitrile (46k). 
 
In addition, conducting the reaction in the presence of isotopically labelled D2O as cosolvent led 
to nearly quantitative deuterium-incorporation in the ortho-position of reisolated substrate 45d 
(Scheme 83a). A minor amount of deuterium-incorporation was observed at the somewhat acidic 
6-position of the pyridine directing group. When deuterated substrate [D]1-45d was subjected to 
the reaction conditions, moderate H/D exchange was observed in the reisolated phenylpyridine, 
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suggesting that the MesCO2H additive (58) or trace amounts of water in the employed base or 
solvent acted as the proton source (Scheme 83b). 
 
 
Scheme 83: H/D exchange studies. 
 
Based on the hypothesis that the aryl halides act as the oxidant in the C–H/C–H activation process, 
most likely via oxidative addition to ruthenium, subsequent proto-demetalation would 
consequently result in the generation of trifluorotoluene (182) as byproduct. Indeed, thorough 
analysis of the reaction mixture by GC and GC-MS revealed the presence of 74% of 182 after 20 h, 
thus substantiating the hypothesized oxidative addition/proto-demetalation pathway (Scheme 
84). 
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Scheme 84: Detection and quantification of trifluorotoluene (182) as byproduct. 
 
To confirm that 45 and not MesCO2H (58) or trace amounts of water is indeed the proton-source 
for the proto-dehalogenation of aryl halide 46, the reaction was conducted with deuterated 
substrate [D]1-45d (Scheme 85). The formation of [D]n-183 was confirmed by GC-MS analysis, 
thereby indicating that the transferred proton/deuteron originates from 45d (see Section 5.3.6.2). 
Unfortunately, isolation of [D]n-183 and characterization by NMR spectroscopy was not possible 
due to the low polarity and non-neglectable vapor pressure of 183. 
 
 
Scheme 85: Proto-dehalogenation of 46k with deuterated phenylpyridine. 
 
The amount of free p-cymene (184) was determined over the course of the reaction to investigate 
the possible formation of arene-ligand-free ruthenium complexes as catalytically active species.[54, 
55, 159] A rapid liberation of p-cymene was observed alongside a fast formation of C–H/C–H 
activated product 181d in the reaction of 45d with 46k (Scheme 86). Already after a reaction time 
of only 3 min, 26% decoordinated p-cymene was detected, which increased to more than 70% 
within 180 min as determined by GC analysis with n-dodecane as the internal standard. 
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Scheme 86: Detection of free p-cymene (184) in the reaction of 45d with 46k by GC analysis with 
n-dodecane as the internal standard. 
 
The same trend, albeit at a reduced rate, was observed, when aryl halide 46j was employed in the 
reaction (Scheme 87). Here, an amount of 40% free p-cymene was determined after a reaction 
time of 180 min. Due to the much slower reaction rate, the increase in p-cymene concentration 
was also significantly slower compared to the reaction with 46k. 
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Scheme 87: Detection of free p-cymene (184) in the reaction of 45d with 46j by GC analysis with 
n-dodecane as the internal standard. 
 
Furthermore, the decoordination of p-cymene from ruthenium was found to be independent of 
the phenylpyridine substrate 45. Employing fluorine-substituted phenylpyridine 45e as the 
substrate, which exclusively undergoes C–H arylation, led to the release of 45% of p-cymene from 
the ruthenium-complex within the first 180 min, thereby indicating that an arene-ligand-free 
complex is the catalytically active species in the C–H/C–H activation as well as the direct C–H 
arylation process (Scheme 88). 
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Scheme 88: Detection of free p-cymene (184) in the reaction of 45e with 46k by GC analysis with 
n-dodecane as the internal standard. 
 
3.9.3 Kinetic Analysis 
To gain further insight into the catalyst’s modus operandi, the reaction kinetics were investigated 
by means of initial rate measurements. Measurements with different concentrations of 
phenylpyridine 45d revealed a first order dependence of the reaction rate on the substrate 
concentration for the C–H/C–H activation as well as the C–H arylation process (Figure 48a). 
Furthermore, a reaction order smaller than 1 was determined with respect to the concentration 
of [RuCl2(p-cymene)]2 catalyst (Figure 48b). While the concentration of [RuCl2(p-cymene)]2 was 
varied in the range of 3.8–12.5 mmol L–1, the concentration of MesCO2H (58) was held constant at 
75 mmol L–1, thereby resulting in different [Ru]/MesCO2H ratios, which could lead to the observed 
non-integer reaction order. Additionally, the reaction rate was found to be independent of the 
aryl halide concentration (Figure 48c). The observed similar kinetic behavior for the two 
competing pathways suggests the reactions to proceed via the same intermediates, with the 
selectivity-determining step occurring late in the catalytic cycle. 
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(b) Reaction order in [RuCl2(p-cymene)]2 
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(c) Reaction order in aryl halide 46j 
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Figure 48: Kinetic analysis of the C–H/C–H activation and direct C–H arylation reactions. 
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Employing well-defined [Ru(O2CMes)2(p-cymene)] (61) as the catalyst led to an unusual reaction 
order of approx. 0.5, indicating a complex rate-law, possibly due to an equilibrium between two 
or more catalytically competent ruthenium species (Figure 49). Additionally, by changing the 
[Ru(O2CMes)2(p-cymene)] (61) concentration, the concentration of MesCO2H (58) was changed 
concurrently, which could influence the rate of the presumed proto-demetalation event. 
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Figure 49: Reaction order in well-defined [Ru(O2CMes)2(p-cymene)] (61). 
 
Further studies with 2-bromobenzonitrile (46k) as the reagent revealed a much higher reaction 
rate compared to 2-bromotrifluorotoluene (46j), indicating a significantly lower activation energy 
(Figure 50). It is noteworthy that in this reaction no induction period was observed. 
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Figure 50: Comparison of aryl halides 46j and 46k. 
 
Considerable changes in the reaction orders were uncovered by detailed kinetic studies using 
2-bromobenzonitrile (46k) as the aryl halide. For the C–H/C–H activation process the reaction 
order in phenylpyridine 45d was found to decrease to a value of 0.4 (Figure 51a), whereas the 
order with respect to the aryl halide 46k concentration increased significantly to approx. 0.7 
(Figure 51c). Again, the reaction rate showed a non-integer order dependence on the 
concentration of [Ru(O2CMes)2(p-cymene)] (61) (Figure 51b). Unfortunately, the reaction order 
for the C–H arylation process could not be derived due to a very slow formation of the arylated 
product 47dk. These observed differences in the reaction kinetics, caused simply by exchanging 
the aryl halide, indicate a distinct change in the turnover-limiting step of the reaction. In contrast 
to 2-bromotrifluorotoluene (46j), 2-bromobenzonitrile (46k) is able to coordinate to ruthenium 
through the nitrile-substituent, thereby changing the coordination environment of the 
catalytically active ruthenium species. In addition, DFT studies showed that the energy barrier for 
the oxidative addition of 46k is comparable to the energy barrier of the C–H ruthenation step, 
thereby rendering both processes kinetically relevant (vide infra). 
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(c) Reaction order in aryl halide 46k 
-0.60 -0.55 -0.50 -0.45 -0.40 -0.35 -0.30 -0.25
-5.1
-5.0
-4.9
-4.8
-4.7
-4.6
-4.5
-4.4
-4.3
2.0 equiv
1.75 equiv
1.5 equiv
1.25 equiv
lo
g
(
 [
1
8
1
d
] 

t 

1
 /
 m
o
l 
L
-1
 s

1
)
log([46k] / mol L
-1
)
1.0 equiv
181d
y = 0.66x - 4.424
R
2
 = 0.94
 
Figure 51: Kinetic analysis of the C–H/C–H activation employing 2-bromobenzonitrile (46k). 
 
3.9.4 Computational Studies 
The transformation was additionally investigated by means of DFT calculations to gain further 
insight into the elemental steps of the reaction. Geometry optimizations were performed at the 
TPSS-D3(BJ)/def2-TZVP level of theory,[125, 126, 127] while single-point calculations were conducted 
at the PBE0-D3(BJ)/def2-TZVP+SMD(MeCN) level[134, 135] (for full details see Section 6.7). For the 
sake of simplicity mesityl carboxylate was replaced by acetate within the calculations. 
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Starting from complex 9.A containing two N-coordinated phenylpyridine motifs in a trans-
configuration, which was found to be 0.5 kcal mol–1 more stable than the corresponding cis-
configured complex (see Section 6.7.2), agostic intermediate 9.B is formed via κ2-κ1 displacement 
of one acetate-ligand with an energy barrier of 10.4 kcal mol–1 (Figure 52). Afterwards, concerted    
C–H cleavage and Ru–C formation generates ruthenacycle 9.C. C–H activation of the second 
substrate proceeds via formation of agostic intermediate 9.D with an energy barrier of 
16.9 kcal mol–1, followed by C–H cleavage with a low barrier of only 4.7 kcal mol–1. In the resulting 
biscyclometalated complex 9.E, the two aryl-ligands adopt a cis-configuration (Figure 53), 
consistent with previous reports.[55] In the presence of a nitrile-containing compound as either the 
reaction medium or the aryl halide reagent, ligand exchange can occur on intermediate 9.C. 
Exchange of the coordinated acetic acid with acetonitrile stabilizes the complex by      
11.0 kcal mol–1 and, furthermore, reduces the energy required for the 2nd C–H activation process 
(Figure 52, red line). 
 
 
Figure 52: Relative Gibbs free energy profile for the cyclometalation of 45d. Ar = o-tolyl. 
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Figure 53: Structure of biscyclometalated complex 9.E. Non-participating hydrogen atoms are 
omitted for clarity. 
 
A careful bond order analysis of the C–H ruthenation steps within a More O’Ferral-Jencks plot[160] 
was performed and indicated a substitutive BIES-type[20] rather than a deprotonative CMD-type[18] 
C–H ruthenation event (Figure 54). 
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Figure 54: More O’Ferral-Jencks plot for the 1st (left) and 2nd (right) C–H ruthenation step. 
 
Following the C–H ruthenation, decoordination of acetic acid and coordination of bromobenzene 
leads to the formation of intermediate 9.F and 9.F’, respectively (Figure 55). After further 
decoordination of HOAc or MeCN, five-coordinated complex 9.G undergoes turnover-limiting 
oxidative addition of the C–Br bond to generate ruthenium(IV) species 9.H via transition state 
TS9.5 with a relative energy of 19.8 kcal mol–1. It is worth mentioning that introduction of a cyano 
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group in the ortho-position of the aryl bromide led to a stabilization of Br-coordinated complex 
9.G’ by 3.0 kcal mol–1 and a subsequent decrease in the energy of oxidative addition transition 
state TS9.5’ by 3.8 kcal mol–1 (Figure 55, blue line). Notably, ruthenium(IV) complexes 9.H and 9.H’ 
only showed a marginal difference in stability of 0.3 kcal mol–1. 
 
 
Figure 55: Relative Gibbs free energy profile for the oxidative addition of aryl bromides. 
 
As a next step selectivity-determining reductive elimination takes place either between the aryl 
groups of the two phenylpyridine motifs to deliver the C–H/C–H functionalized product or 
between an aryl group of one phenylpyridine motif and the aryl ligand originating from the aryl 
halide, thus furnishing the corresponding C–H arylated compound (Figure 56). Complex 9.H 
containing a phenyl ligand shows a strong preference for reductive elimination via TS9.7, thereby 
resulting in the formation of C–H arylated product 9.J. The difference in the energy barriers for 
the two competing pathways was calculated to be ΔΔG‡TS9.6–TS9.7 = 3.9 kcal mol–1. In contrast, 
installation of a cyano group in the 2-position of the aryl ligand resulted in a significant stabilization 
of TS9.6’ along with a destabilization of TS9.7’, resulting in a preferential reductive elimination 
between the two phenylpyridine motifs, hence delivering the C–H/C–H activated product 9.I’ 
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(Figure 56, blue line). In this case, the energy difference between both transition states was 
calculated to be ΔΔG‡TS9.6’–TS9.7’ = –5.7 kcal mol–1 in favor of TS9.6’. This switch in selectivity by a 
change in the aryl halide species is in good agreement with the experimentally obtained product 
distributions (vide supra). Susequent two-fold proto-demetalation of intermediate 9.I by HOAc 
and coordination of two molecules of phenylpyridine 45d liberates the product, generates HBr 
and Ar–H as byproducts, and regenerates catalyst 9.A. With respect to complex 9.J, proto-
demetalation with one molecule of HOAc in combination with the coordination of 45d delivers 
product 47 and HBr. In this case, the catalyst reenters the catalytic cycle as intermediate 9.C/9.C’. 
 
 
Figure 56: Relative Gibbs free energy profile for the selectivity-determining reductive 
elimination. 
 
The formation of C–H/C–H functionalized product 181d by reductive elimination from 
biscyclometalated complex 9.E via transition state TS9.8 exhibited an energy barrier of     
48.8 kcal mol–1, thus rendering a ruthenium(II/0/II) manifold unlikely (Figure 57). In contrast, these 
findings can be better rationalized by an energetically favorable oxidation-induced reductive 
elimination manifold.[161] 
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Figure 57: Relative Gibbs free energy profile for reductive elimination from ruthenium(II). 
 
The involvement of higher spin states, namely triplet and quintet states, can be disregarded due 
to significantly higher energies for a number of representative ruthenium(II), ruthenium(0) as well 
as ruthenium(IV) intermediates (see Table 38 on page 208). 
 
3.10 Manganese-Catalyzed C–H Allylation on Peptides 
As already discussed above, modifications of peptides by C–H activation strategies hold an 
immense potential (see Section 3.8). Despite the inherently more sustainable nature of C–H 
activation approaches compared to traditional cross-coupling reactions, C–H activation on 
peptides[114] is largely limited to precious metal catalysts, whereas the use of inexpensive, less 
toxic[87] 3d transitions metals,[12b] especially manganese, continues to be limited (vide supra).[95] 
The introduction of an allyl substituent into organic molecules can provide a synthetic handle for 
a plethora of functionalizations by means of classical as well as novel methods. Especially allylic 
alcohols or amines provide easy access to a number of important moieties. Considering these 
aspects, N. Kaplaneris in the Ackermann group developed manganese-catalyzed C–H allylations of 
tryptophans and tryptophan-containing peptides with user-friendly Morita-Baylis-Hillman (MBH) 
adducts, providing access to synthetically useful α,β-unsaturated esters 162 (Scheme 89).[162] 
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Employing [MnBr(CO)5] as the catalyst of choice, a variety of diversely decorated hybrid, cyclic, 
and acyclic peptides could be obtained in good to excellent yields. 
 
 
Scheme 89: Optimized reaction conditions for manganese-catalyzed C–H allylations of 
tryptophans 160. 
 
The reaction mechanism was explored in detail to gain further insights into this unprecedented 
transformation. To this end, DFT calculations were performed at the TPSS-D3(BJ)/def2-TZVP level 
of theory[125, 126, 127] for geometry optimizations and PW6B95-D3(BJ)/def2-QZVP+COSMO(1,4-
dioxane) level of theory[127, 142, 145] for single point calculations (for full details see Section 6.8). 
Experimental mechanistic studies indicated a facile, reversible C–H activation process.[163] The      
C–H activation step was therefore omitted within the computational investigations and 
managacycle 10.A was chosen as the starting point (Figure 58). Starting from intermediate 10.A, 
migratory insertion of the coordinated alkene into the Mn–C bond takes place to generate seven-
membered manganacycle 10.B, which is 8.8 kcal mol–1 more stable than 10.A. Coordination of one 
carbonate oxygen to manganese facilitates the key C–O cleavage event via transition state TS10.2 
with an energy barrier of 11.7 kcal mol–1. Ligand exchange with acetic acid leads to the formation 
of complex 10.E containing a κ1-coordinated acetate ligand. It is noteworthy that TS10.2 occurs 
late in the C–O cleavage step. The C–O distance in the transition state structure is already 
increased by 0.53 Å to a value of 2.02 Å and the two geminal protons at the newly forming double 
bond adopt a nearly planar conformation (Figure 59). 
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Figure 58: Relative Gibbs free energy profile for the reaction of 125a with MBH adduct 161a.  
 
 
Figure 59: Structure of key transition state TS10.2. Distances are given in Å and non-participating 
hydrogen atoms are omitted for clarity. 
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3.11 Manganese-Catalyzed C–C Allylation 
In contrast to a vast number of reports on manganese-catalyzed C–H activation,[89] C–C activation 
strategies largely rely on precious transition metals such as rhodium and palladium, whereas 
earth-abundant and less toxic manganese catalysis remains underutilized in C–C activation 
reactions.[96] Although methods for organometallic C–C activation require the prior installment of 
a suitable group in the molecule, this strategy allows for the synthesis of 1,2,3-trisubstituted 
arenes. In contrast, such a substitution pattern can usually not be obtained through C–H activation 
reactions due to a preferred activation at the sterically less hindered C6 position of meta-
substituted arenes. 
It is therefore noteworthy that H. Wang, I. Choi, and N. Kaplaneris in the Ackermann group 
achieved the allylation of arenes 142a by employing a manganese-catalyzed C–C activation 
strategy with vinyldioxolanones 163a or vinyloxazolidinones 163b as substrates (Scheme 90).[164] 
Commercially available [MnBr(CO)5] proved to be the catalyst of choice and, in addition to 
commonly employed organic solvents, non-toxic, non-flammable water could be employed as the 
reaction medium, delivering the desired product in high yield with acetone and CO2 as the sole 
byproducts. 
 
 
Scheme 90: Optimized reaction conditions for the manganese-catalyzed C–C activation. 
 
To shed light on the reaction mechanism, DFT calculations were performed in order to investigate 
the manganese-catalyzed C–C allylation. Geometry optimizations were carried out at the PBE0-
D3(BJ)/def2-SVP+SMD(H2O) level of theory[126, 127, 134, 135] and energies were calculated at the PBE0-
D3(BJ)/def2-QZVP*+SMD(H2O) level[127] (for full details see Section 6.9). 
Starting from manganese-alkoxide 11.A, which is formed via salt metathesis of [MnBr(CO)5] with 
substrate 142a, decoordination of one CO ligand leads to the formation of five-coordinated 
managense complex 11.B, which was also observed by mass spectrometric investigations (Figure 
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60). Turnover-limiting C–C cleavage with an energy barrier of 25.5 kcal mol–1 generates five-
membered manganacycle 11.C, which is in good agreement with experimental kinetic studies 
(Figure 61). Ligand exchange of the coordinated acetone with 163a is followed by migratory 
insertion of the alkene into the Mn–C bond to form seven-membered complex 11.E. Coordination 
of dioxolanone oxygen and subsequent C–O cleavage via β–carbon elimination with an energy 
barrier of 15.3 kcal mol–1 leads to a ring opening and the formation of energetically stable, 
coordinatively saturated intermediate 11.G. Finally, decarboxylation generates alkoxide complex 
11.I, which after proto-demetalation delivers the experimentally obtained compound 164a with a 
reaction Gibbs free energy of –10.1 kcal mol–1 in total. 
Under the reaction conditions [MnBr(CO)5] was employed as the pre-catalyst, therefore energy 
values were also calculated relative to the pre-catalyst and the substrate. Salt-metathesis to 
generate intermediate 11.A formally involves the formation of one molecule of HBr, which in the 
experiment is stabilized by the formation of HBr∙(H2O)n clusters.[165] This stabilization can only be 
incompletely described by the employed gas-phase calculations within the framework of a 
continuum solvation model, hence resulting in considerably higher relative energies. Already the 
explicit introduction of a (H2O)5 cluster resulted in a stabilization of HBr by 7.2 kcal mol–1 and larger 
clusters should lead to even stronger stabilization effects. With these aspects in mind, the Gibbs 
free energies relative to the precatalyst need to be considered with caution. 
 
 
Figure 60: Relative Gibbs free energy profile for the reaction of 142a with vinyldioxolanone 
163a. Values in parenthesis correspond to energies relative to [MnBr(CO)5] + 142a + (H2O)n – 
HBr∙(H2O)n; superscripts correspond to the number of water molecules. 
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Figure 61: Structure of key transition state TS11.1. Distances are given in Å and hydrogen atoms 
are omitted for clarity. 
 
Furthermore, the corresponding high-spin (quintet state) and intermediate spin (triplet state) 
complexes were investigated regarding the occurrence of spin-crossover (Figure 62). For almost 
all calculated structures the low-spin, singlet state was found to be favored, while higher spin-
states were at least 10 kcal mol–1 less stable. Although optimization of intermediate 11.F in a 
triplet state led to a lower energy compared to the singlet state, decoordination of the oxygen 
atom was observed (dMn–O = 3.12 Å), therefore resulting in a structure similar to complex 11.E. For 
the quintet state of intermediate 11.H, a decoordination of the alkene and a coordination of two 
carbonate oxygen atoms in a κ2-fashion was observed. In contrast, the quintet state of transition 
state TS11.3 as well as intermediate 11.G was calculated to be slightly more stable than the 
corresponding low-spin complexes without any change in the coordination environment, 
indicating a possible spin-crossover. Due to the low energy differences between singlet and 
quintet state (ΔΔG = 1.5 and 0.8 kcal mol–1, respectively), calculations at a higher level of theory 
are necessary to confirm a possible spin-crossover event. 
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Figure 62: Relative Gibbs free energy profile for low-spin (black line), intermediate spin (red), 
and high-spin (blue) complexes. 
 
Furthermore, calculations were performed without the SMD solvation model in the geometry 
optimizations (Figure 63). The obtained results are largely in agreement with results at the PBE0-
D3(BJ)/def2-QZVP*+SMD(H2O)//PBE0-D3(BJ)/def2-SVP+SMD(H2O) level of theory and only small 
energy differences of less than 2 kcal mol–1 were observed. It is noteworthy that a significantly 
larger difference was uncovered for intermediate 11.H and omitting the solvation model during 
optimization resulted in a destabilization by 5.7 kcal mol–1. Additionally, decarboxylation 
transition state TS11.4 could be located at this level of theory, which confirmed a facile, not 
turnover-limiting decarboxylation process (Figure 64). 
A comparison with Gibbs free energies obtained in apolar DCE as the solvent, which was shown 
to be a suitable reaction medium for this transformation, resulted in a decrease of the turnover-
limiting C–C cleavage energy barrier by 1.2 kcal mol–1 and a slightly more exergonic reaction Gibbs 
free energy of –11.1 kcal mol–1. 
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Figure 63: Relative Gibbs free energy profile for the reaction of 142a with vinyldioxolanone 163a 
without solvent model in the optimization in water (black line) and DCE (red). 
 
 
Figure 64: Structure of decarboxylation transition state TS11.4. Distances are given in Å and non-
participating hydrogen atoms are omitted for clarity. 
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4 Summary and Outlook 
C–H and C–C activation chemistry holds enormous potential for the formation of C–C and C–Het 
bonds and the development of streamlined, sustainable syntheses of compounds of interest to 
inter alia pharmaceutical industry and material science. To further advance the field of C–H and 
C–C activation, a detailed understanding of the reaction mechanisms and the catalyst’s properties 
is of prime importance. Therefore, a variety of transformations with different ruthenium- and 
manganese-based catalytic systems was investigated within this thesis. 
In the first part of this thesis, a ruthenium-catalyzed meta-C–H bromination approach was applied 
to purines 148 for the introduction of a fluorescent pyrene motif in high yield via a subsequent 
Sonogashira-Hagihara reaction, thereby showcasing the potential of the established protocol for 
the diversification of biologically relevant structural motifs (Scheme 91).[117] Furthermore, kinetic 
studies revealed a first order dependence on the catalyst concentration within a turn-over limiting 
C–H activation regime. 
 
 
Scheme 91: Fluorescent tag labelling of purines via meta-C–H bromination. 
 
In additional studies, the developed approach could be expanded to other bioactive substrates 
and the installed bromine-substituent should prove invaluable as a synthetic handle for a 
multitude of further diversifications. 
Secondly, ruthenium-catalyzed remote meta-C–H alkylations of versatile ketimines 151 with 
secondary and tertiary alkyl halides 100 were developed. The established method featured a 
broad substrate scope and high functional group tolerance including valuable heterocycles and a 
structurally complex cholesterol motif. In addition, this novel transformation gave rise to an 
unprecedented one-pot two-fold meta/ortho-C–H activation protocol for the synthesis of densely 
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substituted arenes 166 in a user-friendly, operationally simple fashion (Scheme 92).[121] Detailed 
mechanistic investigations provided strong support for a radical pathway and a first order rate 
dependence with respect to the concentration of catalyst as well as ketimine, which is consistent 
with results obtained for phenylpyridines as substrates. 
 
 
Scheme 92: One-pot meta/ortho-C–H activation of ketimines 151. 
 
Through a combination of the ketimine-directed meta-C–H alkylation protocol and a 
photochemical alkyl radical generation, a significant reduction of the reaction temperature can 
possibly be achieved, thereby allowing for the extension of the developed protocol towards other 
sensitive functional groups. 
In a related project, Fukui indices were calculated to predict the preferred position of electrophilic 
and radical attacks on cyclometalated complexes of aryloxazolines and phenylpurines.[124, 129] High 
meta/para-selectivities were predicted for a radical addition onto ruthenium(III) complexes, 
which is in good agreement with the experimentally observed exclusive formation of meta-
functionalized products and additional EPR studies (Figure 65). Although the calculations 
suggested the formation of an arene-ligand-free complex, knowledge of the exact coordination 
environment is still underdeveloped, and requires additional investigations through other 
computational methods. 
 
  
Figure 65: Fukui indices for radical addition onto ruthenium(III) species 4.F. 
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In the fourth part of this thesis, the application of carboxylic acids as traceless directing groups in 
ruthenium-catalyzed domino C–H alkenylation/decarboxylation reactions with alkynes 35 was 
investigated (Scheme 93).[132] Extensive DFT studies revealed a turnover-limiting migratory 
insertion event and a subsequent facile decarboxylation process. Furthermore, the 
decarboxylation pathway was found to be preferred over a competing cyclization process. 
However, the energy difference was decreasing significantly with an increased polarity of the 
employed solvent. While a novel C–H alkylation/decarboxylation manifold with maleimides 177 
occurred via a similar reaction mechanism as revealed by DFT calculations and in situ IR 
spectroscopic studies, a possible cyclization process was found to be energetically inaccessible. 
 
 
Scheme 93: Domino C–H alkenylation/decarboxylation under ruthenium catalysis. 
 
The detailed mechanistic insights provided by this study could in the future lead to the 
identification of further viable substrates for decarboxylative C–H activation reactions and to the 
application of this method in complex natural product synthesis. Importantly, these results could 
contribute to the development of unparalleled, highly desirable ruthenium-catalyzed 
carboxylation reactions, since these represent the microscopic reverse process with respect to 
decarboxylative transformations. 
In addition, an unprecedented ruthenium-catalyzed oxidative C–H alkenylation with weakly 
coordinating aryl acetamides 153 as substrates was explored.[141] Detailed experimental and 
computational investigations provided strong support for a facile C–H ruthenation event and the 
formation of an unusual six-membered ruthenacycle (Scheme 94). DFT studies indicated the 
migratory insertion into the Ru–C bond to be the turnover-limiting step. Furthermore, a 
comparison with the C–H ruthenation process of the corresponding benzamide analogue 
highlighted the challenging nature of the distal C–H activation with aryl acetamides. 
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Scheme 94: Distal C–H alkenylation of aryl acetamides 153 by weak O-coordination. 
 
Since primary, secondary, and tertiary amides were viable substrates for the established C–H 
alkenylation protocol, the application towards the diversification of aryl acetamide containing 
natural products and drugs might be worth investigating and could enable the sustainable 
synthesis of previously not easily accessible substitution patterns. In addition, the protocol could 
be extended towards various other weakly coordinating directing groups, such as esters or 
ketones. 
The sixth project was focused on investigating fundamental differences in the chelation-assisted 
C–H ruthenation of ferrocenes 156 bearing weakly coordinating ketone, thioketone or 
selenoketone directing groups (Scheme 95).[148] In silico studies uncovered a considerable energy 
difference between the employed directing groups, with selenoketone-substituted ferrocene 
being thermodynamically preferred. While only small differences in destabilizing distortion 
energies were revealed within a distortion-interaction analysis, the stabilizing interaction energies 
showed larger deviations and unveiled the strongest interactions for thioketone-decorated 
ferrocene. 
 
 
Scheme 95: Chelation-assisted C–H ruthenation of ferrocenes 156. 
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By applying more sophisticated computational methods like DFT-SAPT[166] or DLPNO coupled 
cluster,[167] various energetic contributions could be further dissected and provide more insights 
into the different stabilizing and destabilizing effects. These further studies might prove useful for 
understanding the role of weak interactions in C–H activation with ruthenium complexes, with 
possible extrapolations towards other transformations. 
Furthermore, thorough DFT studies on ruthenium-catalyzed C–H alkylations of indoles 125 as a 
model substrate for tryptophan in a hydroarylation approach were conducted and revealed the 
reaction to occur through reversible chelation-assisted C–H ruthenation, followed by migratory 
insertion and turnover-limiting proto-demetalation (Scheme 96).[156] Additionally, a detailed 
evaluation of different η6-coordinated arene-ligands was performed and indicated a 
destabilization by an increased steric demand and by a reduced π-electron density. 
 
 
Scheme 96: Ruthenium catalysis for C–H alkylation of indoles 125. 
 
The comparison of different arene-ligands could contribute to the development of novel, highly 
active catalysts for these kind of transformations. Likewise, DFT studies for tryptophan or even 
small peptides instead of indole might prove highly rewarding, since these could unveil secondary 
interactions with the metal center, for example through interactions with the peptidic backbone. 
Extensive investigations of oxidative C–H/C–H activations and direct C–H arylations of 
phenylpyridines 45 under ruthenium catalysis uncovered the selectivity to be controlled by steric 
as well as electronic properties of both reagents (Scheme 97).[168] The observation of a 
considerable decoordination of p-cymene from the ruthenium catalyst strongly suggested the 
formation of an arene-ligand-free catalytically active complex, and a kinetic analysis indicated, 
that both processes proceed through largely the same pathway. Unprecedented calculations 
provided strong support for the formation of a biscyclometalated ruthenium(II) intermediate by 
two-fold C–H ruthenation. Afterwards, oxidative addition generates an energetically favorable 
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ruthenium(IV) species, which then undergoes selectivity-determining reductive elimination. 
Notably, the preferred reductive elimination pathway, and thereby the preferentially formed 
product, was controlled by the nature of the aryl halide. 
 
 
Scheme 97: Oxidative C–H/C–H activation and C–H arylation of phenylpyridines 45. 
 
In further studies, the viability of other substrates, such as aryloxazolines or ketimines, for 
oxidative C–H/C–H arylations could be evaluated and should prove useful for the rapid 
construction of substituted, extended π-systems as ligands or functional materials. Since the 
current calculations were focused on the substitution pattern of the aryl halide, a subsequent 
investigation of the phenylpyridine substitution should be conducted to complement the 
mechanistic understanding. In this context, an analysis of the steric and electronic influences 
within a multivariate analysis[169] might be worthwhile and could identify subtle, easily overlooked 
influences. 
In the ninth project, the key steps of manganese-catalyzed C–H allylations of pyridyl-substituted 
tryptophan 160 with MHB adducts 161 were explored by means of DFT calculations (Scheme 
98).[162] Within the computational studies, a facile migratory insertion event along with a turnover-
limiting C–O cleavage step was identified, thus delivering allylated compound 162. 
 
 
Scheme 98: Manganese-catalyzed C–H allylation of tryptophan 160. 
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As already stated above, additional computational studies with the untruncated tryptophan 
instead of pyridylindole as a simplified model might reveal selectivity- or reactivity-influencing 
interactions between the metal catalyst and functional groups of the peptide side chains or 
backbone. 
Within the last part of this thesis, a detailed investigation of unprecedented manganese-catalyzed 
C–C allylations with benzylic alcohols 142 was presented (Scheme 99).[164] Computational studies 
on the catalyst’s mode of action indicated the reaction to proceed via turnover-limiting C–C 
cleavage, followed by migratory insertion into the Mn–C bond. Thereafter, ring-opening by C–O 
bond scission takes place and facile decarboxylation occurs. An examination of various spin states 
showed the reaction to proceed mainly on the singlet, low-spin energy surface. During the C–O 
cleavage and decarboxylation step indications for a possible singlet-quintet, meaning low-spin to 
high-spin, spin crossover could be observed. 
 
 
Scheme 99: Manganese catalysis for C–C allylation of benzylic alcohols 142. 
 
The obtained mechanistic insights should prove invaluable for the further development of novel 
C–C activation reactions under manganese catalysis, which could enable transformations 
complementary to C–H activation methods. Furthermore, a comparison between the energy 
profiles of C–C activation and the corresponding C–H activation pathways could point towards 
fundamental mechanistic differences, thereby allowing for rational advancements in catalyst 
design and the choice of systems worth exploring. 
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5 Experimental Part 
5.1 General Remarks 
Reactions involving air- or moisture-sensitive compounds were conducted under an atmosphere 
of nitrogen using pre-dried glassware and standard Schlenk- or glovebox-techniques. If not 
otherwise noted, yields refer to isolated compounds, estimated to be >95% pure by GC and NMR. 
 
Vacuum 
A pressure of approx. 5∙10–1 mbar was measured on the employed rotary vane pump Vacuubrand 
RD4. 
 
Melting points 
Melting points were measured on a Stuart Melting Point Apparatus SMP3 from Barloworld 
Scientific. All values are uncorrected. 
 
Liquid Chromatography 
Analytical thin layer chromatography (TLC) was performed on TLC Silica gel 60 F254 from Merck 
with detection at 254 nm or 360 nm. Preparative chromatographic separations were carried out 
on Merck Geduran SI 60 (40–63 μm, 70–230 mesh ASTM) silica gel. 
 
High Performance Liquid Chromatography 
Analytical high performance liquid chromatography (HPLC) was performed on an Agilent 
1260/1290 Infinity system equipped with a Daicel IC-3 column (4.6 mm × 250 mm, 3 µm particle 
size). Preparative HPLC purifications were performed on an Agilent 1260 Infinity system equipped 
with a Daicel IC-3 column (20 mm × 250 mm, 5 µm particle size). 
 
Gas Chromatography 
Gas chromatographic analysis (GC) was performed on an Agilent 7890A GC System or Agilent 
7890B GC System equipped with an Agilent HP-5 column (30 m, 0.320 mm diameter, 0.25 µm film 
thickness) and a flame-ionization detector (FID) using hydrogen as the carrier gas. Gas 
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chromatography coupled with mass spectrometry (GC-MS) was performed on the same 
instrument equipped with an Agilent HP-5MS column (30 m, 0.250 mm diameter, 0.25 µm film 
thickness) and an Agilent 5875C Triple-Axis-Detector or an Agilent 5977B MSD. Mass spectra were 
obtained with electron-ionization (EI) at 70 eV in positive ion mode. 
 
Gel Permeation Chromatography 
Gel permeation chromatography (GPC) was performed on a Japan Analytical Industries (JAI) LC-
92XX II NEXT system equipped with a JAIGEL 2.5HR or JAIGEL 2HH column. Chloroform was used 
as the solvent. 
 
Infrared Spectroscopy 
Infrared (IR) spectra of were measured on a Bruker Alpha-P FT-IR spectrometer with a diamond 
ATR probe in the range of 4000–400 cm–1. In situ IR measurements were performed with a 
Mettler-Toledo ReactIR 15 spectrometer equipped with a diamond ATR probe and an MCT 
detector. Spectra were acquired using Mettler-Toledo iC IR software version 7.0.297 in the range 
of 650–2200 cm–1 with a 4 cm–1 resolution. A Pearson’s Correction was used as baseline correction 
in all measurements. 
 
Nuclear Magnetic Resonance Spectroscopy 
Nuclear magnetic resonance (NMR) spectra were recorded on Varian Mercury Plus 300, Inova 500, 
Inova 600 or Bruker Avance III 300, Avance III HD 300, Avance III 400, Avance III HD 400, Avance 
Neo 400, Avance III HD 500 spectrometer. Unless stated otherwise, all measurements were 
performed at 298 K. Chemical shifts (δ) are reported relative to tetramethylsilane and are 
referenced using the residual proton or carbon solvent signal. 19F spectra were referenced using 
CFCl3 as external standard. 
 
Solvent 1H 13C 
CDCl3[170] 7.26 ppm 77.16 ppm 
PhMe-d8[171] 7.09, 7.00, 6.98, 2.09 ppm 
137.86, 129.24, 128.33, 
125.49, 20.40 ppm 
DMF-d7[171] 8.03, 2.92, 2.75 ppm 161.15, 34.89, 29.76 ppm 
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The observed multiplicities are reported as follows: s (singlet), d (doublet), t (triplet), q (quartet), 
m (multiplet) or combinations thereof. A subscript of br indicates a broad signal. The coupling 
constants J are given in Hertz (Hz). All spectra were analyzed using Mestrelab Research 
MestReNova version 10.0.2 software. 
 
Mass Spectrometry 
Electron-ionization (EI) mass spectra were recorded on a Jeol AccuTOF instrument at 70 eV. 
Electrospray-ionization (ESI) mass spectra were obtained on Bruker micrOTOF and maXis 
instruments. All systems are equipped with time-of-flight (TOF) analyzers. The ratios of mass to 
charge (m/z) are reported and the intensity relative to the base peak (I = 100) is given in 
parenthesis. 
 
Fluorescence Spectroscopy 
Fluorescence spectra were recorded on a Jasco FP-8500 spectrometer as 10–5 M (45k, 181k) or   
10–6 M (150) solutions in DMSO and excitation wavelengths were selected according to the 
strongest signal. 
 
Optical Rotation 
Optical rotation measurements were performed on a Jasco P-2000 polarimeter at 589 nm in 
chloroform. 
 
Data Analysis and Plots 
Analysis of data was performed using OriginLab OriginPro 8.5G software, which was also 
employed for linear and non-linear fitting. Histograms were created with Microsoft Excel 2016. 
 
Solvents 
All solvents used for work-up and purification were distilled prior to use. Solvents used in reactions 
involving air- or moisture-sensitive compounds were dried and stored under an inert atmosphere 
of nitrogen or argon according to the following standard procedures: 
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Acetonitrile was dried over 3 Å molecular sieves and degassed using multiple cycles of freeze-
pump-thaw. 
tert-Butylbenzene and toluene-d8 were dried over 4 Å molecular sieves and degassed using 
multiple cycles of freeze-pump-thaw. 
N,N-Dimethylacetamide, N,N-dimethylformamide, N-methyl-2-pyrrolidone, dimethylsulfoxide 
and triethylamine were dried over CaH2 and distilled under an atmosphere of N2. 
Toluene and 1,4-dioxane were dried over Na and distilled under an atmosphere of N2. 
Water was ultra-sonicated for 4 h under an atmosphere of N2. 
 
Reagents 
Reagents obtained from commercial sources were used without further purification unless stated 
otherwise. K2CO3 was dried at 120 °C and 10–2 mbar for 6 h and stored under an atmosphere of 
N2. The following compounds were synthesized according to previously reported procedures: 
Purines 148,[172] 2-phenylpyridines 45d,i-l,n,[173] 2-(fluorophenyl)pyridine (45e),[174] 1-bromo-1-
methylcyclohexane (100c),[175] ketimines 151,[176] [Ru(O2CAd)2(p-cymene)] (167),[33] and 
[Ru(NCMe)6][BF4]2.[177] 
The following compounds were kindly provided by the following people: 
 [Ru(O2CMes)2(p-cymene)] (61), [RuCl2(p-cymene)]2: courtesy of K. Rauch 
 2-(3-tert-Butylphenyl)pyridine (45g): courtesy of J. Koeller 
 2-Aryl pyridine 45m, [Ru(κ2-PhPy)(NCMe)4][PF6]: courtesy of K. Korvorapun 
 
5.2 General Procedures 
5.2.1 General Procedure A: Ruthenium-Catalyzed meta-Alkylation of Ketimines 151 
Under an atmosphere of N2, a Schlenk-tube was charged with ketimine 151 (0.50 mmol, 
1.00 equiv), [RuCl2(p-cymene)]2 (15.3 mg, 25 µmol, 5.0 mol %), AdCO2H (17) (27.3 mg, 0.15 mmol, 
30 mol %) and K2CO3 (138 mg, 1.00 mmol, 2.00 equiv). Alkyl bromide 100 (1.50 mmol, 3.00 equiv) 
and PhCMe3 (2.0 mL) were added and the mixture was stirred at 120 °C for 20 h. After cooling to 
ambient temperature, aq. HCl (2N, 3.0 mL) was added, the mixture was stirred at ambient 
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temperature for 3 h, extracted with EtOAc (3 × 20 mL), dried over Na2SO4 and concentrated in 
vacuo. Purification of the residue by column chromatography on silica gel yielded phenone 165. 
 
5.2.2 General Procedure B: Ruthenium-Catalyzed Oxidative C–H/C–H Activation 
Under an atmosphere of N2, a Schlenk-tube was charged with 2-phenylpyridine 45 (0.50 mmol, 
1.00 equiv), [RuCl2(p-cymene)]2 (7.7 mg, 13 µmol, 2.5 mol %), MesCO2H (58) (24.6 mg, 0.15 mmol, 
30 mol %) and K2CO3 (138 mg, 1.00 mmol, 2.00 equiv). Aryl bromide 46 (0.75 mmol, 1.50 equiv) 
and PhMe (2.0 mL) were added and the mixture was stirred at 120 °C for 20 h. After cooling to 
ambient temperature, H2O (25 mL) was added, the mixture was extracted with Et2O (3 × 25 mL), 
washed with brine (25 mL), dried over Na2SO4 and concentrated in vacuo. Purification of the 
residue by column chromatography on silica gel yielded products 47 and 181. 
 
5.3 Experimental Procedures and Analytical Data 
5.3.1 Ruthenium-Catalyzed meta-Selective C–H Bromination 
5.3.1.1 Synthesis of Fluorescent-Labelled Compounds 
9-isoPropyl-6-[3-(phenylethynyl)phenyl]-9H-purine (150a) 
 
Under an atmosphere of N2, 6-(3-Bromophenyl)-9-isopropyl-9H-purine (149a) (32 mg, 0.10 mmol, 
1.0 equiv.), ethynylbenzene (123a) (15 mg, 0.15 mmol, 1.5 equiv), [Pd(PPh3)2Cl2] (3.5 mg, 
5.0 µmol, 5.0 mol %), CuI (1.0 mg, 5.0 µmol, 5.0 mol %) and NEt3 (40 mg, 0.40 mmol, 4.0 equiv) 
were dissolved in DMF (0.5 mL) and stirred at 70 °C for 20 h. After cooling to ambient temperature, 
H2O (10 mL) was added, the mixture extracted with EtOAc (3 × 15 mL), dried over Na2SO4 and 
concentrated in vacuo. Purification of the residue by column chromatography on silica gel 
(n-hexane/EtOAc 3:1) yielded 150a (31 mg, 92%) as a brown solid. 
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1H-NMR (400 MHz, CDCl3): δ = 9.04 (s, 1H), 8.96 (dd, J = 1.6, 1.6 Hz, 1H), 8.82 (ddd, J = 7.9, 1.6, 
1.6 Hz, 1H), 8.21 (s, 1H), 7.69 (ddd, J = 7.7, 1.6, 1.6 Hz, 1H), 7.59−7.53 (m, 3H), 7.39−7.32 (m, 3H), 
5.00 (hept, J = 6.9 Hz, 1H), 1.69 (d, J = 6.9 Hz, 6H). 13C-NMR (100 MHz, CDCl3): δ = 153.9 (Cq), 152.4 
(Cq), 152.2 (CH), 142.3 (CH), 136.2 (Cq), 133.9 (CH), 132.8 (CH), 131.8 (CH), 131.7 (Cq), 129.9 (CH), 
128.8 (CH), 128.5 (CH), 128.4 (CH), 124.0 (Cq), 123.4 (Cq), 89.9 (Cq), 89.4 (Cq), 47.5 (CH), 22.7 (CH3). 
IR (ATR): ṽ = 1566, 1440, 1324, 1226, 789, 755, 689, 675, 643, 586 cm–1. m.p.: 119 °C. MS (ESI) m/z 
(relative intensity): 339 (100) [M+H]+, 361 (50) [M+Na]+, 699 (40) [2M+Na]+. HR-MS (ESI): m/z calcd 
for C22H19N4+ [M+H]+ 339.1604, found 339.1605. 
 
9-isoPropyl-6-[3-(1-pyrenylethynyl)phenyl]-9H-purine (150b) 
 
Under an atmosphere of N2, 6-(3-Bromophenyl)-9-isopropyl-9H-purine (149b) (32 mg, 0.10 mmol, 
1.0 equiv.), 1-ethynylpyrene (123b) (34 mg, 0.15 mmol, 1.5 equiv), [Pd(PPh3)2Cl2] (3.5 mg, 
5.0 µmol, 5.0 mol %), CuI (1.0 mg, 5.0 µmol, 5.0 mol %) and NEt3 (40 mg, 0.40 mmol, 4.0 equiv) 
were dissolved in DMF (0.5 mL) and stirred at 70 °C for 20 h. After cooling to ambient temperature, 
H2O (10 mL) was added, the mixture extracted with EtOAc (4 × 15 mL), dried over Na2SO4 and 
concentrated in vacuo. Purification of the residue by column chromatography on silica gel 
(n-hexane/EtOAc 3:1) yielded 150b (37 mg, 80%) as a brown solid. 
1H-NMR (400 MHz, CDCl3): δ = 9.12 (d, J = 1.6 Hz, 1H), 9.09 (s, 1H), 8.90 (ddd, J = 7.9, 1.8, 1.2 Hz, 
1H), 8.74 (d, J = 9.1 Hz, 1H), 8.27−8.19 (m, 5H), 8.15 (d, J = 8.0 Hz, 1H), 8.08 (dd, J = 8.9, 8.9 Hz, 
2H), 8.03 (dd, J = 7.7, 7.7 Hz, 1H), 7.88 (ddd, J = 7.7, 1.7, 1.2 Hz, 1H), 7.65 (ddd, J = 7.8, 7.8, 0.6 Hz, 
1H), 5.02 (hept, J = 6.8 Hz, 1H), 1.70 (d, J = 6.8 Hz, 6H). 13C-NMR (100 MHz, CDCl3): δ = 154.0 (Cq), 
152.4 (Cq), 152.2 (CH), 142.4 (CH), 136.4 (Cq), 134.1 (CH), 132.7 (CH), 132.1 (Cq), 131.8 (Cq), 131.4 
(Cq), 131.4 (Cq), 131.3 (Cq), 130.1 (CH), 129.9 (CH), 129.0 (CH), 128.5 (CH), 128.3 (CH), 127.4 (CH), 
126.4 (CH), 125.8 (CH), 125.8 (CH), 125.7 (CH), 124.7 (CH), 124.6 (Cq), 124.5 (Cq), 124.3 (Cq), 118.0 
(Cq), 96.1 (Cq), 89.2 (Cq), 47.5 (CH), 22.7 (CH3). IR (ATR): ṽ = 1562, 1322, 1211, 842, 824, 798, 713, 
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700, 680, 646 cm–1. m.p.: 192 °C (decomp.). MS (EI) m/z (relative intensity): 462 (100) [M]+, 420 
(28), 210 (8). HR-MS (EI): m/z calcd for C32H22N4+ [M]+ 462.1844, found 462.1845. 
 
5.3.1.2 Mechanistic Studies 
H/D Exchange Experiment 
 
9-isoPropyl-6-phenyl-9H-purine (148a) (60 mg, 0.25 mmol, 1.0 equiv), NBS (88) (89 mg, 
0.50 mmol, 2.0 equiv) and RuCl3∙3H2O (5.2 mg, 20 µmol, 8.0 mol %) were dissolved in a mixture of 
DMA (0.4 mL) and D2O (0.1 mL) and stirred open to air at 80 °C for 20 h. After cooling to ambient 
temperature, aq. HCl (1N, 2 mL) and CH2Cl2 (0.5 mL) were added. The mixture was stirred at 
ambient temperature for 30 min and afterwards sat. aq. NaHCO3 (10 mL) was added. The mixture 
was extracted with CH2Cl2 (4 × 10 mL), dried over Na2SO4 and concentrated in vacuo. Purification 
of the residue by column chromatography on silica gel (n-hexane/EtOAc 5:1 → 2:1) yielded 149a 
(19 mg, 24%) as a colorless solid and [D]n-148a (34 mg, 57%) was recovered. The deuterium 
incorporation was determined by 1H-NMR. 
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5.3.1.3 Kinetic Analysis 
Reaction Order with Respect to RuCl3 
The initial rate method was employed to determine the reaction order with respect to RuCl3.[178] 
A mixture of purine 148a (179 mg, 0.75 mmol, 1.00 equiv), NBS (88) (267 mg, 1.50 mmol, 
2.00 equiv), RuCl3∙3H2O (2.8, 4.0, 5.9, 7.9, 9.9, 11.9 mol %) and n-tridecane (30 µL) was dissolved 
in DMA (1.5 mL) and stirred open to air at 81 °C. During the first 60 min aliquots (0.05 mL) were 
removed via a syringe every 10 min, diluted with EtOAc, filtered through a short plug of silica gel 
and Na2SO4 and analyzed by gas chromatography. 
amount / mol % log(c / mol L−1) Δ[149a] Δt−1 / 10−8 mol  L–1 s−1 log(Δ[149a] Δt−1 / mol  L–1 s−1) 
2.8 −1.854 1.625 –7.789 
4.0 −1.699 2.158 –7.666 
5.9 −1.523 3.117 –7.506 
7.9 −1.398 4.158 –7.381 
9.9 –1.310 4.442 –7.352 
11.9 −1.229 4.525 –7.344 
 
Reaction Order with Respect to Phenylpurine 148a 
The initial rate method was employed to determine the reaction order with respect to 
phenylpurine 148a.[178] A mixture of phenylpurine 148a (0.45, 0.56, 0.60, 0.75, 0.94, 1.13 mmol), 
NBS (88) (267 mg, 1.50 mmol), RuCl3∙3H2O (15.6 mg, 60 µmol) and n-tridecane (30 µL) was 
dissolved in DMA (1.5 mL) and stirred open to air at 81 °C. During the first 60 min aliquots 
(0.05 mL) were removed via a syringe every 10 min, diluted with EtOAc, filtered through a short 
plug of silica gel and Na2SO4 and analyzed by gas chromatography. 
amount / mmol log(c / mol L−1) Δ[149a] Δt−1 / 10−8 mol  L–1 s−1 log(Δ[149a] Δt−1 / mol  L–1 s−1) 
0.45 –0.523 7.700 –7.114 
0.56 −0.426 8.684[a] –7.063[a] 
0.60 –0.398 8.200 –7.086 
0.75 −0.301 7.813[a] –7.126[a] 
0.94 −0.204 8.367 –7.077 
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1.13 −0.125 8.317 –7.080 
[a] Average of two measurements. 
 
Reaction Order with Respect to 2-Phenylpyridine (45a) 
The initial rate method was employed to determine the reaction order with respect to 2-
phenylpyridine (45a).[178] A mixture of 2-phenylpyridine (45a) (0.38, 0.56, 0.75, 0.94, 1.13 mmol), 
NBS (88) (267 mg, 1.50 mmol), RuCl3∙3H2O (15.6 mg, 60 µmol) and n-tridecane (30 µL) was 
dissolved in DMA (1.5 mL) and stirred open to air at 81 °C. During the first 60 min aliquots 
(0.05 mL) were removed via a syringe every 10 min, diluted with EtOAc, filtered through a short 
plug of silica gel and Na2SO4 and analyzed by gas chromatography. 
Each reaction was performed two times, the measured rates were averaged and the error 
corresponds to the standard deviation. 
amount / 
mmol 
log(c / 
mol L−1) 
Δ[116a] Δt−1 / 
10−8 mol  L–1 s−1 
log(Δ[116a] Δt−1 / 
mol    L–1 s−1) 
Δlog(Δ[116a] Δt−1 / 
mol  L–1 s−1) 
0.38 −0.602 3.075 -7.512 0.018 
0.56 −0.426 3.167 -7.500 0.034 
0.75 −0.301 3.082 -7.511 0.007 
0.94 −0.204 3.226 -7.492 0.037 
1.13 −0.125 2.884 -7.540 0.015 
 
5.3.2 Ruthenium-Catalyzed meta-C–H Alkylation of Ketimines 
5.3.2.1 Data for Alkylated Phenones 165 
Cholesterol 4-acetyl-2-cycloheptylbenzoate (165aa) 
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General procedure A was followed using ketimine 151a (175 mg, 0.25 mmol) and cyclohexyl 
bromide (100a) (133 mg, 0.75 mmol). Purification by column chromatography on silica gel (n-
hexane/EtOAc 20:1) yielded phenone 165aa (89 mg, 57%) as a colorless solid. 
1H-NMR (400 MHz, CDCl3): δ = 7.92 (d, J = 1.7 Hz, 1H), 7.74 (dd, J = 8.1, 1.7 Hz, 1H), 7.68 (dd, J = 
8.1, 0.4 Hz, 1H), 5.45 (d, J = 5.2 Hz, 1H), 4.94–4.84 (m, 1H), 3.36 (tt, J = 10.6, 3.2 Hz, 1H), 2.61 (s, 
3H), 2.52–2.42 (m, 2H), 2.06–1.78 (m, 9H), 1.76–0.95 (m, 32H), 0.92 (d, J = 6.6 Hz, 3H), 0.87 (dd, J 
= 6.6, 1.8 Hz, 6H), 0.69 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 198.0 (Cq), 167.8 (Cq), 150.3 (Cq), 
139.6 (Cq), 139.1 (Cq), 134.8 (Cq), 129.6 (CH), 127.0 (CH), 125.3 (CH), 123.2 (CH), 75.4 (CH), 56.9 
(CH), 56.3 (CH), 50.2 (CH), 42.5 (Cq), 42.3 (CH), 39.9 (CH2), 39.7 (CH2), 38.3 (CH2), 37.2 (CH2), 36.9 
(CH2), 36.8 (Cq), 36.4 (CH2), 36.0 (CH), 32.1 (CH2), 32.1 (CH), 28.4 (CH2), 28.2 (CH), 28.0 (CH2), 27.9 
(CH2), 27.7 (CH2), 27.0 (CH3), 24.5 (CH2), 24.0 (CH2), 23.0 (CH3), 22.7 (CH3), 21.2 (CH2), 19.5 (CH3), 
18.9 (CH3). IR (ATR): ṽ = 2931, 2850, 1718, 1690, 1464, 1276, 1234, 1143, 1099, 1060 cm−1. m.p.: 
151 °C. MS (ESI) m/z (relative intensity): 651 (100) [M+Na]+, 1281 (39) [2M+Na]+. HR-MS (ESI): m/z 
calcd for C43H64O3Na+ [M+Na]+ 651.4748, found 651.4718. 
 
4-Acetyl-2-cycloheptylphenyl 4-dimethylaminobenzoate (165ba) 
 
General procedure A was followed using ketimine 151b (221 mg, 0.50 mmol) and cyclohexyl 
bromide (100a) (266 mg, 1.50 mmol). Purification by column chromatography on silica gel (n-
hexane/EtOAc 8:1) and GPC purification yielded phenone 165ba (121 mg, 64%) as a colorless solid. 
1H-NMR (300 MHz, CDCl3): δ = 8.08 (d, J = 8.8 Hz, 2H), 7.95 (d, J = 2.1 Hz, 1H), 7.81 (dd, J = 8.4, 
2.1 Hz, 1H), 7.22 (d, J = 8.4 Hz, 1H), 6.73 (d, J = 8.8 Hz, 2H), 3.10 (s, 6H), 2.99–2.88 (m, 1H), 2.61 (s, 
3H), 1.96–1.85 (m, 2H), 1.82–1.39 (m, 10H). 13C-NMR (125 MHz, CDCl3): δ = 197.7 (Cq), 165.2 (Cq), 
154.0 (Cq), 152.4 (Cq), 142.2 (Cq), 134.8 (Cq), 132.2 (CH), 127.9 (CH), 127.1 (CH), 123.1 (CH), 115.5 
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(Cq), 111.0 (CH), 40.4 (CH), 40.2 (CH3), 35.5 (CH2), 27.9 (CH2), 27.6 (CH2), 26.8 (CH3). IR (ATR): ṽ = 
2917, 1706, 1687, 1600, 1276, 1235, 1161, 1074, 1056, 761 cm−1. m.p.: 110 °C. MS (ESI) m/z 
(relative intensity): 402 (100) [M+Na]+, 781 (76) [2M+Na]+, 1160 (53) [3M+Na]+. HR-MS (ESI): m/z 
calcd for C24H29O3Na+ [M+Na]+ 402.2040, found 402.2034. 
 
4-Acetyl-2-tert-butylphenyl 4-dimethylaminobenzoate (165bb) 
 
General procedure A was followed using ketimine 151b (221 mg, 0.50 mmol) and tert-butyl 
bromide (100b) (206 mg, 1.50 mmol). Purification by column chromatography on silica gel (n-
hexane/EtOAc 8:1) and GPC purification yielded phenone 165bb (100 mg, 59%) as a colorless solid. 
1H-NMR (300 MHz, CDCl3): δ = 8.12–8.04 (m, 3H), 7.84 (ddd, J = 8.3, 2.2, 0.7 Hz, 1H), 7.19 (dd, J = 
8.3, 0.7 Hz, 1H), 6.77–6.70 (m, 2H), 3.10 (s, 6H), 2.61 (s, 3H), 1.41 (s, 9H). 13C-NMR (125 MHz, 
CDCl3): δ = 197.7 (Cq), 165.3 (Cq), 154.0 (Cq), 154.0 (Cq), 142.2 (Cq), 134.2 (Cq), 132.3 (CH), 127.7 
(CH), 127.6 (CH), 124.8 (CH), 115.7 (Cq), 111.1 (CH), 40.2 (CH3), 34.9 (Cq), 30.3 (CH3), 26.8 (CH3). IR 
(ATR): ṽ = 1711, 1677, 1599, 1268, 1165, 1079, 1048, 824, 760, 602 cm−1. m.p.: 166 °C. MS (ESI) 
m/z (relative intensity): 340 (24) [M+H]+, 362 (100), [M+Na]+, 701 (80), [2M+Na]+, 1040 (27) 
[3M+Na]+. HR-MS (ESI): m/z calcd for C21H25O3Na+ [M+Na]+ 362.1727, found 362.1730. 
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4-Acetyl-2-cycloheptylphenyl thiophene-2-carboxylate (165ca) 
 
General procedure A was followed using ketimine 151c (206 mg, 0.50 mmol) and cyclohexyl 
bromide (100a) (266 mg, 1.50 mmol). Purification by column chromatography on silica gel (n-
hexane/EtOAc 20:1) yielded phenone 165ca (58 mg, 34%) as a colorless oil. 
1H-NMR (500 MHz, CDCl3): δ = 8.35 (dd, J = 3.1, 1.2 Hz, 1H), 7.96 (d, J = 2.2 Hz, 1H), 7.82 (dd, J = 
8.4, 2.2 Hz, 1H), 7.68 (dd, J = 5.1, 1.2 Hz, 1H), 7.43 (dd, J = 5.1, 3.1 Hz, 1H), 7.22 (d, J = 8.4 Hz, 1H), 
2.91 (tt, J = 10.6, 3.4 Hz, 1H), 2.61 (s, 3H), 1.94–1.86 (m, 2H), 1.83–1.74 (m, 2H), 1.72–1.53 (m, 6H), 
1.51–1.41 (m, 2H). 13C-NMR (125 MHz, CDCl3): δ = 197.5 (Cq), 160.8 (Cq), 151.5 (Cq), 142.0 (Cq), 
135.3 (Cq), 134.5 (CH), 132.5 (Cq), 128.3 (CH), 128.1 (CH), 127.2 (CH), 126.9 (CH), 122.8 (CH), 40.4 
(CH), 35.5 (CH2), 27.8 (CH2), 27.6 (CH2), 26.8 (CH3). IR (ATR): ṽ = 1731, 1681, 1235, 1167, 1105, 
1079, 1058, 857, 739 cm−1. MS (ESI) m/z (relative intensity): 343 (100) [M+H]+, 365 (44) [M+Na]+, 
707 (24) [2M+Na]+. HR-MS (ESI): m/z calcd for C20H23O3S+ [M+H]+ 343.1362, found 343.1358. 
 
5.3.2.2 Additive Test 
 
General procedure A was followed using ketimine 151d (152 mg, 0.50 mmol), cyclohexyl bromide 
(100a) (266 mg, 1.50 mmol) and an additive (0.50 mmol). After hydrolysis with aq. HCl (2N, 
3.0 mL), n-dodecane (40 µL) was added. An aliquot (0.2 mL) was removed from the organic phase 
via a syringe, diluted with EtOAc, filtered through a short plug of silica gel and analyzed by gas 
chromatography. 
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Entry Additive 
Conversion 
165da / %[a] 
Remaining 
Additive / %[a] 
Unreacted 
Ketone / %[a] 
1 none 97 -- 0 
2 valerophenone 96 93 0 
3 
N-(tert-butyl)-2-
phenylacetamide 
(153b) 
52 45 0 
4 N,N-dimethylaniline 78 0 0 
5 aniline 64 0 0 
6 1-decene 71 n.d.[b] 0 
7 methyl(phenyl)sulfane 79 0 0 
8 1-heptanol 41 77 22 
9 nonan-5-one 74 96 0 
10 octylamine 48 0 0 
11 1-chlorodecane 72 100 0 
12 benzaldehyde 4 38 0 
13 pyridine 61 n.d.[b] 0 
14 2-methylpyridine 71 0 0 
15 benzofuran 96 91 0 
16 1H-indole 86 41 0 
17 quinoline 81 0 0 
18 2-chloroquinoline 10 0 0 
19 benzoxazole 2 10 48 
20 2-methylfuran 64 n.d.[b] 0 
21 2-methylthiophene 63 88 0 
22 N-methylimidazole 3 0 44 
[a] Determined by gas chromatography with n-dodecane as the internal standard. [b] Not 
detected due to overlap with the solvent signal. 
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5.3.2.3 One-pot two-fold C–H Activation 
1-[4-(1-Methyl-cyclohexyl)-5-fluoro-4'-methoxy-[1,1'-biphenyl]-2-yl]ethan-1-one (166a) 
 
General procedure A was followed using ketimine 151d (152 mg, 0.50 mmol), 1-bromo-1-
methylcyclohexane (100c) (266 mg, 1.50 mmol) and K2CO3 (276 mg, 2.00 mmol). After 20 h, 
4-bromoanisole (140 mg, 0.75 mmol) was added at ambient temperature and the mixture was 
stirred at 120 °C for an additional 20 h. After cooling to ambient temperature, aq. HCl (2N, 3.0 mL) 
was added, the mixture was stirred at ambient temperature for 3 h, extracted with EtOAc 
(3 × 20 mL), dried over Na2SO4 and concentrated in vacuo. Purification of the residue by column 
chromatography on silica gel (n-hexane/EtOAc 25:1) yielded phenone 166a (118 mg, 69%) as a 
colorless solid. 
1H-NMR (400 MHz, CDCl3): δ = 7.52 (d, J = 8.6 Hz, 1H), 7.25 (d, J = 8.9 Hz, 2H), 6.99 (d, J = 13.3 Hz, 
1H), 6.96 (d, J = 8.9 Hz, 2H), 3.85 (s, 3H), 2.12–2.04 (m, 2H), 1.99 (s, 3H), 1.73–1.65 (m, 2H), 1.64–
1.56 (m, 2H), 1.54–1.38 (m, 4H), 1.32 (d, J = 0.8 Hz, 3H). 13C-NMR (100 MHz, CDCl3): δ = 204.5 (Cq), 
163.1 (d, 1JC–F = 254.4 Hz, Cq), 159.9 (Cq), 140.4 (d, 2JC–F = 9.6 Hz, Cq), 136.5 (d, 4JC–F = 2.9 Hz, Cq), 
135.6 (d, 3JC–F = 9.6 Hz, Cq), 132.1 (d, 4JC–F = 1.7 Hz, Cq), 130.0 (CH), 129.0 (d, 3JC–F = 7.5 Hz, CH), 118.2 
(d, 2JC–F = 25.9 Hz, CH), 114.4 (CH), 55.5 (CH3), 38.0 (d, 3JC–F = 3.5 Hz, Cq), 37.2 (d, 4JC–F = 3.8 Hz, CH2), 
30.7 (CH3), 26.6 (CH2), 26.5 (CH3), 22.8 (CH2). 19F-NMR (470 MHz, CDCl3): δ = –105.0 (dd, J = 13.3, 
8.6 Hz). IR (ATR): ṽ = 1674, 1608, 1485, 1467, 1267, 1245, 1169, 1031, 833, 532 cm−1. m.p.: 58 °C. 
MS (ESI) m/z (relative intensity): 341 [M+H]+ (75), 363 [M+Na]+ (100), 703 [2M+Na]+ (90). HR-MS 
(ESI): m/z calcd for C22H26FO2+ [M+H]+ 341.1911, found 341.1908. 
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1-[1-n-Hexyl-5-(1-methyl-cyclohexyl)-4-fluorophenyl]ethan-1-one (166b) 
 
General procedure A was followed using ketimine 151d (152 mg, 0.50 mmol), 1-bromo-1-
methylcyclohexane (100c) (266 mg, 1.50 mmol) and K2CO3 (276 mg, 2.00 mmol). After 20 h, 
1-bromohexane (92) (248 mg, 0.75 mmol) was added at ambient temperature and the mixture 
was stirred at 120 °C for an additional 20 h. After cooling to ambient temperature, aq. HCl (2N, 
3.0 mL) was added, the mixture was stirred at ambient temperature for 3 h, extracted with EtOAc 
(3 × 20 mL), dried over Na2SO4 and concentrated in vacuo. Purification of the residue by column 
chromatography on silica gel (n-hexane/EtOAc 30:1) and GPC purification yielded phenone 166b 
(89 mg, 56%) as a colorless oil. 
1H-NMR (400 MHz, CDCl3): δ = 7.62 (d, J = 8.5 Hz, 1H), 6.87 (d, J = 13.9 Hz, 1H), 2.84–2.77 (m, 2H), 
2.56 (s, 3H), 2.10–1.97 (m, 2H), 1.72–1.23 (m, 19H), 0.91–0.84 (m, 3H). 13C-NMR (100 MHz, CDCl3): 
δ = 201.1 (Cq), 163.5 (d, 1JC–F = 254.8 Hz, Cq), 144.0 (d, 3JC–F = 9.4 Hz, Cq), 133.7 (d, 4JC–F = 2.8 Hz, Cq), 
133.5 (d, 2JC–F = 11.3 Hz, Cq), 130.2 (d, 3JC–F = 7.7 Hz, CH), 119.1 (d, 2JC–F = 25.0 Hz, CH), 37.7 (d, 3JC–F 
= 3.5 Hz, Cq), 37.2 (d, 4JC–F = 4.0 Hz, CH2), 33.6 (d, 4JC–F = 1.2 Hz, CH2), 31.8 (CH2), 31.4 (CH2), 30.0 
(CH3), 29.5 (CH2), 26.8 (CH3), 26.4 (CH2), 22.8 (CH2), 22.7 (CH2), 14.2 (CH3). 19F-NMR (282 MHz, 
CDCl3): δ = –104.1 (dd, J = 13.9, 8.5 Hz). IR (ATR): ṽ = 2925, 2856, 1684, 1556, 1455, 1389, 1354, 
1247, 1141, 899 cm−1. MS (EI) m/z (relative intensity): 318 (11) [M]+, 303 (100) [M–Me]+, 43 (46). 
HR-MS (EI): m/z calcd for C21H31FO+ [M]+ 318.2359, found 318.2353. 
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5.3.2.4 Mechanistic Studies 
Reaction with chiral Bromide 
 
General procedure A was followed using ketimine 151e (34 mg, 0.10 mmol) and alkyl bromide 
(S)-100d (84% ee, 58 mg, 0.30 mmol). Purification by column chromatography on silica gel (n-
pentane/Et2O 20:1) yielded phenone 165ed (0% ee, 23 mg, 78%) as a colorless oil. The 
enantiomeric excess was determined by HPLC analysis on a chiral stationary phase. 
1H-NMR (500 MHz, CDCl3): δ = 8.31 (s, 1H), 8.15 (d, J = 8.4 Hz, 1H), 7.98 (ddd, J = 8.2, 0.7, 0.7 Hz, 
1H), 7.97 (d, J = 1.8 Hz, 1H), 7.63 (ddd, J = 8.5, 6.8, 1.4 Hz, 1H), 7.54 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 
3.58 (hept, J = 6.8 Hz, 1H), 2.73 (s, 3H), 1.90–1.77 (m, 1H), 1.75–1.66 (m, 1H), 1.40 (d, J = 6.9 Hz, 
3H), 1.32–1.20 (m, 8H), 0.85 (t, J = 7.1 Hz, 3H). 13C-NMR (100 MHz, CDCl3): δ = 198.6 (Cq), 145.1 
(Cq), 134.3 (2 × Cq), 133.3 (Cq), 130.7 (CH), 128.9 (CH), 128.4 (CH), 126.3 (CH), 123.5 (CH), 120.4 
(CH), 37.9 (CH2), 34.0 (CH), 31.9 (CH2), 29.6 (CH2), 27.9 (CH2), 26.8 (CH3), 22.8 (CH2), 21.7 (CH3), 
14.2 (CH3). HPLC (IC-3, n-hexane/i-PrOH 99:1): Rt1 = 10.33 min (area: 49.9%), Rt2 = 11.97 min (area: 
50.1%). 
The analytical data are in accordance with those obtained for the racemic reaction.[121] 
 
 
Figure 66: HPLC trace of rac-165ed. 
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5.3.2.5 Kinetic Analysis 
Reaction Order with Respect to [Ru(O2CAd)2(p-cymene)] (167) 
The initial rate method was employed to determine the reaction order with respect to 
[Ru(O2CAd)2(p-cymene)] (167).[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube 
was charged with (E)-1-(4-fluorophenyl)-N-(3,4,5-trimethoxyphenyl)ethan-1-imine (151d) 
(303 mg, 1.00 mmol, 1.00 equiv), 1-bromo-1-methylcyclohexane (100c) (531 mg, 3.00 mmol, 3.00 
equiv), K2CO3 (276 mg, 2.00 mmol, 2.00 equiv) and 1-fluorononane (37 mg, 0.25 mmol). A solution 
of [Ru(O2CAd)2(p-cymene)] (167) (2.5, 3.5, 7.5, 10.0 mol %) in PhCMe3 (4.0 mL) was added and the 
mixture was stirred at 92 °C. After 60 min aliquots (0.1 mL) were removed via a syringe every 
30 min for 3 h, diluted with PhMe-d8 (0.25 mL) and analyzed by 19F{1H}-NMR spectroscopy. 
amount / mol % log(c / mol L−1) Δ[152dc] Δt−1 / 10−8 mol L–1 s−1 log(Δ[152dc] Δt−1 / mol L–1 s−1) 
2.5 −2.204 0.236 –8.627 
3.5 −2.058 0.379 –8.422 
7.5 −1.727 0.844 –8.074 
10.0 −1.602 1.260 –7.900 
 
Reaction Order with Respect to Ketimine 151d 
The initial rate method was employed to determine the reaction order with respect to ketimine 
151d.[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged with (E)-1-(4-
fluorophenyl)-N-(3,4,5-trimethoxyphenyl)ethan-1-imine (151d) (0.50, 0.75, 1.00, 1.50, 
2.00 mmol), 1-bromo-1-methylcyclohexane (100c) (531 mg, 3.00 mmol), K2CO3 (276 mg, 
2.00 mmol) and 1-fluorononane (37 mg, 0.25 mmol). A solution of [Ru(O2CAd)2(p-cymene)] (167) 
(44.5 mg, 75 µmol) in PhCMe3 (4.0 mL) was added and the mixture was stirred at 92 °C. After 
60 min aliquots (0.1 mL) were removed via a syringe every 30 min for 3 h, diluted with PhMe-d8 
(0.25 mL) and analyzed by 19F{1H}-NMR spectroscopy. 
amount / mmol log(c / mol L−1) Δ[152dc] Δt−1 / 10−8 mol L–1 s−1 log(Δ[152dc] Δt−1 / mol L–1 s−1) 
0.50 −0.903 0.471 –8.327 
0.75 −0.727 0.596 –8.225 
1.00 −0.602 0.944 –8.025 
1.50 −0.426 1.227 –7.911 
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2.00 –0.301 1.650 –7.783 
 
Reaction Order with Respect to Alkyl Bromide 100c 
The initial rate method was employed to determine the reaction order with respect to alkyl 
bromide 100c.[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged with 
(E)-1-(4-fluorophenyl)-N-(3,4,5-trimethoxyphenyl)ethan-1-imine (151d) (303 mg, 1.00 mmol, 
1.00 equiv), 1-bromo-1-methylcyclohexane (100c) (1.00, 1.50, 3.00, 4.50 mmol), K2CO3 (276 mg, 
2.00 mmol, 2.00 equiv), 1-fluorononane (37 mg, 0.25 mmol) and MS (4 Å, 150 mg). A solution of 
[Ru(O2CAd)2(p-cymene)] (167) (44.5 mg, 75 µmol, 7.5 mol %) in PhCMe3 (4.0 mL) was added and 
the mixture was stirred at 92 °C. After 60 min aliquots (0.1 mL) were removed via a syringe every 
30 min for 3 h, diluted with PhMe-d8 (0.25 mL) and analyzed by 19F{1H}-NMR spectroscopy. 
amount / mmol log(c / mol L−1) Δ[152dc] Δt−1 / 10−8 mol L–1 s−1 log(Δ[152dc] Δt−1 / mol  L–1 s−1) 
1.00 –0.602 0.602 –8.220 
1.50 –0.426 0.972 –8.012 
3.00 –0.125 0.844 –8.074 
4.50 0.051 0.616 –8.211 
 
Determination of the Activation Energy 
An Arrhenius plot analysis was employed to determine the activation energy of the reaction with 
reaction rate obtained via the initial rate method.[178] Under an atmosphere of N2 inside a 
glovebox, a Schlenk-tube was charged with (E)-1-(4-fluorophenyl)-N-(3,4,5-
trimethoxyphenyl)ethan-1-imine (151d) (303 mg, 1.00 mmol, 1.00 equiv), 1-bromo-1-
methylcyclohexane (100c) (561 mg, 3.00 mmol, 3.00 equiv), K2CO3 (276 mg, 2.00 mmol, 
2.00 equiv) and 1-fluorononane (37 mg, 0.25 mmol). A solution of [Ru(O2CAd)2(p-cymene)] (167) 
(44.5 mg, 75 µmol, 7.5 mol %) in PhCMe3 (4.0 mL) was added and the mixture was stirred at 
various temperatures (84, 92, 98, 103, 112 °C). Periodically, aliquots (0.1 mL) were removed via a 
syringe, diluted with PhMe-d8 (0.25 mL) and analyzed by 19F{1H}-NMR spectroscopy. 
The Arrhenius plot analysis resulted in a value for the activation energy EA of 23.6±3.0 kcal mol–1. 
Errors were calculated based on the fitting error of the linear regression as implemented in the 
OriginPro software. 
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T / K 
T−1 / 10−3 
K−1 
Δ[152dc] Δt−1 /  
10−8 mol L–1 s−1 
ln(Δ[152dc] Δt−1 /  
mol  L–1 s−1) 
ln(Δ[152dc] Δt−1 T–1/  
mol  L–1 s−1 K–1) 
357.2 2.800 0.326 –19.54 –25.42 
365.2 2.738 0.944 –18.48 –24.38 
371.2 2.694 1.819 –17.82 –23.74 
376.2 2.658 2.246 –17.61 –23.54 
385.2 2.596 3.755 –17.10 –23.05 
 
5.3.3 Ruthenium-Catalyzed meta-C–H Alkylation of Phenylpyridines 
Reaction Order with Respect to [Ru(O2CMes)2(p-cymene)] (61) 
The initial rate method was employed to determine the reaction order with respect to 
[Ru(O2CMes)2(p-cymene)] (61).[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube 
was charged with 2-phenylpyridine (45a) (155 mg, 1.00 mmol, 1.00 equiv), 
[Ru(O2CMes)2(p-cymene)] (61) (2.5, 3.5, 5.0, 7.5, 10.0, 12.5 mol %) and K2CO3 (276 mg, 2.00 mmol, 
2.00 equiv). 1-Bromo-1-methylcyclohexane (100c) (531 mg, 3.00 mmol, 3.00 equiv), n-dodecane 
(50 µL) and 1,4-dioxane (4.0 mL) were added and the mixture was stirred at 92 °C. After 60 min 
aliquots (0.05 mL) were removed via a syringe every 15 min for 3 h, diluted with EtOAc, filtered 
through a short plug of silica gel and Na2SO4 and analyzed by gas chromatography. 
amount / mol % log(c / mol L−1) Δ[104ac] Δt−1 / 10−8 mol L–1  s−1 log(Δ[104ac] Δt−1 / mol  L–1  s−1) 
2.5 −2.204 0.417 –8.380 
3.5 −2.058 0.635 –8.197 
5.0 −1.903 0.925 –8.034 
7.5 −1.727 1.880 –7.726 
10.0 –1.602 2.201 –7.657 
12.5 –1.505 2.470 –7.607 
 
Determination of the Activation Energy 
An Arrhenius plot analysis was employed to determine the activation energy of the reaction with 
reaction rate obtained via the initial rate method.[178] Under an atmosphere of N2 inside a 
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glovebox, a Schlenk-tube was charged with 2-(4-fluorophenyl)pyridine (45c) (173 mg, 1.00 mmol, 
1.00 equiv), [Ru(O2CMes)2(p-cymene)] (61) (28.1 mg, 50 µmol, 5.0 mol %) and K2CO3 (276 mg, 
2.00 mmol, 2.00 equiv). 1-Bromo-1-methylcyclohexane (100c) (531 mg, 3.00 mmol, 3.00 equiv), 
1-fluorononane (36.6 mg, 0.25 mmol) and PhCMe3 (4.0 mL) were added and the mixture was 
stirred at various temperatures (88, 92, 97, 100, 106, 110 °C). Periodically, aliquots (0.1 mL) were 
removed via a syringe, diluted with PhMe-d8 and analyzed by 19F{1H}-NMR spectroscopy. 
The Arrhenius plot analysis resulted in a value for the activation energy EA of 19.9±0.9 kcal mol–1. 
Errors were calculated based on the fitting error of the linear regression as implemented in the 
OriginPro software. 
T / K 
T−1 / 10−3 
K−1 
Δ[104cc] Δt−1 /  
10−8  mol L–1 s−1 
ln(Δ[104cc] Δt−1 /  
mol L–1 s−1) 
ln(Δ[104cc] Δt−1 T–1/  
mol L–1 s−1 K–1) 
365.2 2.739 1.549 –17.98 –23.88 
370.2 2.702 2.280 –17.60 –23.51 
373.2 2.680 2.630 –17.45 –23.38 
379.2 2.637 4.042 –17.02 –22.96 
383.2 2.610 5.782 –16.67 –22.61 
 
5.3.4 Ruthenium-Catalyzed Decarboxylative C–H Activation 
 
The KIE value was determined by the comparison of initial rates of two independent reactions. 
Under an atmosphere of N2, a two-necked Schlenk-tube was charged with 2-fluorobenzoic acid 
(31b) (140 mg, 1.00 mmol, 2.00 equiv) or 6-deutero-2-fluorobenzoic acid ([D]1-31b) (141 mg, 
1.00 mmol, 1.00 equiv), 1-benzyl-1H-pyrrole-2,5-dione (177b) (94 mg, 0.50 mmol, 1.00 equiv) and 
[Ru(O2CMes)2(p-cymene)] (61) (28.1 mg, 50 µmol, 10.0 mol %). PhMe (3.0 mL) was added and the 
mixture was stirred at 110 °C. An in situ IR spectrum was acquired every 1 min for the first 8 h and 
every 2 min for the following 16 h. The initial rates were determined from the decrease in peak 
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area of the peak at 1405 cm–1, which was assigned to the C–F stretching frequency of 31b. The 
peak area was calculated in the range 1422–1399 cm–1 with a two-point baseline at 1422 cm–1 and 
1399 cm–1. A KIE of kH/kD ≈ 1.05 was determined by employing a linear fit for the time interval  
0.5–5.0 h. 
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Figure 67: In situ IR measurements for the reaction of 31b and [D]1-31b. 
 
5.3.5 Ruthenium-Catalyzed C–H Alkenylation of Aryl Acetamides 
 
The KIE value was determined by the comparison of initial rates of two independent reactions. 
Under an atmosphere of N2, a two-necked Schlenk-tube was charged with N-(tert-butyl)-2-
phenylacetamide (153b) (143 mg, 0.75 mmol, 1.00 equiv) or N-(tert-butyl)-2-
(perdeuterophenyl)acetamide ([D]5-153b) (147 mg, 0.75 mmol, 1.00 equiv), [RuCl2(p-cymene)]2 
(23 mg, 38 µmol, 5.0 mol %), AgSbF6 (52 mg, 0.15 mmol, 20 mol %) and Cu(OAc)2∙H2O (299 mg, 
1.50 mmol, 2.00 equiv). n-Butylacrylate (27b) (192 mg, 1.50 mmol, 2.00 equiv) and 1,4-dioxane 
(3.0 mL) were added and the mixture was stirred at 100 °C. An in situ IR spectrum was acquired 
every 30 s for the first 2 h, every 1 min for the following 4 h and every 2 min for the following 16 h. 
The initial rates were determined from the increase in peak area of the peak at 1726 cm–1, which 
was assigned to the C=O stretching frequency of 155bb. The peak area was calculated in the range 
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1744–1701 cm–1 with a one-point baseline at 871 cm–1. A KIE of kH/kD ≈ 1.02 was determined by 
employing a linear fit for the time interval 0.4–0.9 h for the protonated substrate and 0.5–1.0 h 
for the deuterated substrate. 
0 1 2 3 4 5 6
0
1
2
3
4
5
6
[D]
5
-153b
y = 1.822x - 0.782
R
2
 = 0.992
153b
y = 1.854x - 2.037
R
2
 = 0.992
N
o
rm
a
liz
e
d
 P
e
a
k
 A
re
a
 /
 a
.u
.
t / h  
Figure 68: In situ IR measurements for the reaction of 153b and [D]5-153b. 
 
5.3.6 Ruthenium-Catalyzed Oxidative C–H/C–H Activation 
5.3.6.1 Data for Products 47 and 181 
2,2'-(3,6'-Dimethyl-[1,1'-biphenyl]-2,2'-diyl)dipyridine (181d) and 3'-methyl-2'-(pyridin-2-yl)-
[1,1'-biphenyl]-2-carbonitrile (47dk) 
 
General procedure B was followed using 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol) 
and 2-iodobenzonitrile (54c) (172 mg, 0.75 mmol). Purification by column chromatography on 
silica gel (n-hexane/EtOAc 2:1) yielded 181d (66 mg, 78%) as a colorless solid and 47dk (12 mg, 
9%) as an off-white solid. 
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Data for 181d: 
1H-NMR (300 MHz, CDCl3): δ = 8.56 (d, J = 4.6 Hz, 2H), 7.53 (ddd, J = 7.8, 7.7, 1.6 Hz, 2H), 7.31 (d, J 
= 7.8 Hz, 2H), 7.11–7.00 (m, 4H), 6.93 (dd, J = 7.5, 7.5 Hz, 2H), 6.77 (d, J = 7.4 Hz, 2H), 2.10 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ = 159.6 (Cq), 148.8 (CH), 140.4 (Cq), 139.9 (Cq), 136.0 (Cq), 135.6 (CH), 
129.0 (CH), 128.7 (CH), 126.7 (CH), 125.8 (CH), 121.3 (CH), 20.7 (CH3). IR (ATR): ṽ = 1584, 1562, 
1453, 1422, 1023, 783, 748, 621, 525, 399 cm−1. m.p.: 155 °C. MS (ESI) m/z (relative intensity): 337 
[M+H]+ (100), 359 [M+Na]+ (18), 695 [2M+Na]+ (9). HR-MS (ESI): m/z calcd for C24H20N2Na+ [M+Na]+ 
359.1519, found 359.1513. 
The analytical data are in accordance with those reported in the literature.[115] 
 
Data for 47dk: 
1H-NMR (300 MHz, CDCl3): δ = 8.56 (ddd, J = 4.6, 1.7, 1.2 Hz, 1H), 7.58 (dd, J = 7.5, 1.4 Hz, 1H), 7.50 
(ddd, J = 7.7, 7.7, 1.9 Hz, 1H), 7.46–7.37 (m, 2H), 7.34–7.27 (m, 2H), 7.23 (ddd, J = 7.7, 7.7, 1.5 Hz, 
1H), 7.15–7.04 (m, 3H), 2.22 (s, 3H). 13C-NMR (75 MHz, CDCl3): δ = 158.7 (Cq), 149.0 (CH), 145.8 
(Cq), 139.9 (Cq), 137.6 (Cq), 137.0 (Cq), 135.9 (CH), 132.6 (CH), 131.7 (CH), 131.7 (CH), 131.0 (CH), 
128.2 (CH), 127.6 (CH), 127.1 (CH), 125.5 (CH), 121.6 (CH), 118.6 (Cq), 112.7 (Cq), 20.5 (CH3). IR 
(ATR): ṽ =1458, 1419, 796, 772, 748, 618, 581, 558, 521, 422 cm−1. m.p.: 106 °C. MS (ESI) m/z 
(relative intensity): 271 [M+H]+ (100), 293 [M+Na]+ (9). HR-MS (ESI): m/z calcd for C19H15N2+ [M+H]+ 
271.1230, found 271.1231. 
 
2-[3-Methyl-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl]pyridine (47dc) 
 
General procedure B was followed using 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol) 
and 4-bromotrifluorotoluene (46c) (169 mg, 0.75 mmol). Purification by column chromatography 
on silica gel (n-hexane/EtOAc 5:1) yielded 47dc (137 mg, 87%) as a slightly yellow oil. 
1H-NMR (400 MHz, CDCl3): δ = 8.60 (ddd, J = 4.9, 1.8, 1.0 Hz, 1H), 7.44 (ddd, J = 7.7, 7.7, 1.8 Hz, 
1H), 7.39–7.29 (m, 4H), 7.23 (ddd, J = 7.1, 1.7, 0.7 Hz, 1H), 7.20–7.14 (m, 2H), 7.08 (ddd, J = 7.7, 
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4.9, 1.2 Hz, 1H), 6.87 (ddd, J = 7.7, 1.1, 1.1 Hz, 1H), 2.17 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 
159.1 (Cq), 149.1 (CH), 145.5 (Cq), 139.9 (Cq), 139.4 (Cq), 137.1 (Cq), 136.0 (CH), 130.2 (CH), 130.0 
(CH), 128.5 (q, 2JC–F = 32.3 Hz, Cq), 128.3 (CH), 127.5 (CH), 125.6 (CH), 124.6 (q, 3JC–F = 3.8 Hz, CH), 
124.2 (q, 1JC–F = 272.6 Hz, Cq), 121.7 (CH), 20.5 (CH3).19F-NMR (282 MHz, CDCl3): δ = –62.4 (s). IR 
(ATR): ṽ = 1321, 1162, 1107, 1083, 1062, 1017, 844, 788, 748, 610 cm−1. MS (ESI) m/z (relative 
intensity): 314 [M+H]+ (100), 336 [M+Na]+ (7). HR-MS (ESI): m/z calcd for C19H15NF3+ [M+H]+ 
314.1151, found 314.1150. 
The analytical data are in accordance with those reported in the literature.[161a] 
 
2-[3-Methyl-3'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl]pyridine (47dd) 
 
General procedure B was followed using 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol) 
and 3-bromotrifluorotoluene (46d) (169 mg, 0.75 mmol). Purification by column chromatography 
on silica gel (n-hexane/EtOAc 5:1 → 1:1) yielded 47dd (132 mg, 84%) as a slightly yellow oil. 
1H-NMR (400 MHz, CDCl3): δ = 8.57 (ddd, J = 4.9, 1.9, 1.0 Hz, 1H), 7.40 (ddd, J = 7.7, 7.7, 1.8 Hz, 
1H), 7.36–7.15 (m, 7H), 7.04 (ddd, J = 7.7, 4.9, 1.1 Hz, 1H), 6.84 (ddd, J = 7.7, 1.1, 1.0 Hz, 1H), 2.15 
(s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 159.1 (Cq), 149.1 (CH), 142.2 (Cq), 139.8 (Cq), 139.6 (Cq), 
137.0 (Cq), 135.9 (CH), 132.8 (CH), 130.1 (CH), 130.0 (q, 2JC–F = 32.4 Hz, Cq), 128.3 (CH), 128.1 (CH), 
127.4 (CH), 126.6 (q, 3JC–F = 3.9 Hz, CH), 125.3 (CH), 126.6 (q, 3JC–F = 3.9 Hz, CH), 124.1 (q, 1JC–F = 
273.3 Hz, Cq), 121.6 (CH), 20.4 (CH3). 19F-NMR (282 MHz, CDCl3): δ = –62.7 (s). IR (ATR): ṽ = 1334, 
1272, 1163, 1119, 1096, 1070, 784, 748, 699, 660 cm−1. MS (ESI) m/z (relative intensity): 314 
[M+H]+ (100), 336 [M+Na]+ (7). HR-MS (ESI): m/z calcd for C19H15NF3+ [M+H]+ 314.1151, found 
314.1150. 
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2-(3-Methyl-[1,1'-biphenyl]-2-yl)pyridine (47de) 
 
General procedure B was followed using 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol) 
and bromobenzene (46e) (118 mg, 0.75 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc 5:1) yielded 47de (102 mg, 83%) as a colorless oil. 
1H-NMR (300 MHz, CDCl3): δ = 8.64 (ddd, J = 5.0, 1.9, 1.0 Hz, 1H), 7.43 (ddd, J = 7.6, 7.6, 1.7 Hz, 
1H), 7.27–7.39 (m, 3H), 7.19–7.06 (m, 6H), 6.92–6.86 (m, 1H), 2.22 (s, 3H). 13C-NMR (75 MHz, 
CDCl3): δ = 159.6 (Cq), 148.8 (CH), 141.9 (Cq), 141.3 (Cq), 139.4 (Cq), 136.7 (Cq), 135.7 (CH), 129.6 
(CH), 129.4 (CH), 128.0 (CH), 127.6 (2 × CH), 126.2 (CH), 125.6 (CH), 121.3 (CH), 20.5 (CH3). IR (ATR): 
ṽ = 1585, 1562, 1459, 1418, 1025, 787, 746, 700, 578, 403 cm−1. MS (ESI) m/z (relative intensity): 
246 [M+H]+ (100), 268 [M+Na]+ (4). HR-MS (ESI): m/z calcd for C18H16N+ [M+H]+ 246.1277, found 
246.1283. 
The analytical data are in accordance with those reported in the literature.[180] 
 
2-(2'-Fluoro-3-methyl-[1,1'-biphenyl]-2-yl)pyridine (47df) 
 
General procedure B was followed using 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol) 
and 2-bromofluorobenzene (46f) (131 mg, 0.75 mmol). Purification by column chromatography 
on silica gel (n-hexane/EtOAc 7:1) yielded 47df (99 mg, 75%) as a yellow oil. 
1H-NMR (400 MHz, CDCl3): δ = 8.54 (ddd, J = 4.9, 1.9, 1.0 Hz, 1H), 7.42 (ddd, J = 7.7, 7.7, 1.8 Hz, 
1H), 7.36–7.29 (m, 2H), 7.26–7.21 (m, 1H), 7.11–7.04 (m, 1H), 7.04–6.95 (m, 3H), 6.90–6.83 (m, 
2H), 2.19 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 159.5 (d, 1JC–F = 245.7 Hz, Cq), 159.0 (Cq), 148.8 
(CH), 140.2 (Cq), 136.6 (Cq), 135.6 (CH), 135.1 (Cq), 132.2 (d, 4JC–F = 3.4 Hz, CH), 130.1 (CH), 129.1 
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(d, 2JC–F = 16.1 Hz, Cq), 128.6 (d, 3JC–F = 8.0 Hz, CH), 128.0 (d, 4JC–F = 1.2 Hz, CH), 127.8 (CH), 125.0 
(CH), 123.3 (d, 3JC–F = 3.7 Hz, CH), 121.4 (CH), 115.1 (d, 2JC–F = 22.5 Hz, CH), 20.5 (CH3). 19F-NMR 
(282 MHz, CDCl3): δ = –114.7 (s). IR (ATR): ṽ = 1584, 1496, 1461, 1420, 1210, 788, 747, 618, 520, 
402 cm−1. MS (ESI) m/z (relative intensity): 264 [M+H]+ (100). HR-MS (ESI): m/z calcd for C18H15NF+ 
[M+H]+ 264.1183, found 264.1183. 
 
2-(2',3-Dimethyl-[1,1'-biphenyl]-2-yl)pyridine (47dg) 
 
General procedure B was followed using 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol) 
and 2-bromotoluene (46g) (128 mg, 0.75 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc 10:1 → 1:1) and GPC purification yielded 181d (10 mg, 12%) as a colorless 
solid and 47dg (52 mg, 40%) as a colorless oil. 
1H-NMR (300 MHz, CDCl3): δ = 8.55 (ddd, J = 4.9, 1.9, 1.1 Hz, 1H), 7.42–7.28 (m, 3H), 7.17–7.11 (m, 
1H), 7.09–6.94 (m, 5H), 6.87 (ddd, J = 7.8, 1.1, 1.1 Hz, 1H), 2.22 (s, 3H), 2.07 (s, 3H). 13C-NMR 
(75 MHz, CDCl3): δ = 159.2 (Cq), 148.7 (CH), 141.2 (Cq), 140.9 (Cq), 139.8 (Cq), 136.6 (Cq), 136.0 (Cq), 
135.3 (CH), 130.5 (CH), 129.5 (CH), 129.4 (CH), 127.7 (CH), 127.5 (CH), 126.8 (CH), 125.2 (CH), 124.8 
(CH), 121.2 (CH), 20.6 (CH3), 20.4 (CH3). IR (ATR): ṽ = 1584, 1562, 1459, 1420, 786, 746, 727, 621, 
582, 457 cm−1. MS (ESI) m/z (relative intensity): 260 [M+H]+ (100), 282 [M+Na]+ (4). HR-MS (ESI): 
m/z calcd for C19H18N+ [M+H]+ 260.1434, found 260.1427. 
The analytical data are in accordance with those reported in the literature.[179] 
 
2-(2',6'-Difluoro-3-methyl-[1,1'-biphenyl]-2-yl)pyridine (47dh) 
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General procedure B was followed using 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol) 
and 1,3-difluoro-2-bromobenzene (46h) (145 mg, 0.75 mmol). Purification by column 
chromatography on silica gel (n-hexane/EtOAc 8:1 → 1:1) yielded 47dh (21 mg, 15%) as a yellow 
solid. 
1H-NMR (300 MHz, CDCl3): δ = 8.53 (d, J = 4.9 Hz, 1H), 7.49 (ddd, J = 7.7, 7.7, 1.8 Hz, 1H), 7.43–7.33 
(m, 2H), 7.25–7.17 (m, 1H), 7.15–7.06 (m, 3H), 6.71 (t, J = 8.0 Hz, 2H), 2.22 (s, 3H). 13C-NMR 
(75 MHz, CDCl3): δ = 160.0 (dd, 1,3JC–F = 248.5, 7.2 Hz, Cq), 158.7 (Cq), 149.1 (CH), 141.1 (Cq), 136.8 
(Cq), 135.5 (CH), 130.9 (CH), 129.0 (t, 3JC–F = 10.0 Hz, CH), 128.7 (Cq), 128.3 (CH), 128.0 (CH), 124.4 
(CH), 121.6 (CH), 118.5 (t, 2JC–F = 21.4 Hz, Cq), 110.8 (dd, 2,4JC–F = 22.7, 3.6 Hz, CH), 20.5 (CH3). 19F-
NMR (282 MHz, CDCl3): δ = –111.2 (s). m.p.: 101 °C. IR (ATR): ṽ = 1464, 1454, 996, 796, 783, 750, 
726, 511, 408, 396 cm−1. MS (ESI) m/z (relative intensity): 282 [M+H]+ (100), 304 [M+Na]+ (10). HR-
MS (ESI): m/z calcd for C18H14NF2+ [M+H]+ 282.1089, found 282.1086. 
 
1-[3'-Methyl-2'-(pyridin-2-yl)-[1,1'-biphenyl]-2-yl]ethan-1-one (47di) 
 
General procedure B was followed using 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol) 
and 2’-bromoacetophenone (46i) (149 mg, 0.75 mmol). Purification by column chromatography 
on silica gel (n-hexane/EtOAc 8:1 → 1:1) yielded 181d (33 mg, 39%) as a colorless solid and 47di 
(13 mg, 9%) as a brown oil. 
1H-NMR (300 MHz, CDCl3): δ = 8.56–8.49 (m, 1H), 7.51–7.40 (m, 2H), 7.35–7.29 (m, 2H), 7.25–7.15 
(m, 2H), 7.12–6.97 (m, 4H), 2.19 (s, 6H). 13C-NMR (75 MHz, CDCl3): δ = 202.6 (Cq), 158.9 (Cq), 149.1 
(CH), 140.8 (Cq), 140.5 (Cq), 140.1 (Cq), 139.3 (Cq), 136.9 (Cq), 135.7 (CH), 131.9 (CH), 130.3 (CH), 
130.1 (CH), 128.0 (CH), 128.0 (CH), 127.5 (CH), 126.8 (CH), 125.4 (CH), 121.5 (CH), 30.0 (CH3), 20.6 
(CH3). IR (ATR): ṽ = 1681, 1585, 1421, 1354, 1268, 1245, 788, 749, 596, 579 cm−1. MS (ESI) m/z 
(relative intensity): 288 [M+H]+ (100), 310 [M+Na]+ (5). HR-MS (ESI): m/z calcd for C20H18NO+ 
[M+H]+ 288.1383, found 288.1385. 
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2-[3-Methyl-2'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl]pyridine (47dj) 
 
General procedure B was followed using 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol) 
and 2-bromotrifluorotoluene (46j) (169 mg, 0.75 mmol). Purification by column chromatography 
on silica gel (n-hexane/EtOAc 5:1 → 1:1) yielded 181d (43 mg, 51%) as a colorless solid and 47dj 
(35 mg, 22%) as a colorless oil. 
1H-NMR (400 MHz, CDCl3): δ = 8.55 (ddd, J = 4.9, 1.8, 1.0 Hz, 1H), 7.62–7.55 (m, 1H), 7.41 (ddd, J = 
7.7, 7.7, 1.8 Hz, 1H), 7.29-7.35 (m, 2H), 7.25–7.16 (m, 3H), 7.09–7.04 (m, 1H), 7.01 (ddd, J = 7.6, 
4.9, 1.2 Hz, 1H), 6.94 (ddd, J = 7.8, 1.1, 1.1 Hz, 1H), 2.16 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 
159.1 (Cq), 148.8 (CH), 140.0 (q, 3JC–F = 2.0 Hz, Cq), 139.7 (Cq), 138.3 (Cq), 136.5 (Cq), 135.9 (CH), 
133.5 (CH), 130.4 (CH), 130.1 (CH), 128.7 (q, 2JC–F = 29.4 Hz, Cq), 127.5 (q, 4JC–F = 2.2 Hz, CH), 127.2 
(CH), 126.9 (CH), 125.8 (q, 3JC–F = 5.2 Hz, CH), 124.9 (CH), 124.4 (q, 1JC–F = 274.4 Hz, Cq), 121.4 (CH), 
20.5 (CH3). 19F-NMR (282 MHz, CDCl3): δ = –57.0 (s). IR (ATR): ṽ = 1312, 1166, 1109, 1050, 1033, 
789, 748, 654, 579, 402 cm−1. MS (ESI) m/z (relative intensity): 314 [M+H]+ (100), 336 [M+Na]+ (11). 
HR-MS (ESI): m/z calcd for C19H14NF3Na+ [M+Na]+ 336.0971, found 336.0969. 
 
2'-(Pyridin-2-yl)-[1,1':3',1''-terphenyl]-2,2''-dicarbonitrile (47ak) 
 
General procedure B was followed using 2-phenylpyridine (45a) (78 mg, 0.50 mmol) and 
2-bromobenzonitrile (46k) (137 mg, 0.75 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc 1:1) yielded 47ak (65 mg, 48%) as a colorless solid. 
1H-NMR (400 MHz, CDCl3): δ = 8.20 (ddd, J = 4.9, 1.9, 1.0 Hz, 1H), 7.65–7.52 (m, 5H), 7.33–7.20 (m, 
5H), 7.17–6.87 (m, 3H), 6.83 (ddd, J = 7.6, 4.9, 1.2 Hz, 1H). 13C-NMR (100 MHz, CDCl3): δ = 157.1 
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(Cq), 148.7 (CH), 145.1 (Cq), 139.7 (Cq), 138.5 (Cq), 135.1 (CH), 132.8 (CH), 131.8 (CH), 131.6 (CH), 
130.8 (CH), 128.4 (CH), 127.3 (CH), 126.8 (CH), 121.3 (CH), 118.4 (Cq), 112.9 (Cq). m.p.: 209 °C. IR 
(ATR): ṽ = 2226, 1438, 1417, 791, 769, 751, 622, 552, 518, 405 cm−1. MS (ESI) m/z (relative 
intensity): 358 [M+H]+ (100), 380 [M+Na]+ (48), 396 [M+K]+ (6), 737 [2M+Na]+ (8). HR-MS (ESI): 
m/z calcd for C25H16N3+ [M+H]+ 358.1339, found 358.1341. 
 
3'-Fluoro-2'-(pyridin-2-yl)-[1,1'-biphenyl]-2-carbonitrile (47ek) 
 
General procedure B was followed using 2-(2-fluorophenyl)pyridine (45e) (87 mg, 0.50 mmol) and 
2-bromobenzonitrile (46k) (137 mg, 0.75 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc 3:1 → 1:1) yielded 47ek (119 mg, 87%) as a brown solid. 
1H-NMR (400 MHz, CDCl3): δ = 8.41 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H), 7.57 (ddd, J = 7.8, 7.8, 1.9 Hz, 
1H), 7.53 (ddd, J = 7.7, 1.5, 0.6 Hz, 1H), 7.47 (ddd, J = 8.4, 7.6, 5.5 Hz, 1H), 7.37 (ddd, J = 7.7, 7.7, 
1.4 Hz, 1H), 7.32 (dddd, J = 7.8, 1.7, 1.1, 1.1 Hz, 1H), 7.29–7.22 (m, 3H), 7.20 (ddd, J = 7.8, 1.3, 
0.6 Hz, 1H), 7.08 (ddd, J = 7.6, 4.9, 1.2 Hz, 1H). 13C-NMR (100 MHz, CDCl3): δ = 160.3 (d, 1JC–F = 
248.3 Hz, Cq), 153.0 (Cq), 149.1 (CH), 144.3 (d, 3JC–F = 2.7 Hz, Cq), 139.9 (d, 3JC–F = 3.1 Hz, Cq), 135.9 
(CH), 132.7 (CH), 132.0 (CH), 131.4 (CH), 129.9 (d, 3JC–F = 9.2 Hz, CH), 128.5 (d, 2JC–F = 15.9 Hz, Cq), 
127.5 (CH), 126.6 (d, 4JC–F = 2.2 Hz, CH), 126.2 (d, 3JC–F = 3.5 Hz, CH), 122.2 (CH), 118.2 (Cq), 116.5 
(d, 2JC–F = 22.9 Hz, CH), 112.6 (Cq). 19F-NMR (282 MHz, CDCl3): δ = (–115.7)–(–115.9) (m). m.p.: 
76 °C. IR (ATR): ṽ = 1586, 1434, 1424, 1228, 897, 808, 785, 763, 526, 403 cm−1. MS (ESI) m/z 
(relative intensity): 275 [M+H]+ (100), 297 [M+Na]+ (89), 571 [2M+Na]+ (21). HR-MS (ESI): m/z calcd 
for C18H12N2F+ [M+H]+ 275.0979, found 275.0980. 
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4'-Methyl-2'-(pyridin-2-yl)-[1,1'-biphenyl]-2-carbonitrile (47hk) 
 
General procedure B was followed using 2-(3-methylphenyl)pyridine (45h) (85 mg, 0.50 mmol) 
and 2-bromobenzonitrile (46k) (137 mg, 0.75 mmol). Purification by column chromatography on 
silica gel (n-hexane/EtOAc 2:1) yielded 47hk (82 mg, 61%) as a colorless solid. 
1H-NMR (300 MHz, CDCl3): δ = 8.53 (d, J = 4.7 Hz, 1H), 7.62 (d, J = 7.7 Hz, 1H), 7.56 (s, 1H), 7.49–
7.27 (m, 5H), 7.16 (d, J = 7.7 Hz, 1H), 7.12–7.04 (m, 1H), 6.99 (d, J = 7.9 Hz, 1H), 2.47 (s, 3H). 13C-
NMR (75 MHz, CDCl3): δ = 158.6 (Cq), 149.4 (CH), 145.9 (Cq), 140.1 (Cq), 139.2 (Cq), 135.7 (CH), 
134.1 (Cq), 133.0 (CH), 132.1 (CH), 131.8 (CH), 131.2 (CH), 130.7 (CH), 129.4 (CH), 127.2 (CH), 125.0 
(CH), 121.6 (CH), 118.5 (Cq), 112.8 (Cq), 21.4 (CH3). m.p.: 125 °C. IR (ATR): ṽ = 1587, 1471, 1426, 
828, 800, 753, 587, 548, 504, 403 cm−1. MS (ESI) m/z (relative intensity): 271 [M+H]+ (100), 293 
[M+Na]+ (6). HR-MS (ESI): m/z calcd for C19H15N2+ [M+H]+ 271.1230, found 271.1229. 
 
3'-(Dimethylamino)-2'-(pyridin-2-yl)-[1,1'-biphenyl]-2-carbonitrile (47ik) 
 
General procedure B was followed using 2-(2-dimethylaminophenyl)pyridine (45i) (99 mg, 
0.50 mmol) and 2-bromobenzonitrile (46k) (137 mg, 0.75 mmol). Purification by column 
chromatography on silica gel (n-hexane/EtOAc 2:1) yielded 47ik (81 mg, 54%) as a yellow, highly 
viscous oil. 
1H-NMR (400 MHz, CDCl3): δ = 8.36 (ddd, J = 4.9, 1.8, 1.0 Hz, 1H), 7.52 (ddd, J = 7.7, 7.7, 1.8 Hz, 
1H), 7.47 (ddd, J = 7.7, 1.4, 0.6 Hz, 1H), 7.43–7.37 (m, 2H), 7.32 (ddd, J = 7.6, 7.6, 1.4 Hz, 1H), 7.22–
7.15 (m, 3H), 7.01–6.95 (m, 2H), 2.53 (s, 6H). 13C-NMR (100 MHz, CDCl3): δ = 158.3 (Cq), 152.1 (Cq), 
148.8 (CH), 146.2 (Cq), 139.4 (Cq), 135.6 (CH), 133.4 (Cq), 132.2 (CH), 131.5 (CH), 131.5 (CH), 128.9 
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(CH), 127.0 (CH), 126.8 (CH), 123.4 (CH), 121.1 (CH), 118.8 (CH), 118.6 (Cq), 112.7 (Cq), 44.1 (CH3). 
IR (ATR): ṽ = 1587, 1562, 1476, 1458, 1421, 956, 810, 786, 745, 558 cm−1. MS (ESI) m/z (relative 
intensity): 300 [M+H]+ (100), 322 [M+Na]+ (7). HR-MS (ESI): m/z calcd for C20H18N3+ [M+H]+ 
300.1495, found 300.1498. 
 
1,1'-Di(pyridin-2-yl)-2,2'-binaphthalene (181k) and 2-[1-(pyridin-2-yl)naphthalen-2-
yl]benzonitrile (47kk) 
 
General procedure B was followed using 2-(1-naphthyl)pyridine (45k) (103 mg, 0.50 mmol) and 
2-bromobenzonitrile (46k) (137 mg, 0.75 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc 3:1), GPC purification and HPLC purification (n-hexane/i-PrOH 80:20, 
7.5 mL min–1) yielded 181k (63 mg, 62%) as a colorless solid and 47kk (12 mg, 8%) as a light brown 
solid. 
Data for 181k: 
1H-NMR (400 MHz, DMF-d7, 353 K): δ = 8.64 (ddd, J = 4.9, 1.4, 1.4 Hz, 2H), 7.90 (dd, J = 7.6, 2.0 Hz, 
2H), 7.72 (d, J = 8.5 Hz, 2H), 7.68 (ddd, J = 6.4, 6.4, 1.7 Hz, 4H), 7.50 (ddd, J = 7.8, 7.8, 1.4 Hz, 4H), 
7.48–7.39 (m, 2H), 7.31–7.23 (m, 4H). 13C-NMR (100 MHz, DMF-d7, 353 K): δ = 159.5 (Cq), 150.1 
(CH), 139.4 (Cq), 138.8 (Cq), 136.8 (CH), 133.8 (Cq), 133.5 (Cq), 130.4 (CH), 129.0 (CH), 128.0 (CH), 
127.9 (CH), 127.3 (CH), 127.2 (CH), 126.9 (CH), 123.0 (CH). m.p.: 259 °C. IR (ATR): ṽ = 819, 747, 
563, 498, 454, 419, 408, 398, 388, 380 cm−1. MS (ESI) m/z (relative intensity): 409 [M+H]+ (100), 
431 [M+Na]+ (10), 839 [2M+Na]+ (3). HR-MS (ESI): m/z calcd for C30H21N2+ [M+H]+ 409.1699, found 
409.1697. 
 
Data for 47kk: 
1H-NMR (400 MHz, CDCl3): δ = 8.65 (d, J = 4.7 Hz, 1H), 8.01 (d, J = 8.5 Hz, 1H), 7.95 (d, J = 8.1 Hz, 
1H), 7.62 (dd, J = 7.7, 1.4 Hz, 1H), 7.59–7.50 (m, 4H), 7.45 (ddd, J = 8.3, 6.8, 1.3 Hz, 1H), 7.32 (ddd, 
J = 7.6, 7.6, 1.5 Hz, 1H), 7.29–7.23 (m, 1H), 7.22–7.13 (m, 3H). 13C-NMR (100 MHz, CDCl3): δ = 157.8 
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(Cq), 149.2 (CH), 145.7 (Cq), 137.7 (Cq), 136.1 (CH), 135.1 (Cq), 133.7 (Cq), 132.7 (CH), 132.2 (Cq), 
132.1 (CH), 131.8 (CH), 128.8 (CH), 128.3 (CH), 127.3 (CH), 127.2 (CH), 127.1 (CH), 126.6 (CH), 126.6 
(CH), 126.4 (CH), 122.0 (CH), 118.6 (Cq), 112.9 (Cq). m.p.: 111 °C. IR (ATR): ṽ = 1584, 832, 800, 774, 
749, 606, 584, 550, 530, 401 cm−1. MS (ESI) m/z (relative intensity): 307 [M+H]+ (100), 329 [M+Na]+ 
(33). HR-MS (ESI): m/z calcd for C22H14N2Na+ [M+Na]+ 329.1049, found 329.1050. 
 
2,2'-(3,3'-Diisopropyl-[1,1'-biphenyl]-2,2'-diyl)dipyridine (181l) and 3'-isopropyl-2'-(pyridin-2-
yl)-[1,1'-biphenyl]-2-carbonitrile (47lk) 
 
General procedure B was followed using 2-(2-isopropylphenyl)pyridine (45l) (99 mg, 0.50 mmol) 
and 2-bromobenzonitrile (46k) (137 mg, 0.75 mmol). Purification by column chromatography on 
silica gel (n-hexane/EtOAc 7:1 → 2:1) yielded 181l (70 mg, 71%) as a colorless solid and 47lk 
(12 mg, 8%) as a dark brown oil. 
Data for 181l: 
1H-NMR (400 MHz, PhMe-d8, 343 K): δ = 8.39 (d, J = 4.1 Hz, 2H), 7.45 (sbr, 2H), 6.97 (t, J = 1.0 Hz, 
4H), 6.91 (t, J = 7.6 Hz, 2H), 6.86 (dd, J = 7.6, 1.6 Hz, 2H), 6.57 (ddd, J = 7.6, 4.9, 1.2 Hz, 2H), 2.93 
(hept, J = 6.9 Hz, 2H), 1.23 (d, J = 6.9 Hz, 6H), 0.99 (d, J = 6.9 Hz, 6H). 13C-NMR (100 MHz, PhMe-d8, 
343 K): δ = 160.5 (Cq), 148.8 (CH), 147.1 (Cq), 141.5 (Cq), 140.1 (Cq), 134.7 (CH), 129.2 (CH), 127.2 
(CH), 126.6 (CH), 123.9 (CH), 121.1 (CH), 30.5 (CH), 24.4 (CH3), 24.1 (CH3). m.p.: 162 °C. IR (ATR): ṽ 
= 2963, 1582, 1422, 1021, 804, 794, 777, 756, 620, 402 cm−1. MS (ESI) m/z (relative intensity): 393 
[M+H]+ (100), 415 [M+Na]+ (8). HR-MS (ESI): m/z calcd for C28H29N2+ [M+H]+ 393.2325, found 
393.2327. 
 
Data for 47lk: 
1H-NMR (400 MHz, CDCl3): δ = 8.49 (d, J = 4.8 Hz, 1H), 7.54–7.41 (m, 4H), 7.26–7.21 (m, 2H), 7.16 
(dddd, J = 7.6, 7.6, 1.4, 1.4 Hz, 1H), 7.13–7.05 (m, 2H), 7.02 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H), 2.79 
(hept, J = 6.8 Hz, 1H), 1.21 (sbr, 3H), 1.09 (sbr, 3H). 13C-NMR (100 MHz, CDCl3): δ = 158.6 (Cq), 148.8 
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(CH), 147.5 (Cq), 145.9 (Cq), 139.0 (Cq), 137.6 (Cq), 135.7 (CH), 132.5 (CH), 131.9 (CH), 131.5 (CH), 
128.5 (CH), 127.2 (CH), 127.0 (CH), 126.2 (CH), 125.8 (CH), 121.6 (CH), 118.7 (Cq), 112.6 (Cq), 30.1 
(CH), 24.2 (CH3), 23.9 (CH3). IR (ATR): ṽ = 1584, 1563, 1467, 1440, 1422, 788, 751, 731, 620, 
556 cm−1. MS (ESI) m/z (relative intensity): 299 [M+H]+ (100), 321 [M+Na]+ (16). HR-MS (ESI): m/z 
calcd for C21H19N2+ [M+H]+ 299.1543, found 299.1544. 
 
2,2'-[3,3'-Bis(4-fluorobenzyl)-[1,1'-biphenyl]-2,2'-diyl]dipyridine (181m) and 3'-(4-fluorobenzyl)-
2'-(pyridin-2-yl)-[1,1'-biphenyl]-2-carbonitrile (47mk) 
 
General procedure B was followed using 2-[2-(4-fluorobenzyl)phenyl]pyridine (45m) (132 mg, 
0.50 mmol) and 2-bromobenzonitrile (46k) (137 mg, 0.75 mmol). Purification by column 
chromatography on silica gel (n-hexane/EtOAc 7:1 → 2:1) and GPC purification yielded 181m 
(99 mg, 75%) as a colorless solid and 47mk (11 mg, approx. 90% purity, 5%) as a colorless oil. 
Data for 181m: 
1H-NMR (400 MHz, CDCl3): δ = 8.49 (d, J = 4.8 Hz, 2H), 7.37 (dd, J = 7.7, 7.7 Hz, 2H), 7.13 (sbr, 2H), 
7.02 (ddd, J = 7.6, 4.9, 1.2 Hz, 2H), 7.00–6.95 (m, 4H), 6.85–6.74 (m, 10H), 3.86 (d, J = 15.6 Hz, 2H), 
3.75 (d, J = 15.6 Hz, 2H). 13C-NMR (100 MHz, CDCl3): δ = 161.2 (d, 1JC–F = 243.5 Hz, Cq), 158.9 (Cq), 
148.6 (CH), 140.8 (Cq), 140.1 (Cq), 138.9 (Cq), 137.1 (d, 4JC–F = 3.2 Hz, Cq), 135.2 (CH), 130.1 (d, 3JC–F 
= 7.8 Hz, CH), 129.3 (CH), 128.9 (CH), 127.0 (CH), 126.3 (CH), 121.4 (CH), 114.8 (d, 2JC–F = 21.1 Hz, 
CH), 38.7 (CH2). 19F-NMR (376 MHz, CDCl3): δ = –117.9 (s). m.p.: 64 °C. IR (ATR): ṽ = 1587, 1505, 
1420, 1217, 1156, 803, 787, 747, 509, 486 cm−1. MS (ESI) m/z (relative intensity): 525 [M+H]+ (100), 
547 [M+Na]+ (27). HR-MS (ESI): m/z calcd for C36H27N2F2+ [M+H]+ 525.2137, found 525.2134. 
 
Data for 47mk: 
1H-NMR (400 MHz, CDCl3): δ = 8.54 (ddd, J = 4.9, 1.8, 1.0 Hz, 1H), 7.56 (ddd, J = 7.6, 1.5, 0.6 Hz, 
1H), 7.44 (dd, J = 7.7, 7.7 Hz, 1H), 7.36–7.28 (m, 3H), 7.26 (dd, J = 7.6, 1.6 Hz, 1H), 7.10 (ddd, J = 
7.8, 1.4, 0.6 Hz, 1H), 7.02 (ddd, J = 7.6, 4.9, 1.2 Hz, 1H), 6.92–6.74 (m, 6H), 3.90 (s, 2H). 13C-NMR 
5.3 Experimental Procedures and Analytical Data 
159 
(100 MHz, CDCl3): δ = 161.4 (d, 1JC–F = 244.0 Hz, Cq), 158.1 (Cq), 148.9 (CH), 145.5 (Cq), 139.9 (Cq), 
139.9 (Cq), 138.1 (Cq), 136.3 (d, 4JC–F = 3.2 Hz, Cq), 135.8 (CH), 132.6 (CH), 131.7 (CH), 131.7 (CH), 
130.8 (CH), 130.4 (d, 3JC–F = 7.8 Hz, CH), 128.4 (d, 2JC–F = 18.8 Hz, CH), 127.2 (CH), 125.9 (CH), 121.8 
(CH), 118.5 (Cq), 115.2 (CH), 115.0 (CH), 112.7 (Cq), 38.7 (CH2). 19F-NMR (376 MHz, CDCl3): δ =           
(–117.5)–(–117.6) (m). IR (ATR): ṽ = 1507, 1422, 1218, 1157, 809, 789, 750, 620, 511, 494 cm−1. 
MS (ESI) m/z (relative intensity): 365 [M+H]+ (100), 387 [M+Na]+ (26). HR-MS (ESI): m/z calcd for 
C25H18N2F+ [M+H]+ 365.1449, found 365.1451. 
 
5.3.6.2 Mechanistic Studies 
Synthesis of 2-(2-methyl-6-deuterophenyl)pyridine ([D]1-45d) 
 
Under an atmosphere of N2, a Schlenk-tube was charged with 2-(2-methylphenyl)pyridine (45d) 
(338 mg, 2.00 mmol, 1.00 equiv), [RuCl2(p-cymene)]2 (31 mg, 50 µmol, 2.5 mol %), MesCO2H (58) 
(99 mg, 0.60 mmol, 30 mol %) and K2CO3 (553 mg, 4.00 mmol, 2.00 equiv). D2O (5.0 mL) was 
added and the mixture was stirred at 100 °C for 24 h. After cooling to ambient temperature, H2O 
(10 mL) was added, the mixture was extracted with EtOAc (3 × 30 mL), dried over Na2SO4 and 
concentrated in vacuo. Purification of the residue by column chromatography on silica gel 
(n-hexane/EtOAc 7:1) yielded [D]1-45d (232 mg, 68%) as a light yellow oil. The deuterium 
incorporation was found to be 94% in the ortho-position as determined by 1H-NMR spectroscopy. 
1H-NMR (300 MHz, CDCl3): δ = 8.70 (ddd, J = 4.9, 1.9, 0.9 Hz, 0.69H), 7.74 (ddd, J = 7.7, 7.7, 1.5 Hz, 
1H), 7.44–7.37 (m, 1.06H), 7.35–7.27 (m, 3H), 7.26–7.21 (m, 1H), 2.37 (s, 3H). 
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H/D Exchange Studies 
 
Under an atmosphere of N2, a Schlenk-tube was charged with 2-(2-methyl-6-
deuterophenyl)pyridine ([D]1-45d) (43 mg, 0.25 mmol, 1.00 equiv), 2-bromobenzonitrile (46k) 
(68 mg, 0.38 mmol, 1.50 equiv), [RuCl2(p-cymene)]2 (3.8 mg, 6.2 µmol, 2.5 mol %), MesCO2H (58) 
(12.3 mg, 0.08 mmol, 30 mol %) and K2CO3 (69 mg, 0.50 mmol, 2.00 equiv). PhMe (1.0 mL) was 
added and the mixture was stirred at 120 °C for 1 h. After cooling to ambient temperature, H2O 
(12 mL) was added, the mixture was extracted with Et2O (3 × 12 mL), washed with brine (12 mL), 
dried over Na2SO4 and concentrated in vacuo. Purification of the residue by column 
chromatography on silica gel (n-hexane/EtOAc 7:1 → 1:1) yielded 181d (8 mg, 19%) and recovered 
45d (14 mg, 33%). The deuterium incorporation was determined by 1H-NMR spectroscopy. 
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Under an atmosphere of N2, a Schlenk-tube was charged with 2-(2-methylphenyl)pyridine (45d) 
(85 mg, 0.50 mmol, 1.00 equiv), 2-bromobenzonitrile (46k) (137 mg, 0.75 mmol, 1.50 equiv), 
[RuCl2(p-cymene)]2 (7.7 mg, 12.5 µmol, 2.5 mol %), MesCO2H (58) (24.6 mg, 0.15 mmol, 30 mol %) 
and K2CO3 (138 mg, 1.00 mmol, 2.00 equiv). PhMe (1.8 mL) and D2O (0.2 mL) were added and the 
mixture was stirred at 120 °C for 30 min. After cooling to ambient temperature, H2O (25 mL) was 
added, the mixture was extracted with Et2O (3 × 25 mL), washed with brine (25 mL), dried over 
Na2SO4 and concentrated in vacuo. Purification of the residue by column chromatography on silica 
gel (n-hexane/EtOAc 7:1 → 1:1) yielded 181d (18 mg, 21%) and recovered 45d (57 mg, 69%). The 
deuterium incorporation was determined by 1H-NMR spectroscopy. 
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Kinetic Isotope Effect (KIE) Studies 
 
The kinetic isotope effect (KIE) was determined by measuring the initial rates of two independent 
reactions. Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged with 2-(2-
methylphenyl)pyridine (45d) (85 mg, 0.50 mmol, 1.00 equiv) or 2-(2-methyl-6-
deuterophenyl)pyridine ([D]1-45d) (85 mg, 0.50 mmol, 1.00 equiv), 2-bromotrifluorotoluene (46j) 
(169 mg, 0.75 mmol, 1.50 equiv), [Ru(O2CMes)2(p-cymene)] (61) (14.1 mg, 25 µmol, 5.0 mol %), 
K2CO3 (138 mg, 1.00 mmol, 2.00 equiv) and n-dodecane (40 µL). PhMe (2.0 mL) was added and the 
mixture was stirred at 102 °C. During the course of the reaction aliquots (0.05 mL) were removed 
via a syringe every 15 min for 60 min, every 20 min for the following 60 min and after the following 
30 min, diluted with EtOAc, filtered through a short plug of silica gel and analyzed by gas 
chromatography. 
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A linear fit was employed for the time 80–150 min and the obtained slopes were used to calculate 
the KIE value. 
 
Table 4: Conversion versus time for 45d and [D]1-45d. 
t / min [181d] / mmol L–1 conversion / % 
Measurement for 45d: 
15 1.31 1.05 
30 1.99 1.59 
45 3.20 2.56 
60 4.65 3.72 
80 7.20 5.76 
100 10.25 8.20 
120 14.84 11.87 
150 19.87 15.90 
Measurement for [D]1-45d: 
15 1.68 1.35 
30 2.11 1.69 
45 2.87 2.30 
60 3.70 2.96 
80 5.40 4.32 
100 7.02 5.61 
120 9.32 7.45 
150 12.62 10.10 
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Figure 69: Initial rate measurement for the reaction of 45d and [D]n-45d. 
 
 
The kinetic isotope effect (KIE) was determined by measuring the initial rates of two independent 
reactions. Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged with 2-(2-
methylphenyl)pyridine (45d) (85 mg, 0.50 mmol, 1.00 equiv) or 2-(2-methyl-6-
deuterophenyl)pyridine ([D]1-45d) (85 mg, 0.50 mmol, 1.00 equiv), 2-bromobenzonitrile (46k) 
(137 mg, 0.75 mmol, 1.50 equiv), [Ru(O2CMes)2(p-cymene)] (61) (14.1 mg, 25 µmol, 5.0 mol %), 
K2CO3 (138 mg, 1.00 mmol, 2.00 equiv) and n-dodecane (40 µL). PhMe (2.0 mL) was added and the 
mixture was stirred at 102 °C. During the course of the reaction aliquots (0.05 mL) were removed 
via a syringe every 3 min for 15 min and every 5 min for the following 15 min, diluted with EtOAc, 
filtered through a short plug of silica gel and analyzed by gas chromatography. 
Each reaction was performed two times, the measured conversions were averaged and the error 
corresponds to the standard deviation. A linear fit with instrumentally weighted errors was 
employed for the time 3–15 min and the obtained errors of the slope were employed in a variance 
formula error propagation to determine the error of the KIE value. 
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Table 5: Conversion versus time for 45d and [D]1-45d. 
t / min 
[181d]run1 / 
mmol L–1 
[181d]run2 / 
mmol L–1 
[181d]average / 
mmol L–1 
conversionaverage 
/ % 
Δconversion 
/ % 
Measurement for 45d: 
3 1.96 2.02 1.99 1.59 0.04 
6 5.04 5.46 5.25 4.20 0.24 
9 8.62 9.05 8.84 7.07 0.24 
12 11.76 13.53 12.65 10.12 1.00 
15 15.19 16.34 15.77 12.61 0.65 
20 16.84 21.18 19.01 15.21 2.45 
25 21.76 25.95 23.86 19.08 2.37 
30 24.05 27.24 25.65 20.51 1.80 
Measurement for [D]1-45d: 
3.08 1.47 1.80 1.64 1.31 0.19 
6.08 2.62 3.11 2.87 2.29 0.28 
9.50 4.44 5.64 5.04 4.03 0.68 
12.08 5.91 7.53 6.72 5.37 0.92 
15.09 7.23 9.49 8.36 6.69 1.28 
20.10 9.18 12.26 10.72 8.58 1.74 
25.08 11.73 13.93 12.83 10.27 1.25 
30.10 14.33 17.56 15.95 12.76 1.83 
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Figure 70: Initial rate measurement for the reaction of 45d and [D]1-45d. 
 
Detection of Byproducts 
 
Under an atmosphere of N2, a Schlenk-tube was charged with 2-(2-methylphenyl)pyridine (45d) 
(42 mg, 0.25 mmol, 1.00 equiv), 2-bromotrifluorotoluene (46j) (84 mg, 0.38 mmol, 1.50 equiv), 
[RuCl2(p-cymene)]2 (3.8 mg, 6.2 µmol, 2.5 mol %), MesCO2H (58) (12.3 mg, 0.08 mmol, 30 mol %) 
and K2CO3 (69 mg, 0.50 mmol, 2.00 equiv). PhMe (2.0 mL) was added and the mixture was stirred 
at 120 °C for 20 h. After cooling to ambient temperature, n-dodecane (40 µL) and EtOAc (3 mL) 
were added. A portion of the mixture (approx. 0.7 mL) was removed via a syringe, diluted with 
EtOAc, filtered through a short plug of silica gel and analyzed by gas chromatography. The 
conversion was determined by gas chromatography and the structure of 182 was confirmed by 
GC-MS and by comparison with commercially obtained 182. 
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Under an atmosphere of N2, a Schlenk-tube was charged with 2-(2-methyl-6-
deuterophenyl)pyridine (45d) (85 mg, 0.50 mmol, 1.00 equiv), 2-bromobenzonitrile (46k) 
(137 mg, 0.75 mmol, 1.50 equiv), [RuCl2(p-cymene)]2 (7.7 mg, 12.5 µmol, 2.5 mol %), MesCO2H 
(58) (25 mg, 0.15 mmol, 30 mol %) and K2CO3 (138 mg, 1.00 mmol, 2.00 equiv). PhMe (2.0 mL) was 
added and the mixture was stirred at 120 °C for 20 h. After cooling to ambient temperature, EtOAc 
(3 mL) was added. A portion of the mixture (approx. 0.7 mL) was removed via a syringe, diluted 
with EtOAc, filtered through a short plug of silica gel and analyzed by gas chromatography. The 
structure of 183 was confirmed by GC-MS and by comparison with commercially obtained 183. 
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Effect of Additional Nitrile 
 
Under an atmosphere of N2, a Schlenk-tube was charged with 2-(2-methylphenyl)pyridine (45d) 
(85 mg, 0.50 mmol, 1.00 equiv), 2-bromotrifluorotoluene (46j) (169 mg, 0.75 mmol, 1.50 equiv), 
[Ru(O2CMes)2(p-cymene)] (61) (14.1 mg, 25.0 µmol, 5.0 mol %), benzonitrile (26 mg, 0.25 mmol, 
0.50 equiv or 0 equiv) and K2CO3 (138 mg, 1.00 mmol, 2.00 equiv). PhMe (2.0 mL) was added and 
the mixture was stirred at 120 °C for 3 h. After cooling to ambient temperature, EtOAc (3 mL) and 
n-dodecane (40 µL) were added. A portion of the mixture (approx. 0.7 mL) was removed via a 
syringe, diluted with EtOAc, filtered through a short plug of silica gel and analyzed by gas 
chromatography. 
Table 6: Effect of benzonitrile addition. 
PhCN conversion 181d / %[a] conversion 47dj / %[a] 
0 equiv 23 9 
0.5 equiv 75 2 
[a] Determined by GC analysis with n-dodecane as the internal standard. 
 
Detection of free p-Cymene 
 
Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged with 2-(2-
methylphenyl)pyridine (45d) (85 mg, 0.50 mmol, 1.00 equiv), 2-bromobenzonitrile (46k) (137 mg, 
0.75 mmol, 1.50 equiv), [Ru(O2CMes)2(p-cymene)] (61) (14.1 mg, 25 µmol, 5.0 mol %), K2CO3 
(138 mg, 1.00 mmol, 2.00 equiv) and n-dodecane (40 µL). PhMe (2.0 mL) was added and the 
mixture was stirred at 102 °C. During the course of the reaction aliquots (0.15 mL) were removed 
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via a syringe after 3 min, 15 min, 60 min and 180 min, diluted with EtOAc, filtered through a short 
plug of silica gel and analyzed by gas chromatography. 
t / min [181d] / mmol L–1 [184] / mmol L–1 
3 2.84 3.28 
15 15.8 6.80 
30 22.6 7.21 
60 49.1 7.86 
180 93.8 9.16 
 
 
Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged with 2-(2-
methylphenyl)pyridine (45d) (85 mg, 0.50 mmol, 1.00 equiv), 2-bromotrifluorotoluene (46j) 
(169 mg, 0.75 mmol, 1.50 equiv), [Ru(O2CMes)2(p-cymene)] (61) (14.1 mg, 25 µmol, 5.0 mol %), 
K2CO3 (138 mg, 1.00 mmol, 2.00 equiv) and n-dodecane (40 µL). PhMe (2.0 mL) was added and the 
mixture was stirred at 102 °C. During the course of the reaction aliquots (0.15 mL) were removed 
via a syringe after 3 min, 15 min, 60 min and 180 min, diluted with EtOAc, filtered through a short 
plug of silica gel and analyzed by gas chromatography. 
t / min [181d] / mmol L–1 [47dj] / mmol L–1 [184] / mmol L–1 
3 1.27 1.15 0.29 
15 1.82 1.52 0.84 
30 2.86 2.34 1.50 
60 6.37 4.97 2.46 
180 28.3 22.5 5.02 
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Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged with 2-(2-
fluorophenyl)pyridine (45e) (87 mg, 0.50 mmol, 1.00 equiv), 2-bromobenzonitrile (46k) (137 mg, 
0.75 mmol, 1.50 equiv), [Ru(O2CMes)2(p-cymene)] (61) (14.1 mg, 25 µmol, 5.0 mol %), K2CO3 
(138 mg, 1.00 mmol, 2.00 equiv) and n-dodecane (40 µL). PhMe (2.0 mL) was added and the 
mixture was stirred at 102 °C. During the course of the reaction aliquots (0.15 mL) were removed 
via a syringe after 3 min, 15 min, 60 min and 180 min, diluted with EtOAc, filtered through a short 
plug of silica gel and analyzed by gas chromatography. 
t / min [47ek] / mmol L–1 [184] / mmol L–1 
3 2.32 0.37 
15 7.77 0.81 
30 20.1 1.27 
60 51.2 2.10 
180 193 4.94 
 
 
Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged with 2-(2-
fluorophenyl)pyridine (45e) (87 mg, 0.50 mmol, 1.00 equiv), 2-bromobenzonitrile (46k) (137 mg, 
0.75 mmol, 1.50 equiv), [Ru(O2CMes)2(p-cymene)] (61) (7.0 mg, 13 µmol, 2.5 mol %), K2CO3 
(138 mg, 1.00 mmol, 2.00 equiv) and n-dodecane (40 µL). PhMe (2.0 mL) was added and the 
mixture was stirred at 102 °C. During the course of the reaction aliquots (0.15 mL) were removed 
via a syringe after 3 min, 15 min, 60 min and 180 min, diluted with EtOAc, filtered through a short 
plug of silica gel and analyzed by gas chromatography. 
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t / min [47ek] / mmol L–1 [184] / mmol L–1 
3 2.25 0.28 
15 5.53 0.62 
30 13.4 0.89 
60 33.6 1.36 
180 139 2.83 
 
To determine the background decoordination of p-cymene (184), an experiment was conducted 
as follows: 
Under an atmosphere of N2, a Schlenk-tube was charged with [Ru(O2CMes)2(p-cymene)] (61) 
(14.1 mg, 25 µmol) and K2CO3 (138 mg, 1.00 mmol). PhMe (2.0 mL) was added and the mixture 
was stirred at 102 °C for 180 min. Afterwards, the reaction mixture was quickly cooled to ambient 
temperature and n-dodecane (40 µL) was added. An aliquot (0.15 mL) were removed via a syringe, 
filtered through a short plug of silica gel and analyzed by gas chromatography. A concentration of 
0.41 mmol L–1 of p-cymene (184) was determined, which corresponds to 3.3% of the maximum 
possible amount. 
 
5.3.6.3 Kinetic Analysis 
5.3.6.3.1 Reaction Order Determination with 2-Bromotrifluorotoluene (46j) 
Reaction Order with Respect to Phenylpyridine 45d 
The initial rate method was employed to determine the reaction order with respect to 
phenylpyridine 45d.[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged 
with 2-(2-methylphenyl)pyridine (45d) (0.30, 0.38, 0.50, 0.63, 0.75 mmol), 2-
bromotrifluorotoluene (46j) (169 mg, 0.75 mmol), MesCO2H (58) (25 mg, 0.15 mmol), K2CO3 
(138 mg, 1.00 mmol) and n-dodecane (40 µL). A solution of [RuCl2(p-cymene)]2 (7.7 mg, 
12.5 µmol) in PhMe (2.0 mL) was added and the mixture was stirred at 102 °C. Aliquots (0.05 mL) 
were removed via a syringe after 15, 30, 45, 60, 80, 100, 120 and 150 min, diluted with EtOAc 
(1.0 mL), filtered through a short plug of silica gel and analyzed by gas chromatography. 
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Table 7: Initial rates for C–H arylation at various phenylpyridine 45d concentrations. 
amount / mmol log(c / mol L−1) Δ[47dj] Δt−1 / 10−6 mol L–1 s−1 log(Δ[47dj] Δt−1 / mol L–1 s−1) 
0.30 –0.824 1.660 –5.780 
0.38 –0.727 2.108 –5.676 
0.50 –0.602 2.990 –5.524 
0.63 –0.505 3.756 –5.425 
0.75 –0.426 4.737 –5.325 
 
Table 8: Initial rates for C–H/C–H activation at various phenylpyridine 45d concentrations. 
amount / mmol log(c / mol L−1) Δ[181d] Δt−1 / 10−6 mol L–1 s−1 log(Δ[181d] Δt−1 / mol L–1 s−1) 
0.30 –0.824 1.987 –5.702 
0.38 –0.727 2.794 –5.554 
0.50 –0.602 3.506 –5.455 
0.63 –0.505 3.817 –5.418 
0.75 –0.426 6.190 –5.208 
 
Reaction Order with Respect to [RuCl2(p-cymene)]2 
The initial rate method was employed to determine the reaction order with respect to 
[RuCl2(p-cymene)]2.[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged 
with 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol, 1.00 equiv), 2-bromotrifluorotoluene 
(46j) (169 mg, 0.75 mmol, 1.50 equiv), MesCO2H (58) (25 mg, 0.15 mmol, 30 mol %), K2CO3 
(138 mg, 1.00 mmol, 2.00 equiv) and n-dodecane (40 µL). A solution of [RuCl2(p-cymene)]2 (1.5, 
2.5, 3.5, 5.0 mol %) in PhMe (2.0 mL) was added and the mixture was stirred at 102 °C. Aliquots 
(0.05 mL) were removed via a syringe after 15, 30, 45, 60, 80, 100, 120 and 150 min, diluted with 
EtOAc (1.0 mL), filtered through a short plug of silica gel and analyzed by gas chromatography. 
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Table 9: Initial rates for C–H arylation at various [RuCl2(p-cymene)]2 concentrations. 
amount / mol % log(c / mol L−1) Δ[47dj] Δt−1 / 10−6 mol L–1 s−1 log(Δ[47dj] Δt−1 / mol L–1 s−1) 
1.5 –2.426 1.910 –5.719 
2.5 –2.204 2.990 –5.524 
3.5 –2.058 3.714 –5.430 
5.0 –1.903 4.550 –5.342 
 
Table 10: Initial rates for C–H/C–H activation at various [RuCl2(p-cymene)]2 concentrations. 
amount / mol % log(c / mol L−1) Δ[181d] Δt−1 / 10−6 mol L–1 s−1 log(Δ[181d] Δt−1 / mol L–1 s−1) 
1.5 –2.426 2.563 –5.591 
2.5 –2.204 3.507 –5.455 
3.5 –2.058 4.433 –5.353 
5.0 –1.903 6.813 –5.166 
 
Reaction Order with Respect to 2-Bromotrilfuorotoluene (46j) 
The initial rate method was employed to determine the reaction order with respect to aryl halide 
46j.[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged with 2-(2-
methylphenyl)pyridine (45d) (85 mg, 0.50 mmol, 1.00 equiv), 2-bromotrifluorotoluene (46j) (0.38, 
0.50, 0.63, 0.75, 0.88 mmol), MesCO2H (58) (25 mg, 0.15 mmol, 30 mol %), K2CO3 (138 mg, 
1.00 mmol, 2.00 equiv) and n-dodecane (40 µL). A solution of [RuCl2(p-cymene)]2 (7.7 mg, 
12.5 µmol, 2.5 mol %) in PhMe (2.0 mL) was added and the mixture was stirred at 102 °C. Aliquots 
(0.05 mL) were removed via a syringe after 15, 30, 45, 60, 80, 100, 120 and 150 min, diluted with 
EtOAc (1.0 mL), filtered through a short plug of silica gel and analyzed by gas chromatography. 
 
Table 11: Initial rates for C–H arylation at various 2-bromotrifluorotoluene (46j) concentrations. 
amount / mmol log(c / mol L−1) Δ[47dj] Δt−1 / 10−6 mol L–1 s−1 log(Δ[47dj] Δt−1 / mol L–1 s−1) 
0.38 –0.727 2.479 –5.606 
0.50 –0.602 2.528 –5.597 
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0.63 –0.505 2.942 –5.531 
0.75 –0.426 2.990 –5.524 
0.88 –0.359 2.528 –5.597 
 
Table 12: Initial rates for C–H/C–H activation at various 2-bromotrifluorotoluene (46j) 
concentrations. 
amount / mmol log(c / mol L−1) Δ[181d] Δt−1 / 10−6 mol L–1 s−1 log(Δ[181d] Δt−1 / mol L–1 s−1) 
0.38 –0.727 3.159 –5.501 
0.50 –0.602 2.062 –5.686 
0.63 –0.505 3.075 –5.512 
0.75 –0.426 2.990 –5.524 
0.88 –0.359 2.509 –5.600 
 
Reaction Order with Respect to [Ru(O2CMes)2(p-cymene)] (61) 
The initial rate method was employed to determine the reaction order with respect to 
[Ru(O2CMes)2(p-cymene)] (61).[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube 
was charged with 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol, 1.00 equiv), 
2-bromotrifluorotoluene (46j) (169 mg, 0.75 mmol, 1.50 equiv), K2CO3 (138 mg, 1.00 mmol, 
2.00 equiv) and n-dodecane (40 µL). A solution of [Ru(O2CMes)2(p-cymene)] (61) (5.0, 6.5, 7.5, 
10.0 mol %) in PhMe (2.0 mL) was added and the mixture was stirred at 102 °C. Aliquots (0.05 mL) 
were removed via a syringe after 15, 30, 45, 60, 80, 100, 120 and 150 min, diluted with EtOAc 
(1.0 mL), filtered through a short plug of silica gel and analyzed by gas chromatography. 
 
Table 13: Initial rates for C–H/C–H activation at various [Ru(O2CMes)2(p-cymene)] (61) 
concentrations. 
amount / mol % log(c / mol L−1) Δ[181d] Δt−1 / 10−6 mol L–1 s−1 log(Δ[181d] Δt−1 / mol L–1 s−1) 
5.0 –1.903 3.073 –5.512 
6.5 –1.790 3.684 –5.434 
7.5 –1.727 3.707 –5.431 
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10.0 –1.602 4.493 –5.348 
 
5.3.6.3.2 Reaction Order Determination with 2-Bromobenzonitrile (46k) 
Reaction Order with Respect to Phenylpyridine 45d 
The initial rate method was employed to determine the reaction order with respect to 
phenylpyridine 45d.[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was charged 
with 2-(2-methylphenyl)pyridine (45d) (0.30, 0.35, 0.40, 0.50, 0.60 mmol), 2-bromobenzonitrile 
(46k) (137 mg, 0.75 mmol), K2CO3 (138 mg, 1.00 mmol) and n-dodecane (40 µL). A solution of 
[Ru(O2CMes)2(p-cymene)] (61) (14.1 mg, 25.0 µmol) in PhMe (2.0 mL) was added and the mixture 
was stirred at 102 °C. Aliquots (0.05 mL) were removed via a syringe after 3, 6, 9, 12, 15, 20, 25 
and 30 min, diluted with EtOAc (1.0 mL), filtered through a short plug of silica gel and analyzed by 
gas chromatography. 
Each reaction was performed two times, the logarithmic values of the measured rates were 
averaged and the error corresponds to the standard deviation. 
 
Table 14: Initial rates for C–H/C–H activation at various phenylpyridine 45d concentrations. 
amount / 
mmol 
log(c / 
mol L−1) 
Δ[181d] Δt−1 /  
10−5 mol L–1 s−1 
logaverage(Δ[181d] Δt−1 / 
mol L–1 s−1) 
Δlogaverage(Δ[181d] 
Δt−1 / mol L–1 s−1) 
0.30 –0.824 
2.050 
1.387 
–4.773 0.120 
0.35 –0.757 
1.462 
1.657 
–4.808 0.039 
0.40 –0.699 
2.933 
2.333 
–4.582 0.070 
0.50 –0.602 
1.850 
2.039 
–4.712 0.030 
0.60 –0.523 
1.883 
2.619 
–4.653 0.101 
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Reaction Order with Respect to [Ru(O2CMes)2(p-cymene)] (61) 
The initial rate method was employed to determine the reaction order with respect to 
[Ru(O2CMes)2(p-cymene)] (61).[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube 
was charged with 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol, 1.00 equiv), 
2-bromobenzonitrile (46k) (137 mg, 0.75 mmol, 1.50 equiv), K2CO3 (138 mg, 1.00 mmol, 
2.00 equiv) and n-dodecane (40 µL). A solution of [Ru(O2CMes)2(p-cymene)] (61) (2.5, 3.5, 5.0, 7.5, 
10.0 mol %) in PhMe (2.0 mL) was added and the mixture was stirred at 102 °C. Aliquots (0.05 mL) 
were removed via a syringe after 3, 6, 9, 12, 15, 20, 25 and 30 min, diluted with EtOAc (1.0 mL), 
filtered through a short plug of silica gel and analyzed by gas chromatography. 
Each reaction was performed two times, the logarithmic values of the measured rates were 
averaged and the error corresponds to the standard deviation. 
 
Table 15: Initial rates for C–H/C–H activation at various [Ru(O2CMes)2(p-cymene)] (61) 
concentrations. 
amount / 
mol % 
log(c / 
mol L−1) 
Δ[181d] Δt−1 /  
10−5 mol L–1 s−1 
logaverage(Δ[181d] Δt−1 / 
mol L–1 s−1) 
Δlogaverage(Δ[181d] 
Δt−1 / mol L–1 s−1) 
2.5 –2.204 
1.505 
1.504 
–4.823 1.9∙10–4 
3.5 –2.058 
1.595 
2.198 
–4.728 0.099 
5.0 –1.903 
1.854 
2.039 
–4.711 0.029 
7.5 –1.727 
2.410 
3.177 
–4.558 0.085 
10.0 –1.602 
3.721 
3.720 
–4.429 0.5∙10–4 
 
Reaction Order with Respect to 2-Bromobenzonitrile (46k) 
The initial rate method was employed to determine the reaction order with respect to 
2-bromobenzonitrile (46k).[178] Under an atmosphere of N2 inside a glovebox, a Schlenk-tube was 
charged with 2-(2-methylphenyl)pyridine (45d) (85 mg, 0.50 mmol, 1.00 equiv), 
2-bromobenzonitrile (46k) (0.50, 0.63, 0.75, 0.88, 1.00 mmol), K2CO3 (138 mg, 1.00 mmol, 
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2.00 equiv) and n-dodecane (40 µL). A solution of [Ru(O2CMes)2(p-cymene)] (61) (14.1 mg, 
25.0 µmol, 5.0 mol %) in PhMe (2.0 mL) was added and the mixture was stirred at 102 °C. Aliquots 
(0.05 mL) were removed via a syringe after 3, 6, 9, 12, 15, 20, 25 and 30 min, diluted with EtOAc 
(1.0 mL), filtered through a short plug of silica gel and analyzed by gas chromatography. 
Each reaction was performed two times, the logarithmic values of the measured rates were 
averaged and the error corresponds to the standard deviation. 
 
Table 16: Initial rates for C–H/C–H activation at various 2-bromobenzonitrile (46k) 
concentrations. 
amount / 
mmol 
log(c / 
mol L−1) 
Δ[181d] Δt−1 /  
10−5 mol L–1 s−1 
logaverage(Δ[181d] Δt−1 / 
mol L–1 s−1) 
Δlogaverage(Δ[181d] 
Δt−1 / mol L–1 s−1) 
0.50 –0.602 
1.623 
1.284 
–4.841 0.072 
0.63 –0.505 
1.855 
1.972 
–4.718 0.019 
0.75 –0.426 
1.854 
2.039 
–4.711 0.029 
0.88 –0.359 
2.003 
2.076 
–4.691 0.011 
1.00 –0.301 
2.776 
2.181 
–4.609 0.074 
 
5.3.6.4 X-Ray Crystallography 
Single crystals of C30H20N2 (181k) were grown by slow evaporation from a saturated solution in 
PhMe-d8. A suitable crystal was selected and the crystal was mounted on a MITIGEN holder in NVH 
oil on a Bruker D8 Venture diffractometer. The crystal was kept at 100.02 K during data collection. 
Using Olex2,[181] the structure was solved with the XT structure solution program[182] using Intrinsic 
Phasing and refined with the XL refinement package[183] using Least Squares minimization. 
Crystal Data for C30H20N2 (M =408.48 g/mol): monoclinic, space group P21/c (no. 14), a = 
10.3579(10) Å, b = 16.1134(16) Å, c = 13.4520(10) Å, β = 111.680(3)°, V = 2086.3(3) Å3, Z = 4, T = 
100.02 K, μ(MoKα) = 0.076 mm–1, Dcalc = 1.300 g/cm3, 34183 reflections measured (4.93° ≤ 2Θ ≤ 
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61.07°), 6252 unique (Rint = 0.0266, Rsigma = 0.0200) which were used in all calculations. The final 
R1 was 0.0429 (I > 2σ(I)) and wR2 was 0.1148 (all data). 
The X-Ray crystallographic data for compound 181k was deposited at the Cambridge 
Crystallographic Data Centre (CCDC) under deposition number 1942734. 
 
Table 17: Crystal data and structure refinement for 181k. 
Empirical formula C30H20N2 
Formula weight 408.48 
Temperature/K 100.02 
Crystal system monoclinic 
Space group P21/c 
a/Å 10.3579(10) 
b/Å 16.1134(16) 
c/Å 13.4520(10) 
α/° 90 
β/° 111.680(3) 
γ/° 90 
Volume/Å3 2086.3(3) 
Z 4 
ρcalcg/cm3 1.3 
μ/mm–1 0.076 
F(000) 856 
Crystal size/mm3 0.446 × 0.439 × 0.228 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.93 to 61.07 
Index ranges –14 ≤ h ≤ 14, –22 ≤ k ≤ 22, –19 ≤ l ≤ 17 
Reflections collected 34183 
Independent reflections 6252 [Rint = 0.0266, Rsigma = 0.0200] 
Data/restraints/parameters 6252/0/289 
Goodness-of-fit on F2 1.058 
Final R indexes [I>=2σ (I)] R1 = 0.0429, wR2 = 0.1102 
Final R indexes [all data] R1 = 0.0477, wR2 = 0.1148 
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Largest diff. peak/hole / e Å–3 0.40/–0.22 
 
Table 18: Bond lengths. 
Atom Atom Length / Å Atom Atom Length / Å 
N1 C1 1.3427(13) C12 C22 1.4192(13) 
N1 C5 1.3448(12) C13 C14 1.4952(13) 
N2 C14 1.3458(12) C13 C19 1.4364(12) 
N2 C18 1.3405(13) C14 C15 1.3945(13) 
C1 C2 1.3887(15) C15 C16 1.3890(14) 
C2 C3 1.3890(15) C16 C17 1.3881(16) 
C3 C4 1.3894(13) C17 C18 1.3878(16) 
C4 C5 1.3923(13) C19 C20 1.4242(13) 
C5 C6 1.4928(12) C19 C26 1.4219(13) 
C6 C7 1.4256(12) C20 C21 1.4147(14) 
C6 C11 1.3845(12) C20 C23 1.4195(13) 
C7 C8 1.4245(13) C21 C22 1.3669(14) 
C7 C30 1.4222(13) C23 C24 1.3665(16) 
C8 C9 1.4203(13) C24 C25 1.4124(16) 
C8 C27 1.4205(13) C25 C26 1.3762(14) 
C9 C10 1.3680(13) C27 C28 1.3713(14) 
C10 C11 1.4203(13) C28 C29 1.4126(14) 
C11 C12 1.4935(13) C29 C30 1.3728(13) 
C12 C13 1.3858(13)    
 
Table 19: Bond angles. 
Atom Atom Atom Angle / ° Atom Atom Atom Angle / ° 
C1 N1 C5 116.90(9) C12 C13 C14 119.47(8) 
C18 N2 C14 117.26(9) C12 C13 C19 119.80(8) 
N1 C1 C2 124.00(9) C19 C13 C14 120.69(8) 
C1 C2 C3 118.33(9) N2 C14 C13 116.13(8) 
C2 C3 C4 118.65(9) N2 C14 C15 122.66(9) 
C3 C4 C5 118.90(9) C15 C14 C13 121.16(8) 
N1 C5 C4 123.16(9) C16 C15 C14 119.08(9) 
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N1 C5 C6 116.93(8) C17 C16 C15 118.70(10) 
C4 C5 C6 119.91(8) C18 C17 C16 118.27(10) 
C7 C6 C5 119.23(8) N2 C18 C17 124.00(10) 
C11 C6 C5 120.18(8) C20 C19 C13 118.96(8) 
C11 C6 C7 120.53(8) C26 C19 C13 122.96(9) 
C8 C7 C6 119.33(8) C26 C19 C20 118.02(8) 
C30 C7 C6 122.09(8) C21 C20 C19 119.67(9) 
C30 C7 C8 118.55(8) C21 C20 C23 120.65(9) 
C9 C8 C7 118.78(8) C23 C20 C19 119.65(9) 
C9 C8 C27 122.05(9) C22 C21 C20 120.36(9) 
C27 C8 C7 119.15(9) C21 C22 C12 121.10(9) 
C10 C9 C8 120.76(9) C24 C23 C20 120.87(10) 
C9 C10 C11 121.09(9) C23 C24 C25 119.90(9) 
C6 C11 C10 119.42(8) C26 C25 C24 120.62(10) 
C6 C11 C12 120.75(8) C25 C26 C19 120.91(9) 
C10 C11 C12 119.80(8) C28 C27 C8 120.86(9) 
C13 C12 C11 122.05(8) C27 C28 C29 120.08(9) 
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6 Computational Details 
6.1 General Remarks 
Calculations were performed using Gaussian 09,[184] Gaussian 16,[185] Orca version 3.0.3[186] or Orca 
version 4.0[187] software packages on the high performance computing (HPC) system of the 
research group of Prof. Dr. Lutz Ackermann, the HPC cluster of the Gesellschaft für 
wissenschaftliche Datenverarbeitung Göttingen GmbH (GWDG) and the HPC cluster of the 
Institute Charles Gerhardt, Université de Montpellier. 
Images of 3D structures were created using PyMOL version 1.8.x.[188] 
Cartesian coordinates of all calculated structures are stored on the attached DVD disc as xyz-files 
and can be obtained from the author upon reasonable request. 
 
6.2 Selectivity Prediction for meta-C–H Functionalization 
6.2.1 Computational Methods 
All calculations were performed with the Orca version 3.0.3 package.[186] Geometry optimizations 
were performed at the TPSS level of theory[125] including D3 dispersion correction[126] with Becke-
Johnson damping scheme. Ruthenium was described with a def2-TZVP basis set[127] in combination 
with Stuttgart-Dresden (SDD) pseudopotential,[189] while all other atoms were described with a 
def2-TZVP basis set. Numerical frequency calculations were performed at the same level of theory 
to characterize all stationary points as intermediates (no imaginary frequencies). RIJCOSX 
approximation was used in all calculations together with def2-TZVP/J auxiliary basis set.[190] In all 
calculations the GRID4, TightSCF, SlowConv keywords and in the geometry optimizations 
additionally TightOPT keyword was used. 
NBO charges were obtained through single point calculations on the optimized structures at the 
B3LYP level of theory[128] including D3(BJ) correction. Ruthenium was described with a def2-TZVP 
basis set in combination with Stuttgart-Dresden (SDD) pseudopotential, while all other atoms 
were described with a def2-TZVP basis set. The single point calculations were performed with the 
Gaussian 09, Revision D.01 package employing the implemented NBO version.[184] 
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6.2.2 Fukui Indices 
Fukui indices[191] were calculated based on atomic charges values obtained from NBO calculations. 
Radical Fukui indices fA0 were calculated according to equation (1), where δN+1 corresponds to the 
atomic charges of the anionic species, δN–1 to the cationic species and N to the number of 
electrons. 
𝑓𝐴
0 =  
1
2
 (𝛿𝑁+1 −  𝛿𝑁−1)     (1) 
 
Nucleophilicity Fukui indices fA– were calculated according to equation (2), where δN corresponds 
to the atomic charges of the neutral species, δN–1 to the cationic species and N to the number of 
electrons. 
𝑓𝐴
− = 𝛿𝑁 −  𝛿𝑁−1      (2) 
 
6.2.2.1 Oxazoline as Directing Group 
 
Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.1916 6.1700 6.2160 0.0216 0.41 0.0230 0.34 
C2 5.9223 5.8967 5.9644 0.0256 0.49 0.0338 0.50 
C3 6.2514 6.2385 6.2607 0.0129 0.25 0.0111 0.16 
C4 6.1727 6.1527 6.2887 0.0200 0.38 0.0680 1.00 
C5 6.2365 6.1844 6.2434 0.0521 1.00 0.0295 0.43 
C6 6.1581 6.1477 6.2256 0.0104 0.20 0.0389 0.57 
C7 5.4149 5.3986 5.5207 0.0163 0.31 0.0610 0.90 
C8 6.2546 6.2575 6.2480 –0.0029 –0.06 –0.0048 –0.07 
C9 6.0854 6.0858 6.0827 –0.0003 –0.01 –0.0015 –0.02 
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Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.2147 6.1616 6.2256 0.0531 0.69 0.0320 0.72 
C2 5.9864 6.0237 6.0170 –0.0373 –0.49 –0.0034 –0.08 
C3 6.2605 6.2151 6.2667 0.0454 0.59 0.0258 0.58 
C4 6.1735 6.1670 6.2564 0.0064 0.08 0.0447 1.00 
C5 6.2557 6.1792 6.2578 0.0765 1.00 0.0393 0.88 
C6 6.1616 6.1570 6.2165 0.0046 0.06 0.0298 0.67 
C7 5.4192 5.4122 5.4932 0.0069 0.09 0.0405 0.91 
C8 6.2416 6.2450 6.2345 –0.0034 –0.04 –0.0052 –0.12 
C9 6.0888 6.0892 6.0867 –0.0004 0.00 –0.0013 –0.03 
 
 
Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.1994 6.1503 6.2060 0.0491 0.64 0.0279 0.47 
C2 6.0259 6.0583 6.0142 –0.0324 –0.42 –0.0220 –0.37 
C3 6.2440 6.1977 6.2503 0.0463 0.60 0.0263 0.44 
C4 6.1743 6.1673 6.2114 0.0070 0.09 0.0221 0.37 
C5 6.2458 6.1688 6.2874 0.0770 1.00 0.0593 1.00 
C6 6.1620 6.1542 6.1788 0.0078 0.10 0.0123 0.21 
C7 5.4149 5.4034 5.4668 0.0115 0.15 0.0317 0.53 
C8 6.2437 6.2480 6.2405 –0.0043 –0.06 –0.0037 –0.06 
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C9 6.0885 6.0893 6.0871 –0.0008 –0.01 –0.0011 –0.02 
 
 
Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.1726 6.1205 6.1967 0.0521 0.58 0.0381 0.51 
C2 5.9648 5.9505 5.9506 0.0143 0.16 0.0001 0.00 
C3 6.2407 6.1970 6.2600 0.0437 0.49 0.0315 0.42 
C4 6.1722 6.1571 6.2007 0.0151 0.17 0.0218 0.29 
C5 6.2266 6.1375 6.2875 0.0892 1.00 0.0750 1.00 
C6 6.1570 6.1527 6.1725 0.0042 0.05 0.0099 0.13 
C7 5.4196 5.4126 5.4615 0.0070 0.08 0.0244 0.33 
C8 6.2486 6.2543 6.2472 –0.0057 –0.06 –0.0035 –0.05 
C9 6.0855 6.0871 6.0858 –0.0016 –0.02 –0.0006 –0.01 
 
 
Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.1786 6.1514 6.2104 0.0272 0.46 0.0295 0.52 
C2 5.9519 5.9336 5.9218 0.0184 0.31 –0.0059 –0.10 
C3 6.2363 6.2099 6.2569 0.0263 0.44 0.0235 0.41 
C4 6.1735 6.1661 6.1871 0.0074 0.13 0.0105 0.18 
C5 6.2155 6.1563 6.2698 0.0592 1.00 0.0568 1.00 
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C6 6.1614 6.1532 6.1697 0.0081 0.14 0.0082 0.15 
C7 5.4069 5.4036 5.4197 0.0033 0.06 0.0080 0.14 
C8 6.2465 6.2497 6.2456 –0.0032 –0.05 –0.0021 –0.04 
C9 6.0866 6.0876 6.0867 –0.0010 –0.02 –0.0005 –0.01 
 
 
Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.1577 6.1113 6.1976 0.0464 0.56 0.0431 0.57 
C2 5.9517 5.9285 5.9209 0.0232 0.28 –0.0038 –0.05 
C3 6.2264 6.1791 6.2567 0.0473 0.57 0.0388 0.52 
C4 6.1781 6.1741 6.1920 0.0039 0.05 0.0089 0.12 
C5 6.2137 6.1302 6.2804 0.0835 1.00 0.0751 1.00 
C6 6.1630 6.1575 6.1697 0.0055 0.07 0.0061 0.08 
C7 5.4187 5.4190 5.4315 –0.0003 0.00 0.0062 0.08 
C8 6.2472 6.2501 6.2460 –0.0028 –0.03 –0.0020 –0.03 
C9 6.0866 6.0873 6.0867 –0.0007 –0.01 –0.0003 0.00 
 
6.2.2.2 Purine as Directing Group 
 
Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.1830 6.1179 6.1427 0.0651 0.77 0.0124 0.17 
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C2 5.9771 6.0224 6.0335 –0.0453 –0.54 0.0056 0.08 
C3 6.2632 6.2082 6.2721 0.0550 0.65 0.0320 0.44 
C4 6.1694 6.1719 6.2598 –0.0025 –0.03 0.0439 0.60 
C5 6.2551 6.1710 6.2519 0.0841 1.00 0.0405 0.56 
C6 6.1625 6.1648 6.2264 –0.0023 –0.03 0.0308 0.42 
C7 5.7391 5.7538 5.8991 –0.0147 –0.17 0.0726 1.00 
N8 7.4216 7.4343 7.4370 –0.0127 –0.15 0.0014 0.02 
C9 5.7381 5.7402 5.7564 –0.0021 –0.02 0.0081 0.11 
N10 7.4775 7.4346 7.5756 0.0429 0.51 0.0705 0.97 
C11 5.6769 5.6624 5.7066 0.0145 0.17 0.0221 0.30 
N12 7.3399 7.3290 7.3485 0.0109 0.13 0.0097 0.13 
C13 5.7871 5.7542 5.8783 0.0329 0.39 0.0620 0.85 
N14 7.4412 7.4430 7.4679 –0.0019 –0.02 0.0124 0.17 
C15 5.9843 5.9663 5.9786 0.0180 0.21 0.0061 0.08 
 
 
Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.1637 6.0948 6.1549 0.0689 0.76 0.0301 0.50 
C2 6.0232 6.0581 6.0308 –0.0348 –0.38 –0.0137 –0.23 
C3 6.2441 6.1856 6.2474 0.0585 0.64 0.0309 0.51 
C4 6.1726 6.1765 6.2196 –0.0038 –0.04 0.0216 0.36 
C5 6.2421 6.1511 6.2721 0.0910 1.00 0.0605 1.00 
C6 6.1629 6.1656 6.1836 –0.0027 –0.03 0.0090 0.15 
C7 5.7385 5.7581 5.8166 –0.0196 –0.21 0.0292 0.48 
N8 7.4368 7.4568 7.4301 –0.0200 –0.22 –0.0133 –0.22 
C9 5.7310 5.7313 5.7294 –0.0004 0.00 –0.0009 –0.02 
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N10 7.4731 7.4294 7.5287 0.0437 0.48 0.0497 0.82 
C11 5.6707 5.6553 5.7080 0.0154 0.17 0.0263 0.44 
N12 7.3398 7.3278 7.3472 0.0120 0.13 0.0097 0.16 
C13 5.7838 5.7497 5.8387 0.0341 0.37 0.0445 0.74 
N14 7.4391 7.4410 7.4550 –0.0019 –0.02 0.0070 0.12 
C15 5.9824 5.9612 5.9752 0.0212 0.23 0.0070 0.12 
 
 
Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.1279 6.0540 6.1656 0.0739 0.72 0.0558 0.66 
C2 5.9729 5.9563 5.9469 0.0166 0.16 –0.0047 –0.06 
C3 6.2304 6.1747 6.2549 0.0557 0.54 0.0401 0.47 
C4 6.1731 6.1703 6.1946 0.0028 0.03 0.0121 0.14 
C5 6.2163 6.1131 6.2828 0.1032 1.00 0.0849 1.00 
C6 6.1594 6.1654 6.1662 –0.0059 –0.06 0.0004 0.01 
C7 5.7453 5.7674 5.7645 –0.0221 –0.21 –0.0014 –0.02 
N8 7.3346 7.3318 7.3248 0.0028 0.03 –0.0035 –0.04 
C9 5.7253 5.7301 5.7315 –0.0048 –0.05 0.0007 0.01 
N10 7.4555 7.4069 7.5029 0.0486 0.47 0.0480 0.57 
C11 5.6742 5.6579 5.6987 0.0162 0.16 0.0204 0.24 
N12 7.3363 7.3233 7.3477 0.0130 0.13 0.0122 0.14 
C13 5.7801 5.7411 5.8196 0.0390 0.38 0.0392 0.46 
N14 7.4382 7.4369 7.4440 0.0013 0.01 0.0036 0.04 
C15 5.9711 5.9457 5.9809 0.0254 0.25 0.0176 0.21 
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Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.1406 6.0898 6.1743 0.0508 0.67 0.0423 0.65 
C2 5.9632 5.9482 5.9302 0.0150 0.20 –0.0090 –0.14 
C3 6.2408 6.2036 6.2624 0.0372 0.49 0.0294 0.45 
C4 6.1807 6.1775 6.1919 0.0032 0.04 0.0072 0.11 
C5 6.2172 6.1415 6.2723 0.0757 1.00 0.0654 1.00 
C6 6.1631 6.1666 6.1665 –0.0035 –0.05 –0.0001 0.00 
C7 5.7339 5.7563 5.7338 –0.0224 –0.30 –0.0113 –0.17 
N8 7.3894 7.4013 7.3713 –0.0119 –0.16 –0.0150 –0.23 
C9 5.6967 5.7059 5.6922 –0.0092 –0.12 –0.0069 –0.10 
N10 7.4548 7.4160 7.4922 0.0388 0.51 0.0381 0.58 
C11 5.6655 5.6555 5.6799 0.0099 0.13 0.0122 0.19 
N12 7.3367 7.3257 7.3458 0.0110 0.15 0.0101 0.15 
C13 5.7786 5.7476 5.8101 0.0310 0.41 0.0313 0.48 
N14 7.4417 7.4421 7.4418 –0.0004 –0.01 –0.0002 0.00 
C15 5.9703 5.9515 5.9803 0.0188 0.25 0.0144 0.22 
 
 
Atom δN δN–1 δN+1 fA– fA– (norm.) fA0 fA0 (norm.) 
C1 6.1226 6.0592 6.1650 0.0634 0.68 0.0529 0.66 
C2 5.9555 5.9326 5.9179 0.0229 0.25 –0.0074 –0.09 
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C3 6.2258 6.1728 6.2579 0.0530 0.57 0.0426 0.53 
C4 6.1767 6.1800 6.1882 –0.0033 –0.04 0.0041 0.05 
C5 6.2095 6.1163 6.2760 0.0932 1.00 0.0798 1.00 
C6 6.1634 6.1684 6.1663 –0.0050 –0.05 –0.0011 –0.01 
C7 5.7356 5.7633 5.7399 –0.0277 –0.30 –0.0117 –0.15 
N8 7.3752 7.3864 7.3622 –0.0112 –0.12 –0.0121 –0.15 
C9 5.7173 5.7228 5.7153 –0.0054 –0.06 –0.0037 –0.05 
N10 7.4584 7.4179 7.5021 0.0405 0.43 0.0421 0.53 
C11 5.6688 5.6565 5.6856 0.0123 0.13 0.0146 0.18 
N12 7.3382 7.3274 7.3476 0.0108 0.12 0.0101 0.13 
C13 5.7783 5.7434 5.8141 0.0348 0.37 0.0353 0.44 
N14 7.4411 7.4434 7.4412 –0.0023 –0.02 –0.0011 –0.01 
C15 5.9722 5.9465 5.9845 0.0257 0.28 0.0190 0.24 
 
6.3 Ruthenium-Catalyzed Decarboxylative C–H Activation 
6.3.1 Computational Methods 
All calculations were performed with the Gaussian 09, Revision D.01 package.[184] Geometry 
optimizations were performed at the PBE0 level of theory.[134] Ruthenium was described with a 
def2-SVP basis set[127] in combination with SDD pseudopotential,[189] while all other atoms were 
described with a def2-SVP basis set. Analytical frequency calculations were performed at the same 
level of theory to characterize all stationary points as either intermediates (no imaginary 
frequencies) or transition states (exactly one imaginary frequency). The connection of transition 
states to intermediates was confirmed by IRC calculations. The electronic energy was refined 
through single point calculations at the PBE0 level of theory[134] including D3 dispersion 
correction[126] with Becke-Johnson damping scheme. Ruthenium was described with a def2-QZVP 
basis set[127] in combination with SDD pseudopotential, hydrogen was described with def2-
QZVP(-f) basis set and all other atoms were described with def2-QZVP(-g) basis set. This basis set 
is denoted as def2-QZVP*. In the single point calculations solvent effects were taken into 
consideration through the use of the SMD continuum solvation model[135] as implemented in 
Gaussian. Unless stated otherwise, all energies are Gibbs free energies in kcal mol–1, which were 
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calculated by addition of the gas-phase Gibbs free energy contribution at 383 K and 1 atm 
(denoted as ΔΔG(383)) to the single point energies (denoted as E). 
 
6.3.2 Relative Energies in Various Solvents 
The energies for the reaction of benzoic acid (31a) with alkyne 35a were calculated with DCE (ε = 
10.125), PhMe (ε = 2.3741), TFE (ε = 26.726), and water (ε = 78.3553) as solvent. 
 
Table 20: Gibbs free energies in kcal mol–1 for the reaction of 31a with 35a relative to 5.A. 
Structure ΔG383 (DCE) ΔG383 (PhMe) ΔG383 (TFE) ΔG383 (Water) 
5.A 0.0 0.0 0.0 0.0 
TS5.1 16.6 19.6 12.5 10.5 
5.B 14.5 17.6 12.4 10.5 
TS5.2 19.3 21.9 19.2 17.3 
5.C 10.8 12.4 11.3 9.7 
5.D 3.7 6.6 3.9 0.5 
TS5.3 19.9 22.8 19.5 15.8 
5.E –5.4 –3.3 –4.8 –8.5 
TS5.4 13.9 14.5 16.9 13.6 
5.F 2.3 2.3 6.1 2.9 
5.G –9.0 –10.8 –2.3 –6.0 
TS5.5 –1.8 –3.4 4.5 0.9 
5.H –6.6 –7.6 –2.5 –6.2 
TS5.6 –3.8 –4.5 –1.5 –5.3 
5.I –12.2 –12.9 –7.8 –11.5 
5.J –1.5 –3.5 2.0 –1.2 
TS5.7 17.2 15.5 19.6 16.5 
5.K –19.0 –20.6 –17.8 –20.2 
TS5.8 17.1 19.5 17.1 13.7 
5.L –18.1 –17.4 –15.4 –19.3 
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The energies for the reaction of benzoic acid (31a) with malimide 177a were calculated with DCE 
(ε = 10.125), PhMe (ε = 2.3741), TFE (ε = 26.726), and water (ε = 78.3553) as solvent. 
 
Table 21: Gibbs free energies in kcal mol–1 for the reaction of 31a with 177a relative to 5.A. 
Structure ΔG383 (DCE) ΔG383 (PhMe) ΔG383 (TFE) ΔG383 (Water) 
5.D’ 3.7 9.1 2.2 –0.9 
5.D’’ 1.1 4.2 0.8 –1.8 
TS5.3’ 19.3 23.4 18.2 15.3 
TS5.3’’ 22.2 24.7 21.1 18.6 
5.E’ –0.6 2.7 –1.9 –4.6 
5.E’’ 0.3 2.2 –0.1 –2.7 
TS5.4’ 16.2 17.2 17.5 15.2 
5.F’ 6.6 6.6 7.3 5.3 
5.G’ –3.9 –5.7 0.2 –2.4 
TS5.5’ 3.4 2.8 6.9 3.9 
5.H’ –3.2 –3.1 –1.8 –4.9 
TS5.6’ 0.2 1.3 0.5 –2.6 
5.I’ –6.8 –7.9 –5.1 –6.8 
5.J’ 15.0 13.0 14.8 13.7 
TS5.7’ 21.0 19.9 20.2 19.0 
5.K’ –13.7 –15.2 –13.0 –14.2 
TS5.8’ 69.0 71.1 70.5 67.7 
5.L’ 24.6 26.7 25.3 22.3 
 
6.3.3 Calculated KIE Values 
The Gaussian freqchk utility was used to rerun thermochemical calculations on the optimized 
structures for 2-D-PhCO2D. KIE values were then calculated using the following equation (3): 
KIE =
𝑘H
𝑘D
= exp [ 
∆𝐺D
‡− ∆𝐺H
‡
𝑘𝐵𝑇
 ]     (3) 
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Table 22: Calculated KIE values. 
Elemental Step ΔGH‡ ΔGD‡ KIE 
5.A → TS5.1 16.58 16.64 1.082 
5.B → TS5.2 4.76 5.60 2.991 
5.D’ → TS5.3’ 15.62 15.62 0.993 
5.E’ → TS5.4’ 16.88 16.90 1.027 
5.G’→ TS5.5’ 7.34 8.39 3.973 
5.H’ → TS5.6’ 3.34 3.25 0.897 
5.J’ → TS5.7’ 5.99 6.81 2.928 
 
6.3.4 Electronic Energies and Correction Values 
Table 23: Electronic energies and correction values in Hartree. 
Structure E(DCE) E(PhMe) E(TFE) E(Water) ΔΔG(383) 
5.A –1324.140250 –1324.135296 –1324.139198 –1324.129988 0.340471 
TS5.1 –1324.114823 –1324.105113 –1324.120302 –1324.114174 0.341459 
5.B –1324.116815 –1324.107039 –1324.119224 –1324.113020 0.340197 
TS5.2 –1324.107754 –1324.098615 –1324.106825 –1324.100653 0.338725 
5.C –1324.124550 –1324.117055 –1324.122744 –1324.116030 0.341961 
5.D –1442.648623 –1442.639053 –1442.644637 –1442.632468 0.412898 
TS5.3 –1442.622817 –1442.613298 –1442.619725 –1442.608047 0.412900 
5.E –1442.664224 –1442.655966 –1442.659661 –1442.647912 0.414031 
TS5.4 –1442.631915 –1442.626019 –1442.623527 –1442.611116 0.412463 
5.F –1442.647465 –1442.642568 –1442.637690 –1442.625244 0.409485 
5.G –1674.756695 –1674.751208 –1674.747548 –1674.730188 0.507052 
TS5.5 –1674.740739 –1674.734992 –1674.732286 –1674.714689 0.502638 
5.H –1674.750890 –1674.744126 –1674.745785 –1675.728433 0.505028 
TS5.6 –1674.747796 –1674.740651 –1674.745520 –1674.728351 0.506390 
5.I –1674.760316 –1674.753270 –1674.754900 –1674.737395 0.505620 
5.J –2095.327323 –2095.320150 –2095.319671 –2095.301198 0.604973 
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TS5.7 –2095.298031 –2095.290354 –2095.292166 –2095.273482 0.605471 
5.K –2095.348376 –2095.340505 –2095.344211 –2095.324632 0.598040 
TS5.8 –1442.628996 –1442.620157 –1442.625172 –1442.612982 0.414509 
5.L –1442.691440 –1442.685374 –1442.683440 –1442.671923 0.420906 
5.D’ –1302.085811 –1302.072513 –1302.084742 –1302.083204 0.330949 
5.D’’ –1302.084298 –1302.074574 –1302.081250 –1302.078942 0.325249 
TS5.3’ –1302.058491 –1302.047284 –1302.056715 –1302.055013 0.328527 
TS5.3’’ –1302.055653 –1302.046859 –1302.053802 –1302.051448 0.330231 
5.E‘ –1302.091204 –1302.081233 –1302.089713 –1302.087636 0.329443 
5.E’’ –1302.090172 –1302.082397 –1302.087168 –1302.084965 0.329856 
TS5.4’ –1302.061867 –1302.055623 –1302.056302 –1302.053551 0.327006 
5.F’ –1302.073012 –1302.068258 –1302.068425 –1302.065180 0.322776 
5.G’ –1534.180911 –1534.175730 –1534.176130 –1534.168128 0.420308 
TS5.5’ –1534.164766 –1534.157819 –1534.160980 –1534.153567 0.415859 
5.H’ –1534.177402 –1534.169329 –1534.176961 –1534.169738 0.417963 
TS5.6’ –1534.173070 –1534.163163 –1534.174138 –1534.167054 0.418946 
5.I’ –1534.185851 –1534.179509 –1534.184753 –1534.175440 0.420628 
5.J’ –1954.739077 –1954.732241 –1954.737515 –1954.726956 0.523945 
TS5.7’ –1954.718383 –1954.710064 –1954.717674 –1954.707390 0.512801 
5.K’ –1954.775556 –1954.767932 –1954.772565 –1954.762160 0.514664 
TS5.8’ –1301.976474 –1301.968321 -1301.970488 –1301.968626 0.325617 
5.L’ –1302.049391 –1302.041377 –1302.044862 –1302.043171 0.327922 
CO2 –188.475352 –188.476577 –188.466471 –188.471946 –0.015755 
Acetate –228.467437 –228.434781 –228.484031 –228.491139 0.011227 
HOAc –228.957205 –228.955049 –228.955291 –228.957869 0.025500 
Alkyne 35a –539.066228 –539.064129 –539.059897 –539.051295 0.139615 
Alkene 177a –398.499250 –398.497411 –398.493110 –398.495725 0.053558 
Benzoate –420.073662 –420.043122 –420.085704 –420.089967 0.059398 
PhCO2H (31a) –420.557916 –420.555806 –420.554241 –420.554049 0.073175 
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Table 24: Electronic energies in Hartree without D3(BJ) correction in DCE as solvent. 
Structure E(DCE) 
5.A –1324.075031 
TS5.1 –1324.042681 
5.B –1324.044735 
TS5.2 –1324.035395 
5.C –1324.052405 
5.D –1442.553339 
TS5.3 –1442.528313 
5.E –1442.569376 
TS5.4 –1442.537732 
5.F –1442.552364 
5.G –1674.643165 
TS5.5 –1674.628079 
5.H –1674.638489 
TS5.6 –1674.634657 
5.I –1674.648406 
5.J –2095.186463 
TS5.7 –2095.156420 
5.K –2095.223212 
TS5.8 –1442.535726 
5.L –1442.593517 
5.D’ –1302.009228 
TS5.3’ –1301.982447 
5.E’ –1302.015551 
TS5.4’ –1301.986660 
5.F’ –1301.997605 
5.G’ –1534.087169 
TS5.5’ –1534.070892 
5.H’ –1534.084453 
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TS5.6’ –1534.081498 
5.I’ –1534.093462 
5.J’ –1954.617153 
TS5.7’ –1954.602613 
5.K’ –1954.669018 
TS5.8’ –1301.903319 
5.L’ –1301.976594 
CO2 –188.474581 
Acetate –228.464423 
HOAc –228.953759 
Alkyne 35a –539.042204 
Alkene 177a –398.488839 
Benzoate –420.060916 
PhCO2H (31a) –420.544653 
 
6.4 Ruthenium-Catalyzed C–H Alkenylation of Aryl Acetamides 
6.4.1 Computational Methods 
All calculations were performed with the Orca version 3.0.3 package.[186] Geometry optimizations 
were performed at the TPSS level of theory[125] including D3 dispersion correction[126] with Becke-
Johnson damping scheme. Ruthenium was described with a def2-TZVP basis set[127] in combination 
with Stuttgart-Dresden (SDD) pseudopotential,[189] while all other atoms were described with a 
def2-TZVP basis set. Numerical frequency calculations were performed at the same level of theory 
to characterize all stationary points as either intermediates (no imaginary frequencies) or 
transition states (exactly one imaginary frequency). The electronic energy was refined through 
single point calculations at the B3LYP[128], PW6B95[145] or PBE0[134] level of theory including D3(BJ) 
correction. Ruthenium was described with a def2-TZVP basis set in combination with SDD 
pseudopotential and all other atoms were described with def2-TZVP basis set. In the single point 
calculations solvent effects were taken into consideration through the use of the COSMO 
continuum solvation model[142] with a dielectric constant of ε = 2.2099, which corresponds to 1,4-
dioxane. RIJCOSX approximation was used in all calculations together with def2-TZVP/J auxiliary 
basis set.[190] In all calculations the GRID4, TightSCF, SlowConv keywords and in the geometry 
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optimizations additionally TightOPT keyword was used. Unless stated otherwise, all energies are 
Gibbs free energies in kcal mol–1, which were calculated by addition of the gas-phase thermal and 
non-thermal correction at 298 K and 1 atm (denoted as ΔΔH(298)) and entropy contribution at 
298 K and 1 atm (denoted as S(298)) to the single point energies (denoted as E). 
Bond orders correspond to Mayer bond orders at the TPSS-D3(BJ)/def2-TZVP level of theory as 
implemented in Orca. 
 
6.4.2 Electronic Energies and Correction Values 
Table 25: Electronic energies and correction values in Hartree for calculations at the B3LYP level 
of theory. 
Structure E(1,4-dioxane) ΔΔH(298) S(298) Dispersion 
6.A –1192.220650 0.471210 0.079505 –0.126830 
TS6.1 –1192.198748 0.471948 0.083377 –0.132817 
6.B –1192.202723 0.473625 0.086341 –0.136157 
TS6.2 –1192.182713 0.466945 0.082182 –0.133205 
6.C –1192.204000 0.471347 0.080652 –0.132806 
6.D –1269.566300 0.507600 0.084158 –0.147457 
6.D’ –1269.565137 0.509431 0.087951 –0.149437 
TS6.3 –1269.537908 0.507730 0.083027 –0.148115 
TS6.3’ –1269.544278 0.508041 0.086803 –0.149002 
6.E –1269.575208 0.509161 0.085560 –0.150630 
6.E’ –1269.576493 0.509264 0.084764 –0.152011 
6.F –1269.594740 0.507067 0.083282 –0.139476 
6.F’ –1269.549865 0.507043 0.083792 –0.140617 
TS6.4 –1269.560022 0.504154 0.082883 –0.139860 
TS6.4’ –1269.545720 0.504288 0.083186 –0.140883 
6.G –1269.565777 0.506833 0.086054 –0.140634 
6.G’ –1269.553465 0.506350 0.086405 –0.141610 
6.A5 –1152.911091 0.442482 0.079138 –0.117837 
6.B5 –1152.886421 0.440792 0.079425 –0.122848 
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TS6.25 –1152.881243 0.435628 0.074262 –0.123297 
6.C5 –1152.904701 0.441906 0.078963 –0.122790 
HOAc –229.081963 0.064232 0.030836 –0.006990 
Acrylate 27a –306.445470 0.100263 0.038215 –0.013845 
 
Table 26: Electronic energies and correction values in Hartree for calculations at the PW6B95 
level of theory. 
Structure E(1,4-dioxane) ΔΔH(298) S(298) Dispersion 
6.A –1194.269411 0.471210 0.079505 –0.043620 
TS6.1 –1194.245634 0.471948 0.083377 –0.045956 
6.B –1194.251280 0.473625 0.086341 –0.047042 
TS6.2 –1294.228733 0.466945 0.082182 –0.045920 
6.C –1194.250519 0.471347 0.080652 –0.045675 
6.D –1271.761212 0.507600 0.084158 –0.050852 
TS6.3 –1271.735498 0.507730 0.083027 –0.051367 
6.E –1271.773879 0.509161 0.085560 –0.052427 
6.F –1271.759862 0.507067 0.083282 –0.047582 
TS6.4 –1271.754530 0.504154 0.082883 –0.047735 
6.G –1271.758157 0.506833 0.086054 –0.047995 
6.A5 –1154.886322 0.442482 0.079138 –0.040235 
6.B5 –1154.858117 0.440792 0.079425 –0.042239 
TS6.25 –1154.852438 0.435628 0.074262 –0.042334 
6.C5 –1154.876830 0.441906 0.078963 –0.042089 
HOAc –229.454407 0.064232 0.030836 –0.001767 
Acrylate 27a –306.963192 0.100263 0.038215 –0.003774 
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Table 27: Electronic energies and correction values in Hartree for calculations at the PBE0 level 
of theory. 
Structure E(1,4-dioxane) ΔΔH(298) S(298) Dispersion 
6.A –1191.572517 0.471210 0.079505 –0.068722 
TS6.1 –1191.548034 0.471948 0.083377 –0.071964 
6.B –1191.553489 0.473625 0.086341 –0.073651 
TS6.2 –1191.538332 0.466945 0.082182 –0.071991 
6.C –1191.558868 0.471347 0.080652 –0.071637 
6.D –1268.872575 0.507600 0.084158 –0.079749 
TS6.3 –1268.848760 0.507730 0.083027 –0.080398 
6.E –1268.886796 0.509161 0.085560 –0.081835 
6.F –1268.876587 0.507067 0.083282 –0.075150 
TS6.4 –1268.871682 0.504154 0.082883 –0.075351 
6.G –1268.874343 0.506833 0.086054 –0.075737 
6.A5 –1152.285999 0.442482 0.079138 –0.063340 
6.B5 –1152.262555 0.440792 0.083377 –0.066137 
TS6.25 –1152.259888 0.435628 0.086341 –0.066320 
6.C5 –1152.282994 0.441906 0.082182 –0.065963 
HOAc –228.938403 0.064232 0.080652 –0.003433 
Acrylate 27a –306.249209 0.471210 0.084158 –0.006941 
 
6.5 Ruthenium-Catalyzed Thiocarbonyl-Directed Ferrocene C–H Arylation 
6.5.1 Computational Methods 
All calculations were performed with the Orca version 3.0.3 package.[186] Geometry optimizations 
were performed at the TPSS level of theory[125] including D3 dispersion correction[126] with Becke-
Johnson damping scheme. Ruthenium was described with a def2-TZVP basis set[127] in combination 
with Stuttgart-Dresden (SDD) pseudopotential,[189] while all other atoms were described with a 
def2-TZVP basis set. Numerical frequency calculations were performed at the same level of theory 
to characterize all stationary points as either intermediates (no imaginary frequencies) or 
transition states (exactly one imaginary frequency). The electronic energy was refined through 
single point calculations at the PW6B95 level of theory[145] including D3(BJ). Ruthenium was 
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described with a def2-TZVP basis set in combination with SDD pseudopotential and all other atoms 
were described with def2-TZVP basis set. In the single point calculations solvent effects were taken 
into consideration through the use of the COSMO continuum solvation model[142] with a dielectric 
constant of ε = 2.3741, which corresponds to toluene. RIJCOSX approximation was used in all 
calculations together with def2-TZVP/J auxiliary basis set.[190] In all calculations the GRID4, 
TightSCF, SlowConv keywords and in the geometry optimizations additionally TightOPT keyword 
was used. Unless stated otherwise, all energies are Gibbs free energies in kcal mol–1, which were 
calculated by addition of the gas-phase thermal and non-thermal correction at 298 K and 1 atm 
(denoted as ΔΔH(298)) and entropy contribution at 298 K and 1 atm (denoted as S(298)) to the 
single point energies (denoted as E). 
The prefix O-, S- and Se- corresponds to ketone, thioketone and selenoketone as directing group, 
respectively. 
 
6.5.2 Influence of Dispersion 
Table 28: Comparison of energies with and without dispersion correction relative to S-7.A in 
kcal mol–1. 
Structure ΔG298 w/ D3(BJ) ΔG298 w/o D3(BJ) 
O-7.A 8.6 7.8 
O-TS7.1 21.6 21.8 
O-7.B 19.9 20.5 
O-TS7.2 27.8 28.6 
O-7.C 17.5 18.3 
S-7.A 0.0 0.0 
S-TS7.1 10.9 11.8 
S-7.B 8.9 10.3 
S-TS7.2 14.8 16.3 
S-7.C 5.6 6.7 
Se-7.A –3.1 –2.9 
Se-TS7.1 9.5 10.8 
Se-7.B 8.7 10.5 
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Se-TS7.2 12.7 14.5 
Se-7.C 4.3 5.8 
 
6.5.3 Selected Bond Distances 
 
Table 29: Selected bond distances for ketone as directing group in Å. 
Structure dO-Ru dC=O dC-Ru 
O-7.A 2.069 1.263 3.461 
O-TS7.1 2.104 1.263 2.632 
O-7.B 2.101 1.262 2.356 
O-TS7.2 2.102 1.267 2.187 
O-7.C 2.097 1.273 2.061 
 
Table 30: Selected bond distances for thioketone as directing group in Å. 
Structure dS-Ru dC=S dC-Ru 
S-7.A 2.368 1.685 3.398 
S-TS7.1 2.373 1.676 2.644 
S-7.B 2.347 1.673 2.331 
S-TS7.2 2.350 1.682 2.197 
S-7.C 2.343 1.688 2.067 
 
Table 31: Selected bond distances for selenoketone as directing group in Å. 
Structure dSe-Ru dC=Se dC-Ru 
Se-7.A 2.498 1.844 3.433 
Se-TS7.1 2.497 1.831 2.646 
Se-7.B 2.484 1.831 2.334 
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Se-TS7.2 2.474 1.837 2.198 
Se-7.C 2.468 1.841 2.077 
 
6.5.4 Distortion-Interaction Analysis 
Transition state TS7.1 was analyzed with distortion-interaction analysis at the PW6B95-
D3(BJ)/def2-TZVP+COSMO(toluene)//TPSS-D3(BJ)/def2-TZVP level of theory.[151] The structure of 
TS7.1 was separated in two fragments: a [Ru(OAc)(p-cymene)]+ fragment and a substrate 
fragment, for which frequency and single point calculations were performed. The obtained 
energies were compared to freely optimized [Ru(OAc)(p-cymene)]+ and substrates. 
 
Table 32: Distortion and interaction energies in kcal mol–1 relative to corresponding complex 
7.A. 
X Edist(metal) Edist(substrate) Einteraction ΔE‡ 
O 22.4 5.8 –15.2 13.0 
S 22.8 6.3 –18.3 10.9 
Se 22.9 6.2 –16.5 12.6 
 
6.5.5 Electronic Energies and Correction Values 
Table 33: Electronic energies and correction values in Hartree. 
Structure E(PhMe) ΔΔH(298) S(298) Dispersion 
O-7.A –2637.134608 0.582353 0.090453 –0.058787 
O-TS7.1 –2637.111758 0.581552 0.091871 –0.060434 
O-7.B –2637.112667 0.583518 0.095505 –0.060895 
O-TS7.2 –2637.099559 0.576325 0.088907 –0.061275 
O-7.C –2637.119678 0.582806 0.091680 –0.061319 
S-7.A –2960.323367 0.581919 0.092748 –0.063026 
S-TS7.1 –2960.302065 0.580467 0.095281 –0.064517 
S-7.B –2960.305691 0.579813 0.094134 –0.065181 
S-TS7.2 –2960.293760 0.575171 0.091999 –0.065362 
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S-7.C –2960.313171 0.580870 0.092939 –0.064815 
Se-7.A –4964.433931 0.580703 0.094660 –0.064328 
Se-TS7.1 –4964.411729 0.580310 0.096397 –0.065996 
Se-7.B –4964.412920 0.578872 0.094963 –0.066830 
Se-TS7.2 –4964.403734 0.575903 0.094899 –0.066866 
Se-7.C –4964.422284 0.580154 0.093911 –0.066243 
O-156a –1923.247239 0.303270 0.059776 –0.025596 
S-156a –2246.421598 0.301153 0.061083 –0.028595 
Se-156a –4250.530244 0.299663 0.059680 –0.029530 
 
Table 34: Electronic energies and correction values in Hartree for distortion-interaction analysis. 
Structure E(PhMe) ΔΔH(298) S(298) Dispersion 
Complex –713.832500 0.277321 0.058485 –0.020992 
Ketone metal –713.795859 0.276007 0.058198 –0.021445 
Ketone substrate –1923.236776 0.302633 0.060397 –0.025540 
Thioketone metal –713.794586 0.275915 0.058676 –0.021296 
Thioketone substrate –2246.412928 0.300075 0.058581 –0.028326 
Selenoketone metal –713.794200 0.275895 0.058884 –0.021265 
Selenoketone substrate –4250.521553 0.299959 0.058788 –0.029200 
 
6.6 Ruthenium-Catalyzed C–H Alkylation on Peptides 
6.6.1 Computational Methods 
All calculations were performed with the Gaussian 16, Revision A.03 package.[185] Geometry 
optimizations were performed at the PBE0 level of theory[134] including D3 dispersion 
correction[126] with Becke-Johnson damping scheme or at the M06[157] level of theory including D3 
correction. Ruthenium was described with a def2-SVP basis set[127] in combination with SDD 
pseudopotential,[189] while all other atoms were described with a def2-SVP basis set. Analytical 
frequency calculations were performed at the same level of theory to characterize all stationary 
points as either intermediates (no imaginary frequencies) or transition states (exactly one 
imaginary frequency). The connection of transition states to intermediates was confirmed by IRC 
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calculations. The electronic energy was refined through single point calculations at the PBE0 or 
PW6B95[145] level of theory including D3(BJ) dispersion correction. Ruthenium was described with 
a def2-QZVP basis set[127] in combination with SDD pseudopotential, hydrogen was described with 
def2-QZVP(-f) basis set and all other atoms were described with def2-QZVP(-g) basis set. This basis 
set is denoted as def2-QZVP*. In the single point calculations solvent effects were taken into 
consideration through the use of the SMD continuum solvation model[135] with acetic acid (ε = 
6.2528) as implemented in Gaussian. Unless stated otherwise, all energies are Gibbs free energies 
in kcal mol–1, which were calculated by addition of the gas-phase Gibbs free energy contribution 
at 353 K and 1 atm (denoted as ΔΔG(353)) to the single point energies (denoted as E). 
Superscripts correspond to the arene-ligand. If no superscript is given, p-cymene is implied as the 
arene-ligand. 
Wiberg bond order analysis was performed at the PW6B95-D3(BJ)/def2-TZVP//M06-D3/def2-SVP 
level of theory employing NBO 6 software.[192] 
 
6.6.2 Wiberg Bond Order Analysis 
Table 35: Wiberg bond order analysis for C–H ruthenation with unsubstituted, methyl-
substituted and trifluoromethyl-substituted pyridyl indole 125a. 
Structure C–H bond order Ru–C bond order 
8.A 0.9047 0.0041 
TS8.1 0.8728 0.1273 
8.B 0.8653 0.2494 
TS8.2 0.5086 0.4231 
8.C 0.0344 0.6986 
8.B (Me) 0.8640 0.2567 
TS8.2 (Me) 0.5061 0.4295 
8.C (Me) 0.0335 0.6996 
8.B (CF3) 0.8689 0.2310 
TS8.2 (CF3) 0.5137 0.4079 
8.C (CF3) 0.0330 0.6970 
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6.6.3 Electronic Energies and Correction Values 
Table 36: Electronic energies and correction values in Hartree at the PBE0-D3(BJ)/def2-
QZVP*+SMD(HOAc)//PBE0-D3(BJ)/def2-SVP level of theory. 
Structure E(HOAc) ΔΔG(353) 
8.A –1322.919154 0.396571 
TS8.1 –1322.898926 0.393381 
8.B –1322.902812 0.394631 
8.C –1322.921971 0.395220 
8.D –1400.244897 0.428333 
TS8.3 –1400.225382 0.429702 
8.E –1400.248995 0.432568 
8.F –1629.209186 0.487612 
TS8.4 –1629.183552 0.483402 
8.G –1629.201819 0.485205 
8.H –1629.232680 0.484414 
8.Abenzene –1165.763414 0.293233 
TS8.1benzene –1165.743738 0.291709 
8.Bbenzene –1165.748628 0.291483 
8.Cbenzene –1165.767420 0.291483 
8.Dbenzene –1243.089690 0.325409 
TS8.3benzene –1243.071195 0.327083 
8.Ebenzene –1243.095101 0.329739 
8.Fbenzene –1472.052792 0.384520 
TS8.4benzene –1472.030998 0.379853 
8.Gbenzene –1472.048548 0.382223 
8.Hbenzene –1472.077144 0.381587 
8.At-Bubenzene –1322.908834 0.398323 
TS8.1t-Bubenzene –1322.888185 0.397227 
8.Bt-Bubenzene –1322.893220 0.395954 
8.Ct-Bubenzene –1322.912188 0.397145 
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8.Dt-Bubenzene –1400.235611 0.430170 
TS8.3t-Bubenzene –1400.216070 0.428204 
8.Et-Bubenzene –1400.238856 0.434368 
8.Ft-Bubenzene –1629.196825 0.489014 
TS8.4t-Bubenzene –1629.175555 0.484630 
8.Gt-Bubenzene –1629.194335 0.486437 
8.Ht-Bubenzene –1629.222437 0.486591 
HOAc –228.952262 0.029151 
Acetate –228.467675 0.014592 
Acrylate 27a –306.263685 0.058388 
p-Cymene –389.215198 0.166011 
Benzene –232.072172 0.067643 
t-Bubenzene –389.210794 0.170727 
Indole 125a –610.478575 0.154933 
[Ru(OAc)2(p-cymene)] (79) –940.928367 0.254300 
 
Table 37: Electronic energies and correction values in Hartree at the PW6B95-D3(BJ)/def2-
QZVP*+SMD(HOAc)//M06-D3/def2-SVP level of theory. 
Structure E(HOAc) ΔΔG(353) 
8.A –1325.968745 0.389382 
TS8.1 –1325.948371 0.389554 
8.B –1325.951899 0.388463 
TS8.2 –1325.941160 0.385173 
8.C –1325.963398 0.385144 
8.D –1403.482404 0.423396 
TS8.3 –1403.462204 0.423437 
8.E –1403.486541 0.426426 
8.F –1632.962863 0.480600 
TS8.4 –1632.936304 0.475273 
8.G –1632.965014 0.479009 
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8.H –1632.988615 0.478226 
HOAc –229.469374 0.028749 
Acrylate 27a –306.978933 0.057218 
 
6.7 Ruthenium-Catalyzed Oxidative C–H/C–H Activation 
6.7.1 Computational Methods 
All calculations were performed with the Orca version 4.0.1 package.[187] Geometry optimizations 
were performed at the TPSS[125] level of theory including D3 dispersion correction[126] with Becke-
Johnson damping scheme. Ruthenium was described with a def2-TZVP basis set[127] in combination 
with Stuttgart-Dresden (SDD) pseudopotential,[189] while all other atoms were described with a 
def2-TZVP basis set. Numerical frequency calculations were performed at the same level of theory 
to characterize all stationary points as either intermediates (no imaginary frequencies) or 
transition states (exactly one imaginary frequency). The electronic energy was refined through 
single point calculations at the PBE0[134] level of theory including D3(BJ). Ruthenium was described 
with a def2-TZVP basis set[127] in combination with SDD pseudopotential and all other atoms were 
described with def2-TZVP basis set. In the single point calculations solvent effects were taken into 
consideration through the use of the SMD solvation model[135] for MeCN as implemented in Orca. 
RIJCOSX approximation was used in all calculations together with def2-TZVP/J auxiliary basis 
set.[190] In all calculations the GRID4, TightSCF, SlowConv keywords and in the geometry 
optimizations additionally TightOPT keyword was used. Unless stated otherwise, all energies are 
Gibbs free energies in kcal mol–1, which were calculated by addition of the gas-phase thermal and 
non-thermal correction at 298 K and 1 atm (denoted as ΔΔH(298)) and entropy contribution at 
298 K and 1 atm (denoted as S(298)) to the single point energies (denoted as E). 
Bond order analysis was performed with NBO 5.9 software using Wiberg bond orders in the NAO 
basis employing electron densities generated with Orca at the PBE0-D3(BJ)/def2-TZVP level of 
theory.[193] 
Superscripts correspond to the spin state of the structure (1 = singlet; 3 = triplet; 5 = quintet). If 
no superscript is given, a singlet spin state is implied. 
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Scheme 100: Comparison of biscyclometalated complexes 9.E*. 
 
6.7.2 Comparison of Spin States 
Table 38: Gibbs free energies in kcal mol–1 for different spin states relative to 9.A1. 
Structure ΔG298 (singlet) ΔG298 (triplet) ΔG298 (quintet) 
9.A 0.0 8.1 37.5 
9.Acis 0.5 -- -- 
9.E’’ –7.6 31.2 44.8 
9.F’ –2.0 31.7 --[a] 
9.G 4.1 30.0 64.6 
9.H –16.4 3.6 44.7 
9.I –25.9 –5.3 27.9 
9.I’ –34.0 –15.4 21.1 
9.J –34.5 –19.6 17.2 
9.J’ –39.3 –18.2 12.1 
9.K 36.3 --[a] 54.3 
[a] No convergence was achieved employing this spin state. 
 
6.7.3 Influence of Dispersion 
Table 39: Comparison of relative Gibbs free energies in kcal mol–1 with and without dispersion 
correction. All energies are relative to intermediate 9.A. 
Structure ΔG298 w/ D3(BJ) ΔG298 w/o D3(BJ) 
9.A 0.0 0.0 
TS9.1 10.4 10.4 
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9.B 4.3 4.1 
TS9.2 10.1 10.4 
9.C 6.5 7.3 
9.C’ –4.5 –5.1 
TS9.3 16.9 18.9 
TS9.3’ 4.3 4.8 
9.D 3.5 4.8 
9.D’ –4.6 –5.0 
TS9.4 4.7 5.9 
TS9.4’ –1.0 –1.4 
9.E –0.6 0.1 
9.E’ –4.8 –5.8 
9.F 1.6 9.3 
9.F’ –2.0 3.8 
9.G 4.1 6.8 
9.G’ 1.1 5.3 
TS9.5 19.8 22.3 
TS9.5’ 16.0 20.7 
9.H –16.4 –14.7 
9.H’ –16.7 –12.9 
TS9.6 –5.8 –3.4 
TS9.6’ –11.4 –7.2 
9.I –25.9 –21.9 
9.I’ –34.0 –28.3 
TS9.7 –9.7 –7.8 
TS9.7’ –5.7 –1.4 
9.J –34.5 –30.1 
9.J’ –39.3 –33.8 
TS9.8 41.2 40.1 
9.K 36.3 38.7 
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6.7.4 Wiberg Bond Order Analysis 
Table 40: Wiberg bond order analysis for C–H ruthenation steps. 
Structure C–H bond order Ru–C bond order O–H bond order 
9.A 0.9100, 0.9051[a] 0.0028, 0.0049[a] 0.0019, 0.0028[a] 
TS9.1 0.8590 0.0673 0.0107 
9.B 0.6150 0.3947 0.0456 
TS9.2 0.2861 0.6310 0.3406 
9.C 0.8875, 0.0451[a] 0.0040, 0.8544[a] 0.0112, 0.6250[a] 
TS9.3 0.8452 0.0523 0.0201 
9.D 0.5708 0.3958 0.0668 
TS9.4 0.3347 0.5524 0.2610 
9.E 0.0522 0.7449 0.6196 
[a] Values correspond to the bond order for both coordinated phenylpyridines. 
 
6.7.5 Electronic Energies and Correction Values 
Table 41: Electronic energies and correction values in Hartree. 
Structure E(MeCN) ΔΔH(298) S(298) Dispersion 
9.A –1588.218616 0.527699 0.096206 –0.094209 
9.A3 –1588.201636 0.527505 0.100046 –0.097622 
9.A5 –1588.151503 0.525865 0.101783 –0.098207 
9.Acis –1588.219358 0.528226 0.095170 –0.094210 
TS9.1 –1588.203283 0.526794 0.094118 –0.094280 
9.B –1588.211608 0.526594 0.095186 –0.093732 
TS9.2 –1588.199588 0.522062 0.093560 –0.094813 
9.C –1588.209294 0.527143 0.094660 –0.095464 
9.C’ –1491.935965 0.511054 0.093305 –0.092134 
TS9.3 –1588.192601 0.525589 0.093242 –0.097417 
TS9.3’ –1491.921833 0.509757 0.092110 –0.093820 
9.D –1588.213037 0.525381 0.093895 –0.096201 
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9.D’ –1491.934866 0.509518 0.093098 –0.092478 
TS9.4 –1588.207307 0.521071 0.093401 –0.096106 
TS9.4’ –1491.925437 0.504574 0.091728 –0.092434 
9.E –1588.220165 0.526647 0.094548 –0.095246 
9.E’ –1491.935224 0.509729 0.093289 –0.091521 
9.E’’ –1395.648796 0.493807 0.092126 –0.087128 
9.E’’ 3 –1395.581008 0.490759 0.094995 –0.087175 
9.E’’ 5 –1395.557514 0.490508 0.096556 –0.090463 
9.E*1 –1317.092070 0.435078 0.086548 –0.078643 
9.E*2 –1317.090279 0.435151 0.086357 –0.078385 
9.E*3 –1317.065071 0.435561 0.086517 –0.077586 
9.E*4 –1317.074268 0.435474 0.086995 –0.077288 
9.F –4164.599618 0.556395 0.098787 –0.114715 
9.F’ –4068.314736 0.540339 0.097257 –0.110544 
9.F’ 3 –4068.256026 0.538010 0.099903 –0.109692 
9.G –3935.630368 0.489209 0.086979 –0.103336 
9.G3 –3935.585951 0.487860 0.088700 –0.103694 
9.G5 –3935.527206 0.486438 0.090995 –0.100703 
9.G’ –4027.804899 0.489517 0.090405 –0.108676 
TS9.5 –3935.605218 0.487705 0.085529 –0.102956 
TS9.5’ –4027.781124 0.487992 0.088843 –0.109373 
9.H –3935.664269 0.489902 0.086357 –0.101731 
9.H3 –3935.628620 0.488962 0.089321 –0.099376 
9.H5 –3935.559560 0.488377 0.092190 –0.099357 
9.H’ –4027.835916 0.490865 0.089050 –0.107972 
TS9.6 –3935.648268 0.488348 0.084015 –0.102905 
TS9.6’ –4027.827156 0.488803 0.087361 –0.108668 
9.I –3935.679119 0.489664 0.086405 –0.105373 
9.I3 –3935.643063 0.488695 0.088732 –0.103780 
9.I5 –3935.587087 0.487428 0.090501 –0.108368 
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9.I’ –4027.862125 0.490172 0.089799 –0.111075 
9.I’ 3 –4027.828189 0.489574 0.093401 –0.109524 
9.I’ 5 –4027.763665 0.487824 0.093210 –0.108420 
TS9.7 –3935.654172 0.488528 0.084525 –0.102144 
TS9.7’ –4027.818709 0.489648 0.087584 –0.108772 
9.J –3935.693517 0.490154 0.086198 –0.105959 
9.J3 –3935.668053 0.490584 0.088397 –0.107345 
9.J5 –3935.604375 0.488114 0.090947 –0.107512 
9.J’ –4027.870238 0.490265 0.090134 –0.110614 
9.J’ 3 –4027.832820 0.489744 0.093401 –0.106839 
9.J’ 5 –4027.782206 0.488448 0.094485 –0.112568 
TS9.8 –1395.569659 0.490915 0.090596 –0.090170 
9.K –1395.579997 0.493294 0.090469 –0.095850 
9.K5 –1395.544096 0.488615 0.093003 –0.095754 
MeCN –132.654365 0.048221 0.028637 –0.002319 
HOAc –228.943471 0.065121 0.032509 –0.003437 
PhBr (46e) –2805.325865 0.094683 0.037115 –0.011683 
2-CN-C6H4Br (46k) –2897.493981 0.094894 0.042087 –0.014632 
 
6.8 Manganese-Catalyzed C–H Allylation on Peptides 
6.8.1 Computational Methods 
All calculations were performed with the Orca version 3.0.3 package.[186] Geometry optimizations 
were performed at the TPSS[125] level of theory including D3 dispersion correction[126] with Becke-
Johnson damping scheme. Manganese was described with a def2-TZVP basis set[127] in 
combination with Stuttgart-Dresden (SDD) pseudopotential,[189] while all other atoms were 
described with a def2-TZVP basis set. Numerical frequency calculations were performed at the 
same level of theory to characterize all stationary points as either intermediates (no imaginary 
frequencies) or transition states (exactly one imaginary frequency). The electronic energy was 
refined through single point calculations at the PW6B95[145] level of theory including D3(BJ). All 
atoms were described with a def2-QZVP basis set.[127] In the single point calculations solvent 
effects were taken into consideration through the use of the COSMO continuum solvation 
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model[142] with a dielectric constant of ε = 2.2099, which corresponds to 1,4-dioxane. RIJCOSX 
approximation was used in all calculations together with def2-TZVP/J or def2-QZVP/J auxiliary 
basis set.[190] In all calculations the GRID4, TightSCF, SlowConv keywords and in the geometry 
optimizations additionally TightOPT keyword was used. Unless stated otherwise, all energies are 
Gibbs free energies in kcal mol–1, which were calculated by addition of the gas-phase thermal and 
non-thermal correction at 298 K and 1 atm (denoted as ΔΔH(298)) and entropy contribution at 
298 K and 1 atm (denoted as S(298)) to the single point energies (denoted as E). 
 
6.8.2 Electronic Energies and Correction Values 
Table 42: Electronic energies and correction values in Hartree. 
Structure E(1,4-dioxane) ΔΔH(298) S(298) Dispersion 
10.A –2871.829322 0.498143 0.095489 –0.055376 
TS10.1 –2871.815161 0.497346 0.094357 –0.054894 
10.B –2871.842524 0.499360 0.097465 –0.056811 
10.C –2871.847688 0.501311 0.098134 –0.060350 
TS10.2 –2871.826529 0.497088 0.096429 –0.061325 
10.D –2871.853554 0.499092 0.098166 –0.060475 
10.E –2678.361683 0.407793 0.090899 –0.052414 
HOAc –229.470747 0.065125 0.032254 –0.001769 
HOCO2t-Bu –422.967631 0.157755 0.043218 –0.007221 
 
6.9 Manganese-Catalyzed C–C Allylation 
6.9.1 Computational Methods 
All calculations were performed with the Gaussian 09, Revision D.01 package.[184] Geometry 
optimizations were performed at the PBE0[134] level of theory including D3 dispersion 
correction[126] with Becke-Johnson damping scheme. Manganese was described with a def2-SVP 
basis set[127] in combination with SDD pseudopotential,[189] while all other atoms were described 
with a def2-SVP basis set. Analytical frequency calculations were performed at the same level of 
theory to characterize all stationary points as either intermediates (no imaginary frequencies) or 
transition states (exactly one imaginary frequency). The connection of transition states to 
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intermediates was confirmed by IRC calculations. The electronic energy was refined through single 
point calculations at the PBE0 level of theory including D3(BJ) dispersion correction. Manganese 
was described with a def2-QZVP basis set,[127] while hydrogen was described with def2-QZVP(-f) 
basis set and a def2-QZVP(-g) basis set was used for all other atoms. In all calculations solvent 
effects were taken into consideration through the use of the SMD continuum solvation model[135] 
with water (ε = 78.3553) as implemented in Gaussian. Unless stated otherwise, all energies are 
Gibbs free energies in kcal mol–1, which were calculated by addition of the gas-phase Gibbs free 
energy contribution at 393 K and 1 atm (denoted as ΔΔG(393)) to the single point energies 
(denoted as E). Previously reported structures were employed as initial geometries for the 
optimization of (H2O)5[194] and HBr∙(H2O)5 cluster.[165] 
Superscripts correspond to the spin state of the structure (1 = singlet; 3 = triplet; 5 = quintet). If 
no superscript is given, a singlet spin state is implied. 
 
6.9.2 Comparison of Spin States 
Table 43: Gibbs free energies in kcal mol–1 for different spin states relative to 11.A1. 
Structure ΔG393 (singlet) ΔG393 (triplet) ΔG393 (quintet) 
11.A 0.0 26.3 --[a] 
11.B 5.9 17.8 17.0 
TS11.1 25.5 48.9 --[a] 
11.C –1.0 17.5 30.3 
11.D –1.7 15.8 29.3 
TS11.2 12.3 45.0 54.2 
11.E –4.5 3.8 11.8 
11.F 10.5 6.0 11.7 
TS11.3 15.3 19.7 13.8 
11.G –15.5 –6.8 –16.3 
11.H –12.6 –4.6 –15.6 
11.I –10.1 2.1 –8.7 
[a] Structure could not be located with a quintet spin state. 
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6.9.3 Electronic Energies and Correction Values 
Table 44: Electronic energies and correction values in Hartree. 
Structure E(Water) ΔΔG(393) 
11.A –2253.284060 0.190844 
11.A3 –2253.230136 0.179862 
11.B –2140.020217 0.185627 
11.B3 –2139.994038 0.179538 
11.B5 –2139.984952 0.169204 
TS11.1 –2139.991768 0.188401 
TS11.13 –2139.939079 0.174160 
11.C –2140.023726 0.178087 
11.C3 –2139.984015 0.168997 
11.C5 –2139.954001 0.159374 
11.D –2366.546883 0.203054 
11.D3 –2366.500882 0.186023 
11.D5 –2366.474591 0.181227 
TS11.2 –2366.526776 0.205190 
TS11.23 –2366.459891 0.191472 
TS11.25 –2366.437271 0.183628 
11.E –2366.551899 0.203560 
11.E3 –2366.534132 0.200132 
11.E5 –2366.509585 0.188305 
11.F –2366.530278 0.205763 
11.F3 –2366.529009 0.198401 
11.F5 –2366.507104 0.185717 
TS11.3 –2366.520966 0.204125 
TS11.33 –2366.505098 0.196393 
TS11.35 –2366.502393 0.184227 
11.G –2366.570800 0.204968 
11.G3 –2366.547295 0.196372 
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11.G5 –2366.553561 0.187533 
11.H –2366.562047 0.200881 
11.H3 –2366.541586 0.194150 
11.H5 –2366.549775 0.184862 
11.I –2178.060347 0.191866 
11.I3 –2178.031224 0.183199 
11.I5 –2178.040029 0.174893 
CO –113.227997 –0.021251 
Acetone –193.027356 0.044006 
142a –649.964819 0.184960 
Carbonate 163a –419.544482 0.063934 
CO2 –188.471938 –0.016861 
[MnBr(CO)5] –4291.132370 –0.015749 
HBr –2574.512774 –0.020466 
HBr∙(H2O)5 –2956.568422 0.075871 
(H2O)5 –382.019841 0.072041 
 
Table 45: Electronic energies and correction values in Hartree w/o SMD model in the 
optimizations. 
Structure E(Water) E(DCE) ΔΔG(393) 
11.A –2253.282382 –2253.297944 0.190245 
11.A3 –2253.227919 -- 0.178893 
11.A5 –2253.211784 -- 0.166386 
11.B –2140.018235 –2140.029970 0.183553 
11.B3 –2139.992170 -- 0.178089 
11.B5 –2139.981798 -- 0.167714 
TS11.1 –2139.990519 –2140.004684 0.188252 
TS11.13 –2139.933537 -- 0.174293 
TS11.15 –2139.928479 -- 0.163027 
11.C –2140.022531 –2140.040512 0.180853 
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11.C3 –2139.977717 -- 0.167004 
11.C5 –2139.944362 -- 0.156045 
11.D –2366.544867 –2366.559636 0.204038 
11.D3 –2366.497844 -- 0.186393 
11.D5 –2366.464943 -- 0.174325 
TS11.2 –2366.524040 –2366.538504 0.204755 
TS11.23 –2366.457672 -- 0.191281 
TS11.25 –2366.431715 -- 0.179364 
11.E –2366.549183 –2366.563818 0.203767 
11.E3 –2366.530314 -- 0.199354 
11.E5 –2366.506394 -- 0.188628 
11.F –2366.528587 –2366.543745 0.205569 
11.F3 –2366.526659 -- 0.197121 
11.F5 –2366.505115 -- 0.187232 
TS11.3 –2366.519548 –2366.532664 0.204276 
TS11.33 –2366.500849 -- 0.196097 
TS11.35 –2366.486594 -- 0.185373 
11.G –2366.566180 –2366.575253 0.205513 
11.G3 –2366.542789 -- 0.194733 
11.G5 –2366.545270 -- 0.183950 
11.H –2366.551149 –2366.562264 0.201041 
11.H3 –2366.533064 -- 0.189846 
11.H5 –2366.543783 -- 0.184266 
TS11.4 –2366.538969 –2366.554971 0.198142 
TS11.43 –2366.512995 -- 0.187615 
TS11.45 –2366.519518 -- 0.179225 
11.I’ –2366.537994 –2366.554372 0.194598 
11.I’3 –2366.513729 -- 0.184045 
11.I’5 –2366.517842 -- 0.175333 
11.I –2178.057804 –2178.069431 0.192056 
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CO –113.227991 –113.231316 –0.021226 
Acetone –193.026822 –193.028946 0.043844 
142a –649.964138 –649.971816 0.184774 
Carbonate 163a –419.543171 –419.545496 0.063906 
CO2 –188.471946 –188.475353 –0.016608 
[MnBr(CO)5] –4291.130985 –4291.142604 –0.014531 
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